Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992834-94121148 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Age-related macular degeneration, Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "choroid plexus: 144.6;retina: 461.0" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 450.4;Rod photoreceptor cells: 482.9" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in some" 6 "hippocampal formation: 9.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.1;EFO-21: 6.8;HeLa: 2.3;SK-BR-3: 3.0;SuSa: 3.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA064420, HPA078826" Enhanced Approved Cytosol NA NA "Cluster 79: Retina - Phototransduction" "Cluster 38: EFO-21 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "HPA064420: , HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.72e-4)" 0.5 0.0 0.4 0.1 0.3 0.0 0.8 1.1 0.7 0.5 144.6 0.2 2.5 0.1 8.4 0.2 0.4 0.1 0.2 9.3 0.1 8.7 0.9 0.3 0.4 0.4 0.5 0.2 0.0 0.0 0.1 0.6 0.2 0.2 0.1 461.0 0.0 1.4 0.1 2.1 2.9 0.0 0.1 0.1 0.1 1.0 1.4 0.3 0.4 0.0 0.1 0.2 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 6.8 0.3 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.4 2.3 0.7 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.9 0.5 0.0 1.2 0.0 0.1 0.1 0.2 0.2 0.3 0.3 0.0 0.0 0.6 3.0 0.1 3.1 0.3 0.0 0.1 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 0.7 9.3 0.1 0.4 0.5 0.2 0.1 1.4 0.4 1.2 0.0 1.1 1.3 0.0 0.1 0.2 1.7 0.0 27.9 0.5 1.3 1.1 0.0 1.8 7.3 450.4 0.3 0.0 0.0 0.0 0.0 8.8 0.3 0.1 3.1 0.0 0.0 0.4 0.0 1.5 0.2 0.0 0.9 0.0 0.2 1.4 0.3 0.1 10.1 0.6 16.2 0.0 0.3 0.0 21.9 0.0 0.0 0.0 19.7 0.0 37.3 0.0 0.5 0.0 0.0 0.0 0.4 0.0 2.6 1.3 0.4 2.3 482.9 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.3 0.0 0.3 0.6 0.7 ABCC1 "GS-X, MRP, MRP1" ENSG00000103222 "ATP binding cassette subfamily C member 1" P33527 16 15949138-16143257 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport "Hydrolase, Translocase" "Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 79.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002380, HPA076011" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "Cell Junctions" "HPA002380: AB_1844432, HPA076011: " "unprognostic (9.97e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.42e-1)" "unprognostic (3.31e-1)" "unprognostic (4.07e-2)" "unprognostic (9.78e-3)" "unprognostic (7.19e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-2)" 10.4 11.6 0.3 4.0 0.2 3.6 8.6 0.3 0.7 10.4 4.1 16.1 1.1 11.0 0.1 22.8 7.0 3.1 11.2 0.3 0.5 8.0 2.3 15.5 4.4 1.1 0.8 8.9 8.9 3.6 7.2 2.0 0.7 15.2 0.7 0.4 9.2 0.9 21.2 9.7 12.4 6.3 0.5 15.7 15.0 13.1 0.6 4.3 21.0 0.1 1.1 15.4 12.8 0.9 4.3 43.7 0.3 11.7 3.2 4.5 0.5 15.4 19.0 13.1 13.8 6.7 34.8 7.0 79.6 29.6 11.0 12.1 3.4 12.4 4.6 22.2 4.4 16.4 22.0 16.3 25.1 5.9 39.5 15.0 9.0 1.1 2.3 3.8 10.2 28.6 17.8 6.8 0.5 5.4 12.0 0.9 3.5 1.8 8.2 41.9 7.8 5.3 0.7 15.2 6.4 11.8 18.9 17.8 3.6 11.9 6.2 0.8 3.5 0.4 2.0 11.4 11.9 13.5 7.4 3.3 6.6 0.6 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.7 0.3 0.5 1.1 0.8 0.7 0.5 0.6 0.9 8.6 25.6 5.6 10.7 13.1 8.8 8.5 18.2 9.6 3.1 4.4 3.7 6.0 4.3 14.4 5.5 22.9 0.9 9.8 2.7 3.9 9.1 11.0 15.7 12.9 8.6 18.6 16.0 26.6 6.2 3.2 12.3 49.5 17.8 22.1 16.8 8.6 0.4 8.5 5.0 38.5 6.6 14.2 21.4 9.1 14.3 7.5 12.2 3.6 11.2 10.5 1.2 5.2 12.1 15.9 11.2 4.5 6.8 15.7 18.7 0.5 1.1 9.9 8.8 0.0 6.4 5.1 4.9 6.6 18.1 5.1 0.5 17.4 37.1 3.7 11.6 ABCD1 "adrenoleukodystrophy, ALD, ALDP, AMN" ENSG00000101986 "ATP binding cassette subfamily D member 1" P33897 X 153724856-153744755 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Translocase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 19.5;Proximal enterocytes: 39.2;Syncytiotrophoblasts: 27.4" "Cancer enhanced" "Detected in all" "melanoma: 36.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 69.7;PC-3: 50.0;SK-BR-3: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035214 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 45: Enterocytes - Digestion" "HPA035214: " "unprognostic (1.90e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-3)" "unprognostic (5.57e-3)" "unprognostic (8.81e-3)" "unprognostic (1.54e-1)" "unprognostic (3.37e-3)" "unprognostic (1.34e-1)" "unprognostic (6.14e-3)" "unprognostic (3.40e-2)" "unprognostic (1.41e-1)" "unprognostic (6.17e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (4.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.57e-1)" "unprognostic (4.23e-2)" 14.6 33.3 3.1 5.4 3.9 4.7 12.5 3.4 3.8 7.5 2.2 14.7 10.6 33.2 1.7 3.7 9.3 3.4 11.9 2.9 3.4 7.0 13.3 7.6 3.9 4.4 3.6 5.4 11.9 2.1 10.0 4.7 4.8 9.9 1.8 0.5 6.2 5.6 20.5 4.4 17.4 4.8 3.1 13.8 7.2 19.0 5.5 4.3 6.0 4.6 1.7 11.9 6.1 4.2 13.2 4.0 2.6 11.2 7.4 3.2 34.3 6.3 6.8 4.2 7.4 2.6 7.1 3.5 69.7 8.6 11.3 1.7 1.6 1.4 0.5 11.8 2.1 10.3 42.1 34.1 9.8 6.4 22.4 6.2 1.7 4.8 0.4 4.4 6.7 4.7 6.0 12.4 5.9 4.7 4.5 6.1 3.3 3.2 50.0 7.8 6.2 5.7 3.2 1.4 2.8 11.5 16.4 49.2 26.4 3.0 3.7 10.8 7.9 5.5 7.4 14.3 7.0 12.2 5.7 8.4 6.9 21.7 7.8 0.4 3.2 2.5 0.8 3.0 4.0 1.0 1.0 1.2 2.7 0.7 1.1 0.8 1.7 0.7 2.8 1.7 0.3 2.5 3.1 3.9 3.4 3.8 2.9 3.4 4.4 3.6 4.8 3.1 5.5 4.2 5.0 0.0 1.1 3.6 3.8 3.2 1.6 1.6 0.6 2.2 2.7 2.8 2.4 2.8 2.2 3.7 2.1 12.2 4.8 9.5 0.0 3.8 0.7 2.0 3.5 3.4 6.0 3.6 0.5 6.9 19.5 4.5 3.6 4.0 0.0 6.9 5.7 6.8 12.6 8.4 0.9 5.0 2.0 15.9 8.4 2.7 4.1 12.3 1.8 0.0 5.9 2.4 0.0 0.0 1.2 5.0 2.1 5.7 2.4 0.8 39.2 2.8 1.2 0.7 6.6 2.3 2.8 3.8 4.8 0.8 1.3 27.4 4.0 7.8 5.5 1.4 AC002996.1 ENSG00000257767 "Novel protein" 12 111753890-111791418 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 64.3;brain: 46.2;skeletal muscle: 37.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 88.5;myeloid DC: 88.0" "Group enriched" "Detected in many" 5 "dendritic cells: 88.0;monocytes: 88.5" "Cell line enhanced" "Detected in many" "BEWO: 9.1;EFO-21: 17.4;SK-BR-3: 8.7" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "unprognostic (4.89e-1)" "unprognostic (1.20e-1)" 64.3 16.5 24.4 2.9 25.1 0.3 6.5 23.2 18.0 4.1 6.5 11.7 9.7 7.5 0.0 5.8 7.2 0.1 14.1 15.2 25.4 7.7 24.0 9.9 0.7 31.1 34.5 5.3 1.4 0.0 2.4 0.8 25.0 1.8 0.2 1.6 5.7 1.6 37.8 5.4 6.5 0.0 33.7 1.9 17.7 1.3 46.2 0.1 3.6 0.0 0.2 7.6 4.2 39.4 3.5 0.0 0.0 0.9 0.0 1.4 9.1 1.0 4.2 1.6 0.8 0.0 2.0 0.0 17.4 1.9 1.5 3.2 0.0 0.7 0.1 0.5 0.4 0.0 2.6 0.0 0.0 0.4 0.0 0.0 1.9 1.9 0.0 0.0 4.5 0.0 1.6 0.2 0.7 0.0 0.0 0.7 5.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.6 4.7 0.0 8.7 0.1 0.1 6.3 3.4 0.0 0.0 2.0 0.3 0.0 1.3 2.1 5.4 2.5 0.1 0.0 2.1 88.5 18.7 0.3 38.6 0.7 3.2 0.0 0.2 88.0 1.1 0.2 0.1 3.7 1.0 13.0 23.7 0.4 53.5 24.4 25.1 23.2 18.0 15.2 25.4 31.1 34.5 25.0 33.7 46.2 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTBL2 DKFZp686D0972 ENSG00000169067 "Actin beta like 2" Q562R1 5 57480018-57482811 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.1;Club cells: 1.0;Ductal cells: 1.7;Early spermatids: 2.4;Exocrine glandular cells: 1.1;Pancreatic endocrine cells: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 1.3;RPTEC TERT1: 1.6;SiHa: 2.9;U-2 OS: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041264, HPA041271" Uncertain NA NA 830000000 "Cluster 38: EFO-21 - Unknown function" "Cluster 10: Non-specific - Unknown function" "HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (7.83e-2)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (8.66e-2)" "unprognostic (2.57e-2)" "unprognostic (2.39e-1)" "unprognostic (3.63e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-3)" "unprognostic (3.20e-1)" "unprognostic (2.48e-3)" "unprognostic (1.60e-2)" "unprognostic (2.04e-2)" "unprognostic (1.92e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.3 1.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 2.4 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654088-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 141.1;Alveolar cells type 2: 111.8;Astrocytes: 86.5;Club cells: 61.7;granulocytes: 63.1;Inhibitory neurons: 91.6;Oligodendrocytes: 75.2;Respiratory ciliated cells: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 12.1;hTERT-RPE1: 3.6;RPTEC TERT1: 14.0;TIME: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034773, HPA034774" Uncertain Uncertain Vesicles "Secreted in other tissues" NA NA 270000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA034773: AB_10601965, HPA034774: AB_2674326" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.3 4.2 1.1 1.0 1.7 0.0 1.7 1.4 1.0 3.1 4.4 10.6 1.4 6.9 1.5 3.3 4.4 1.1 10.7 1.1 1.1 3.3 10.4 7.4 1.1 1.4 1.5 1.2 7.3 0.8 1.4 10.4 1.7 6.6 3.2 0.3 2.4 7.1 2.6 1.4 1.8 4.7 1.5 1.9 4.6 2.7 1.1 1.0 2.6 4.8 0.5 5.2 2.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 14.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.0 13.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.7 1.4 1.0 1.1 1.1 1.4 1.5 1.7 1.5 1.1 3.0 8.7 141.1 111.8 86.5 0.1 7.0 5.2 1.7 0.6 0.2 0.2 0.3 9.4 0.0 61.7 1.8 0.0 0.1 0.8 0.0 0.0 0.5 14.9 0.6 0.4 10.6 0.0 0.0 31.3 2.4 0.2 29.0 1.5 1.2 63.1 0.1 1.1 10.2 0.2 6.7 91.6 0.0 0.0 0.6 0.5 16.9 49.4 5.9 0.0 5.6 0.0 0.1 1.0 4.5 75.2 1.0 0.0 17.0 0.4 2.4 0.0 0.6 56.4 0.2 26.3 13.0 8.3 2.1 2.8 0.6 1.1 0.1 5.0 0.4 0.0 2.3 ADRA1B ENSG00000170214 "Adrenoceptor alpha 1B" P35368 5 159865080-159973012 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 36.9;liver: 11.4;lymphoid tissue: 11.6" "Group enriched" "Detected in some" 7 "Excitatory neurons: 41.5;Inhibitory neurons: 32.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 36.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 11.9;HaCaT: 5.8;TIME: 9.8;U-2 OS: 7.9;U-251 MG: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA074416 Supported "Plasma membrane" NA NA "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "HPA074416: AB_2686688" "unprognostic (4.93e-3)" "unprognostic (2.94e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (6.00e-5)" "prognostic unfavorable (6.98e-4)" "unprognostic (4.08e-3)" "unprognostic (1.67e-3)" "unprognostic (1.68e-1)" "unprognostic (6.12e-2)" "prognostic favorable (2.67e-4)" "unprognostic (2.28e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.40e-6)" "unprognostic (5.24e-4)" "unprognostic (2.54e-1)" "prognostic favorable (3.19e-5)" "unprognostic (1.59e-2)" 4.2 1.8 3.4 0.3 16.1 0.0 1.9 0.0 7.9 0.4 0.0 0.7 0.4 0.9 1.4 0.3 3.0 0.5 2.0 6.0 3.4 3.9 11.4 4.0 1.2 0.0 36.9 2.9 0.4 0.5 0.6 0.3 6.3 0.6 0.3 0.5 0.3 0.7 0.7 0.9 1.4 0.4 0.0 11.6 0.7 0.2 4.5 0.1 1.5 0.7 0.3 0.4 0.6 5.2 0.4 4.5 0.3 0.0 1.9 0.8 0.1 0.5 0.1 0.5 0.2 0.0 3.8 0.0 11.9 3.4 4.4 5.8 0.0 0.5 0.3 0.0 0.2 0.0 1.7 0.0 4.1 0.0 0.0 2.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.7 0.0 3.8 0.0 0.4 0.0 0.0 0.3 0.3 1.7 0.1 0.0 9.8 0.1 7.9 0.0 6.6 0.0 0.0 0.0 2.9 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 16.1 0.0 7.9 6.0 3.4 0.0 36.9 6.3 0.0 4.5 5.2 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.5 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020120-1056118 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 20000000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "Plasma membrane" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 11.4 2.7 8.7 4.3 5.5 2.0 14.7 0.1 13.9 14.4 8.9 10.9 7.9 13.7 1.8 15.6 14.6 7.3 9.9 5.8 0.0 44.0 13.3 19.8 1.6 16.0 1.4 5.5 28.0 3.9 8.3 5.1 6.1 14.4 1.5 0.8 24.8 8.2 4.2 16.5 9.6 2.9 2.2 6.3 13.4 9.7 7.9 2.6 34.7 2.0 1.6 16.2 11.6 9.9 124.3 75.1 11.1 42.7 2.4 3.0 122.1 61.4 19.6 39.7 24.5 60.6 205.3 2.3 236.9 9.6 19.3 210.1 4.1 75.6 4.7 4.4 28.6 0.2 102.1 54.2 17.1 1.8 23.1 10.5 32.2 12.6 27.7 55.9 7.2 1.7 25.7 0.7 3.5 93.0 0.8 17.6 28.4 39.7 54.5 20.1 27.0 18.5 70.0 51.4 2.4 25.9 124.8 129.1 121.9 12.7 114.8 7.4 107.8 47.7 169.0 6.4 50.6 1.2 0.6 3.5 30.4 10.8 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 5.5 0.1 13.9 5.8 0.0 16.0 1.4 6.1 2.2 7.9 9.9 27.4 25.6 8.8 15.0 2.2 15.0 9.2 94.5 19.9 1.4 32.7 39.2 3.1 61.5 42.0 156.3 8.4 1.6 0.9 29.9 1.9 91.2 0.4 37.2 14.0 29.0 6.7 1.7 23.1 16.9 4.8 8.7 17.9 62.7 2.5 7.2 21.8 13.1 4.1 5.0 7.8 11.6 36.7 2.9 10.1 1.0 5.6 4.3 24.9 12.2 15.6 10.5 0.0 15.1 29.6 87.3 17.7 2.6 0.6 22.3 18.1 16.0 33.0 5.3 6.6 3.3 23.3 0.8 11.4 11.7 6.0 1.2 2.9 2.3 18.3 21.2 AL121899.2 ENSG00000286022 "Novel protein" 20 2207328-2341059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 3.1;fallopian tube: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "EFO-21: 1.0" HPA004728 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 38: EFO-21 - Unknown function" "HPA004728: AB_1080360" 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.2 0.3 0.1 0.2 0.1 0.1 3.1 3.4 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.7 0.8 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.7 0.8 0.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AL355315.1 ENSG00000249967 "Novel protein" 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "tongue: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.2;EFO-21: 1.3;GAMG: 1.0;HBEC3-KT: 1.1;hTERT-RPE1: 1.9" HPA076857 Uncertain "Plasma membrane" NA NA "Cluster 8: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Plasma membrane" "HPA076857: AB_2686817" 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.2 0.0 0.4 0.8 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.2 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.0 1.3 0.2 1.0 0.7 0.0 1.1 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.2 0.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP4M1 "MU-4, MU-ARP2, SPG50" ENSG00000221838 "Adaptor related protein complex 4 subunit mu 1" O00189 7 100101549-100110345 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 95.9;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066774 Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA066774: AB_2685718" "unprognostic (6.40e-2)" "unprognostic (3.28e-1)" "unprognostic (1.78e-1)" "unprognostic (1.14e-1)" "unprognostic (7.22e-2)" "unprognostic (2.24e-3)" "prognostic unfavorable (7.63e-5)" "unprognostic (1.58e-2)" "unprognostic (6.98e-3)" "unprognostic (1.73e-1)" "unprognostic (3.05e-2)" "unprognostic (7.18e-2)" "prognostic unfavorable (8.29e-4)" "unprognostic (6.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.63e-1)" "unprognostic (1.46e-1)" 8.4 7.3 9.9 4.7 9.9 4.9 9.6 9.6 12.1 11.4 10.0 15.2 12.5 15.7 6.1 10.3 12.4 8.5 9.8 9.9 10.0 10.3 4.7 8.8 6.3 11.2 10.5 9.3 12.3 7.7 15.4 5.6 10.7 12.3 6.2 6.4 10.1 11.0 10.7 11.7 9.9 8.0 10.0 7.2 12.8 32.6 10.9 6.1 10.9 5.5 4.6 12.4 10.3 10.1 9.3 13.0 13.9 35.4 7.8 17.8 15.8 5.5 9.6 7.1 8.9 10.6 23.7 11.1 25.2 13.4 10.2 9.9 6.1 12.0 3.9 8.9 8.6 6.2 12.7 9.4 16.2 7.2 10.9 15.1 20.5 20.7 12.5 13.7 23.5 14.3 11.9 8.4 24.6 28.7 25.9 14.1 10.9 8.4 13.3 21.8 7.0 13.9 18.0 11.9 24.2 21.1 14.0 40.9 11.9 7.9 18.6 14.0 26.0 21.2 16.9 19.8 9.4 6.2 6.8 16.8 17.7 8.3 18.8 4.3 6.3 9.1 4.5 7.9 4.1 5.3 4.0 5.1 8.7 3.4 1.8 3.2 2.1 3.2 10.8 5.3 4.5 4.3 9.9 9.9 9.6 12.1 9.9 10.0 11.2 10.5 10.7 10.0 10.9 10.1 12.6 16.0 4.6 20.5 10.4 9.4 17.3 17.7 9.1 17.7 14.2 17.8 3.2 20.0 13.3 16.5 52.1 14.7 6.8 17.7 7.9 24.4 69.3 20.3 14.6 12.5 12.1 8.2 9.5 19.0 18.1 12.4 14.8 11.2 3.8 22.8 13.2 3.3 9.9 6.7 7.0 15.6 12.2 7.3 7.7 95.9 14.6 6.9 14.2 10.3 14.5 21.0 8.2 6.0 8.1 19.6 17.7 12.8 5.9 13.7 21.9 11.1 29.5 67.9 13.1 15.3 12.4 84.7 39.5 8.8 8.4 14.0 8.2 16.0 14.2 11.2 APLP2 "APPH, APPL2" ENSG00000084234 "Amyloid beta precursor like protein 2" Q06481 11 130068147-130144811 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 249.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039319 Approved Approved Vesicles NA NA 1500000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA039319: AB_10673141" "unprognostic (2.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.86e-2)" "unprognostic (2.33e-1)" "unprognostic (2.70e-2)" "unprognostic (3.12e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.33e-9)" "unprognostic (3.20e-3)" "unprognostic (4.95e-2)" "prognostic favorable (2.90e-4)" "unprognostic (4.42e-2)" 217.2 130.2 125.6 144.0 126.0 196.5 192.3 164.7 157.9 170.4 252.6 209.9 272.4 176.6 138.6 134.2 167.6 201.8 271.6 131.0 153.2 359.9 334.8 391.4 77.5 130.9 137.5 180.8 136.0 291.5 87.1 324.8 133.1 287.7 176.7 540.8 135.3 291.0 65.9 113.3 226.6 211.5 135.4 95.7 149.7 54.9 157.9 81.5 607.8 85.2 56.8 199.1 129.6 152.8 216.7 170.3 307.1 281.2 1259.7 847.8 393.7 598.6 741.1 294.2 251.8 1300.5 1541.3 107.9 1515.3 1422.2 322.4 540.4 229.1 567.6 168.0 165.6 206.4 180.9 116.7 502.9 191.9 556.7 363.8 566.4 367.8 244.5 469.5 1520.2 912.7 34.1 180.7 228.9 495.2 205.7 26.9 245.3 182.8 256.8 301.1 70.0 69.8 105.5 758.9 589.6 109.9 239.0 706.9 368.0 92.0 535.8 582.2 489.5 1567.6 314.1 211.7 496.8 281.9 33.8 50.6 245.5 347.0 487.7 221.0 55.1 249.3 65.3 17.9 122.2 13.5 16.3 12.7 17.0 110.1 44.8 9.4 12.6 160.8 15.6 94.6 10.5 20.0 149.5 125.6 126.0 164.7 157.9 131.0 153.2 130.9 137.5 133.1 135.4 157.9 152.8 239.6 942.3 550.3 37.9 74.4 106.7 175.4 497.0 78.6 967.9 252.9 183.1 262.0 254.5 460.6 404.6 706.8 798.1 72.0 354.2 52.8 305.5 13.6 211.0 191.3 220.3 92.8 156.3 99.0 107.1 130.3 253.5 86.6 432.8 103.5 109.6 127.1 498.2 652.4 240.6 133.5 159.8 463.9 287.6 214.3 13.8 167.4 405.5 96.0 54.4 293.1 396.1 56.7 45.8 31.6 276.5 220.7 214.4 45.5 190.1 352.0 244.9 258.3 729.0 190.7 148.9 207.7 182.8 240.4 81.6 109.4 927.3 58.8 165.9 161.5 215.4 APOL1 APOL ENSG00000100342 "Apolipoprotein L1" O14791 22 36253071-36267530 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 220.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8" "HPA018885, CAB056156" Supported "Secreted to blood" NA NA 1640000000 9200000000 "Cluster 48: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "CAB056156: AB_2665576, HPA018885: AB_1844953" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.57e-1)" "unprognostic (8.98e-3)" "unprognostic (1.67e-1)" "unprognostic (8.28e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (5.35e-4)" "unprognostic (4.41e-2)" "unprognostic (1.58e-1)" "unprognostic (4.07e-3)" "unprognostic (5.15e-2)" "prognostic unfavorable (7.43e-6)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (5.05e-3)" "prognostic favorable (2.01e-5)" 45.3 15.8 8.1 62.5 8.2 4.2 28.4 7.8 9.8 53.8 9.4 32.0 32.7 38.8 17.7 25.7 36.7 69.0 29.5 7.4 8.4 44.5 220.5 59.5 23.1 10.0 8.5 24.8 9.0 4.9 14.1 53.0 9.6 37.5 27.2 0.9 29.7 52.2 11.7 7.1 28.9 65.4 9.0 56.8 64.9 7.9 10.8 24.9 18.0 13.8 23.6 117.7 29.9 8.2 21.6 5.1 0.1 0.6 46.8 44.6 14.2 2.3 9.0 13.7 38.6 0.6 34.4 7.0 243.9 24.8 31.3 5.3 0.0 19.2 3.6 166.1 0.2 6.1 3.2 41.4 120.3 2.4 20.2 8.3 1.7 38.0 0.8 2.0 27.3 1.3 23.8 85.1 2.4 0.2 8.5 2.1 0.6 0.6 0.2 13.6 2.6 3.2 91.1 146.8 1.9 0.1 10.9 5.8 2.1 0.3 0.8 7.8 24.7 29.5 12.4 3.2 1.5 6.5 4.0 1.6 16.0 12.4 4.6 15.6 6.1 5.5 12.6 6.8 10.7 2.6 8.1 11.2 4.3 1.4 4.6 6.3 16.1 22.4 10.3 0.5 5.4 7.2 8.1 8.2 7.8 9.8 7.4 8.4 10.0 8.5 9.6 9.0 10.8 8.2 37.4 57.7 34.3 0.3 7.2 1.7 21.4 73.5 2.8 0.5 6.3 3.0 3.6 15.7 67.1 18.4 2.1 11.0 12.6 31.2 0.0 37.8 0.8 106.1 48.8 41.3 7.7 3.8 0.1 20.0 8.2 27.3 45.9 216.2 11.4 4.3 49.6 115.6 9.1 0.0 0.1 17.7 32.6 15.8 5.3 1.4 27.4 10.9 0.0 7.5 19.4 0.1 36.0 0.0 0.0 105.1 19.9 24.0 15.0 31.2 20.5 2.1 60.5 1.3 6.6 5.5 10.6 0.4 0.4 3.4 2.3 6.7 12.9 1.6 4.6 62.5 ATP6AP1 "16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3" ENSG00000071553 "ATPase H+ transporting accessory protein 1" Q15904 X 154428633-154436516 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB015218 Uncertain NA NA 700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "CAB015218: " "prognostic unfavorable (2.40e-4)" "unprognostic (1.95e-2)" "unprognostic (2.06e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (1.84e-3)" "unprognostic (4.99e-3)" "unprognostic (2.57e-1)" "unprognostic (1.10e-2)" "unprognostic (1.84e-1)" "prognostic favorable (7.83e-4)" "unprognostic (1.07e-1)" "prognostic favorable (5.26e-8)" "unprognostic (2.45e-1)" "unprognostic (4.66e-2)" "unprognostic (3.39e-1)" "unprognostic (1.62e-1)" 56.3 93.5 108.3 43.1 109.2 59.1 56.7 99.6 118.0 59.6 123.6 61.5 48.4 54.2 145.1 85.2 60.0 46.0 92.7 116.2 115.4 104.3 51.4 96.8 46.9 114.0 96.8 63.3 86.6 176.0 110.4 77.9 121.6 85.1 57.0 74.0 87.4 54.8 53.8 83.6 57.4 49.0 104.6 94.7 70.4 47.5 104.2 40.9 81.9 54.4 42.5 63.7 60.9 121.6 110.1 101.6 88.2 146.2 145.7 77.4 162.2 78.5 116.6 122.5 176.1 93.4 135.1 64.7 337.8 177.1 216.5 112.3 133.8 71.9 76.6 58.6 135.1 37.5 113.7 100.0 170.6 60.9 260.2 98.1 126.7 112.4 68.2 139.5 177.0 47.8 45.6 176.4 84.7 158.1 43.6 96.8 32.1 171.0 100.8 66.6 59.1 170.7 139.9 87.3 84.6 89.7 72.6 289.7 159.3 87.3 123.1 157.8 135.5 87.4 79.0 151.1 135.6 256.3 311.8 77.0 104.4 132.8 90.2 246.6 295.1 363.9 147.3 313.8 148.6 91.7 118.4 127.8 376.7 113.6 107.1 117.8 326.9 140.3 255.6 215.9 155.2 216.9 108.3 109.2 99.6 118.0 116.2 115.4 114.0 96.8 121.6 104.6 104.2 121.6 39.4 38.5 57.5 17.0 32.3 30.2 42.7 122.4 25.6 105.8 58.5 42.2 37.7 54.3 102.1 97.5 47.9 145.1 40.1 84.3 19.6 65.4 3.1 52.5 33.7 50.1 89.0 35.8 17.0 52.5 104.5 48.8 36.7 57.4 77.3 51.8 54.3 46.6 246.3 129.5 24.2 59.0 160.7 143.6 88.2 5.5 41.3 130.3 72.9 15.0 79.9 68.4 27.8 22.1 26.4 42.4 67.5 42.5 61.7 34.1 63.7 49.1 112.5 69.2 65.7 35.7 45.5 64.4 10.7 31.6 32.8 196.5 36.3 74.1 54.6 47.2 ATP9A "ATPIIA, KIAA0611" ENSG00000054793 "ATPase phospholipid transporting 9A (putative)" O75110 20 51596514-51768390 "Enzymes, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 67.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 112.2;Inhibitory neurons: 87.1;Oligodendrocytes: 90.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "EFO-21: 74.0;SK-BR-3: 69.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020699, HPA035630" Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 51: Myeloid cells - Hemostasis" "CAB020699: , HPA035630: AB_10669526" "unprognostic (5.19e-2)" "unprognostic (5.28e-2)" "unprognostic (3.46e-1)" "unprognostic (1.05e-1)" "unprognostic (3.76e-1)" "unprognostic (1.37e-1)" "unprognostic (3.76e-2)" "unprognostic (4.79e-2)" "unprognostic (7.45e-2)" "unprognostic (1.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.79e-1)" "prognostic favorable (5.67e-5)" "unprognostic (5.82e-2)" "unprognostic (5.81e-1)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" 30.6 11.5 55.9 5.8 63.2 2.7 14.1 26.0 63.7 8.5 0.0 18.5 13.6 12.4 18.5 12.9 24.8 12.0 11.6 67.1 52.2 9.2 7.5 9.7 3.7 41.8 50.0 18.8 15.1 29.5 16.2 4.9 46.8 20.5 16.4 20.5 25.7 15.5 16.3 6.8 17.8 12.7 33.2 2.9 20.4 18.8 53.4 7.4 28.1 17.6 3.1 11.9 9.8 48.7 25.8 21.7 17.2 38.8 49.0 36.8 0.4 9.1 17.1 5.8 1.7 50.4 51.9 0.0 74.0 37.2 29.1 20.1 22.9 12.9 5.7 20.2 7.1 0.0 23.2 19.8 6.7 0.0 0.1 12.1 25.6 1.3 3.5 13.3 31.4 4.7 0.1 0.2 6.6 35.9 2.0 0.2 3.1 25.4 27.0 4.1 0.0 0.1 11.6 35.7 32.7 23.2 36.3 69.9 13.2 6.0 13.5 0.6 20.7 48.1 12.7 19.1 3.9 0.0 0.3 0.8 12.7 0.1 4.4 4.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.7 55.9 63.2 26.0 63.7 67.1 52.2 41.8 50.0 46.8 33.2 53.4 48.7 4.8 16.0 13.6 43.4 0.5 2.9 14.6 13.8 4.0 35.9 16.0 11.3 12.7 31.5 19.1 18.4 4.2 0.4 2.5 64.3 1.9 21.4 0.8 20.4 4.7 9.8 55.2 0.8 112.2 17.2 0.5 9.9 26.5 28.8 1.3 14.3 11.0 12.8 5.4 43.7 87.1 34.9 18.3 2.2 2.1 3.4 13.4 12.1 3.6 40.3 0.2 5.0 2.1 60.8 90.3 24.6 28.8 23.3 2.1 33.7 36.3 1.4 34.9 7.4 6.6 10.1 8.0 1.2 8.2 9.9 4.1 0.3 2.3 0.7 24.8 27.3 B9D2 "MGC4093, MKS10, MKSR-2" ENSG00000123810 "B9 domain containing 2" Q9BPU9 19 41354417-41364165 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 64.8;Respiratory ciliated cells: 76.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 127.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042229, HPA042618" Enhanced NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "HPA042229: AB_10959591, HPA042618: AB_10960695" "unprognostic (9.25e-2)" "unprognostic (1.82e-3)" "unprognostic (1.66e-1)" "unprognostic (9.68e-3)" "unprognostic (1.23e-1)" "unprognostic (2.19e-3)" "unprognostic (1.04e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.39e-4)" "unprognostic (2.58e-1)" "unprognostic (8.22e-3)" "unprognostic (4.50e-1)" "unprognostic (1.62e-2)" "unprognostic (1.13e-1)" "unprognostic (1.35e-1)" "unprognostic (2.07e-1)" "unprognostic (1.21e-3)" 4.2 8.5 3.9 4.0 4.2 8.8 4.4 3.7 5.6 5.5 8.1 6.6 3.2 6.5 1.9 4.3 10.5 2.7 4.1 4.3 5.4 9.0 5.0 5.5 3.9 4.0 4.6 3.4 4.5 2.2 5.8 2.1 4.1 5.4 1.8 1.2 4.3 3.6 3.0 3.6 5.1 2.4 4.3 7.8 5.5 8.4 5.5 4.7 5.9 1.5 2.2 5.1 3.8 3.8 6.7 22.0 5.8 5.2 2.1 3.4 1.4 4.2 5.0 7.1 4.4 5.9 5.8 1.7 15.6 5.1 3.0 2.0 3.9 5.8 1.7 6.8 5.9 5.6 7.4 5.1 4.2 7.0 12.6 3.9 4.0 6.3 1.6 4.9 8.0 6.1 4.1 5.9 3.4 5.8 6.5 9.0 2.8 3.1 6.6 5.4 1.3 6.0 6.0 4.3 4.9 4.1 7.3 3.1 3.7 1.1 3.9 12.9 11.9 8.1 3.6 4.3 8.4 2.6 2.4 3.9 8.6 7.4 5.4 47.2 32.3 25.6 10.7 19.8 14.0 15.8 19.7 14.7 22.6 10.3 20.5 14.0 127.5 21.0 16.3 26.1 24.8 18.3 3.9 4.2 3.7 5.6 4.3 5.4 4.0 4.6 4.1 4.3 5.5 3.8 4.0 0.0 9.4 2.0 12.0 4.1 9.8 17.3 5.7 1.6 5.9 3.7 2.0 20.0 17.1 20.2 8.4 8.3 8.0 20.1 37.2 17.4 24.2 64.8 5.6 9.9 15.5 4.8 1.1 16.8 14.9 6.1 8.2 7.6 12.6 4.3 10.0 4.6 13.1 0.0 1.1 13.3 18.3 12.9 4.3 36.7 2.8 8.0 3.6 0.0 8.7 5.4 6.2 0.0 0.6 12.1 37.4 6.4 5.5 7.8 9.9 32.6 76.9 6.1 6.6 9.1 6.8 18.4 12.0 3.9 3.3 6.8 10.3 9.2 10.2 12.6 C1QTNF12 "ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127" ENSG00000184163 "C1q and TNF related 12" Q5T7M4 1 1242446-1246722 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 6.8;skin 1: 6.6" "Cell type enhanced" "Detected in some" "Adipocytes: 19.5;Extravillous trophoblasts: 11.2;Proximal tubular cells: 45.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 4.1;U-2 OS: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024107 Uncertain Approved Vesicles "Secreted to blood" NA NA 38200000 "Cluster 40: NK-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA024107: AB_2101207" "unprognostic (1.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.45e-1)" "unprognostic (1.24e-2)" "unprognostic (6.60e-3)" "unprognostic (2.43e-1)" "unprognostic (2.67e-3)" "unprognostic (1.01e-2)" "unprognostic (2.58e-1)" "unprognostic (1.05e-2)" "unprognostic (8.02e-3)" "unprognostic (1.10e-2)" "unprognostic (9.68e-3)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.09e-1)" "unprognostic (1.20e-1)" 1.3 0.1 0.4 0.2 0.4 0.0 0.7 0.3 0.5 0.5 0.0 3.4 6.8 0.3 0.0 1.3 0.5 0.1 0.8 0.4 0.7 3.4 0.5 0.4 0.0 0.8 0.4 0.2 0.2 0.0 0.3 0.2 0.5 0.3 0.7 0.0 0.3 0.0 0.4 6.6 6.7 0.0 0.4 0.2 0.4 2.4 0.9 0.0 0.4 0.0 0.1 0.3 0.6 0.5 0.1 0.0 0.0 0.3 0.2 0.0 0.8 0.6 0.0 0.0 0.0 0.3 0.2 0.0 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.7 0.0 0.0 0.6 0.1 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 4.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.5 0.4 0.7 0.8 0.4 0.5 0.4 0.9 0.5 19.5 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 3.9 0.5 0.0 0.6 1.2 0.7 0.0 0.0 0.0 0.8 11.2 0.5 0.0 0.7 2.5 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 45.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.3 0.0 0.0 CACNG6 ENSG00000130433 "Calcium voltage-gated channel auxiliary subunit gamma 6" Q9BXT2 19 53991637-54012666 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skeletal muscle: 90.7;tongue: 29.9" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 2.2" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 107 "basophil: 13.3;eosinophil: 8.0" "Lineage enriched" "Detected in single" 133 "granulocytes: 13.3" "Cell line enhanced" "Detected in some" "A549: 12.7;EFO-21: 23.6;HHSteC: 5.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056615 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center" Cytosol "HPA056615: AB_2683192" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (7.07e-2)" "unprognostic (8.58e-2)" "unprognostic (2.89e-2)" "unprognostic (2.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.72e-1)" "unprognostic (1.53e-1)" "unprognostic (6.07e-8)" "unprognostic (9.79e-2)" "unprognostic (1.28e-1)" 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.1 0.9 0.3 0.2 0.1 0.2 0.2 0.0 0.3 8.8 0.0 0.0 0.6 0.6 0.0 0.0 2.2 0.0 1.0 2.0 0.0 0.0 2.9 1.9 0.0 0.8 0.4 0.0 0.1 1.0 0.0 90.7 0.0 0.2 0.0 1.0 0.1 0.3 2.3 0.4 0.0 0.0 29.9 0.1 0.0 0.0 0.5 0.0 12.7 0.2 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 23.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 5.6 0.0 0.1 0.1 0.0 0.0 0.0 1.9 3.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.1 1.6 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.2 0.0 2.8 0.0 0.0 0.0 3.5 0.1 0.2 0.0 0.0 13.3 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.1 0.9 0.6 0.6 1.0 2.0 0.8 1.0 0.4 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 9.1 0.0 0.0 2.3 0.1 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CALB1 CALB ENSG00000104327 "Calbindin 1" P05937 8 90058608-90095475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "kidney: 320.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 26.1;Collecting duct cells: 27.6;Cone photoreceptor cells: 91.8;Distal tubular cells: 31.3;Horizontal cells: 99.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.8" "Group enriched" "Detected in many" 6 "granulocytes: 2.8;monocytes: 1.4" "Cell line enhanced" "Detected in many" "A-431: 134.9;EFO-21: 189.8;HeLa: 65.9" "Region enhanced" "Detected in all" "cerebellum: 430.7" "Group enriched" "Detected in all" 4 "basal ganglia: 49.7;cerebellum: 119.6" "CAB002138, HPA023099, HPA056734" Enhanced Approved Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Vesicles "CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220" "unprognostic (2.19e-1)" "unprognostic (2.28e-3)" "unprognostic (2.61e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.82e-1)" "unprognostic (5.39e-2)" "unprognostic (2.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.37e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (2.11e-1)" "unprognostic (7.88e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-1)" 2.4 1.6 7.4 2.0 31.3 1.3 1.7 63.0 21.1 5.5 0.0 1.7 3.2 1.2 3.4 8.5 1.9 1.4 0.9 9.2 14.0 320.6 2.6 3.6 0.9 16.8 10.4 1.2 2.5 2.2 8.4 3.9 6.3 0.8 2.5 54.1 1.7 0.5 1.9 3.5 2.7 1.3 15.9 1.3 2.3 3.6 32.1 2.7 2.5 0.3 1.2 0.5 0.1 7.8 134.9 6.1 30.2 1.2 1.1 4.9 4.0 2.0 5.8 0.7 1.1 2.9 15.1 0.5 189.8 0.1 0.8 47.8 46.0 54.6 9.1 0.3 2.5 3.2 65.9 0.7 5.3 0.8 4.4 1.5 17.3 2.5 25.4 7.0 36.1 2.6 9.9 3.4 35.9 0.6 1.9 0.1 45.3 2.9 17.9 1.3 1.2 3.9 12.9 0.7 5.0 2.9 38.2 2.3 0.6 45.8 1.7 1.1 0.1 3.9 28.1 6.6 11.9 3.1 3.9 1.0 0.5 0.9 0.2 1.5 0.2 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.4 0.3 0.0 0.4 7.4 31.3 63.0 21.1 9.2 14.0 16.8 10.4 6.3 15.9 32.1 7.8 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.1 1.5 0.0 0.0 27.6 91.8 0.0 0.0 0.0 31.3 0.0 14.9 0.0 0.1 0.3 3.5 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 99.3 14.7 0.0 0.0 0.0 0.0 1.7 0.9 0.0 0.0 0.0 0.0 15.8 0.0 1.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.8 0.0 0.3 0.4 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.1 CBARP "BARP, C19orf26, DOS, MGC40084" ENSG00000099625 "CACN subunit beta associated regulatory protein" Q8N350 19 1228287-1238027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.3;pituitary gland: 22.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 21.8;Early spermatids: 55.9;Late spermatids: 97.4;Spermatocytes: 54.8" "Cancer enhanced" "Detected in many" "glioma: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SH-SY5Y: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012777 Approved Nucleoplasm NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA012777: AB_2067005" "unprognostic (1.31e-1)" "unprognostic (4.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.10e-2)" "unprognostic (3.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.54e-5)" "unprognostic (3.48e-1)" "unprognostic (2.17e-1)" "unprognostic (4.58e-2)" "unprognostic (2.86e-3)" "unprognostic (3.03e-1)" "unprognostic (5.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.12e-1)" "unprognostic (2.40e-1)" "unprognostic (7.42e-5)" 1.4 2.6 6.0 0.1 9.8 0.0 0.4 2.0 15.3 0.7 0.0 0.6 0.1 0.5 0.0 1.4 0.5 0.1 1.7 12.3 3.1 2.3 0.3 1.0 0.0 5.6 1.3 4.9 0.4 0.0 22.3 0.1 1.3 0.8 0.0 0.3 0.4 0.1 0.4 3.1 0.2 0.0 0.0 0.1 0.4 1.7 1.8 0.0 0.6 0.0 0.0 0.3 0.9 0.0 0.3 0.4 1.1 3.1 0.1 0.5 0.4 2.7 0.8 0.5 0.5 1.1 0.1 0.0 2.7 0.5 0.3 0.9 0.4 0.6 0.1 0.5 0.7 0.1 1.1 0.9 1.4 0.0 1.0 0.6 0.2 0.6 0.1 0.5 0.4 0.5 1.7 0.0 0.3 2.3 0.0 0.6 1.6 0.1 1.2 2.0 0.4 0.2 0.1 0.2 1.4 4.2 0.0 0.0 3.1 0.1 0.4 0.5 1.2 0.7 2.6 2.3 0.7 0.1 0.2 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 9.8 2.0 15.3 12.3 3.1 5.6 1.3 1.3 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 1.2 21.8 1.7 1.8 0.0 1.5 0.0 0.0 2.1 0.0 0.6 0.0 1.9 0.1 55.9 0.9 2.2 0.7 0.0 0.0 0.0 0.2 0.1 1.2 1.1 1.6 0.0 0.9 1.4 0.1 0.3 3.3 0.0 0.0 0.0 0.8 0.0 97.4 1.8 1.2 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.9 0.0 0.2 0.0 1.7 0.0 0.7 1.4 54.8 7.0 1.1 0.0 0.0 0.3 0.1 0.0 0.3 CCM2L "C20orf160, dJ310O13.5" ENSG00000101331 "CCM2 like scaffold protein" Q9NUG4 20 32010438-32032180 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 141.6" "Cell type enriched" "Detected in some" 5 "Theca cells: 248.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008434, HPA071063" Uncertain Supported Nucleoplasm NA NA "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA008434: AB_1845671, HPA071063: AB_2686339" "unprognostic (1.71e-1)" "unprognostic (4.64e-2)" "unprognostic (2.43e-3)" "unprognostic (5.84e-3)" "unprognostic (1.91e-1)" "unprognostic (3.09e-3)" "unprognostic (1.27e-3)" "unprognostic (2.37e-1)" "unprognostic (2.04e-1)" "unprognostic (4.34e-2)" "unprognostic (1.00e-3)" "unprognostic (7.84e-2)" "unprognostic (4.66e-3)" "unprognostic (2.19e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" 15.9 5.4 7.2 1.6 7.3 0.0 15.0 9.5 6.8 8.7 4.2 4.6 1.3 8.9 0.6 3.7 7.7 2.5 23.2 6.1 5.8 13.3 2.2 11.8 1.5 6.8 6.4 3.6 2.6 1.4 4.1 7.8 7.0 5.8 1.1 0.4 3.4 1.8 4.8 3.9 5.4 3.3 6.1 141.6 4.2 1.6 7.3 0.8 10.2 4.8 0.9 6.4 6.3 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.0 0.9 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.1 0.0 0.6 3.2 0.1 0.0 0.0 7.7 0.9 0.2 0.0 0.0 1.1 2.5 0.0 4.8 0.0 1.3 0.0 0.0 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 7.3 9.5 6.8 6.1 5.8 6.8 6.4 7.0 6.1 7.3 5.2 45.8 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.5 0.6 4.6 2.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.2 32.1 0.0 0.0 2.9 0.2 0.0 1.0 0.0 0.2 0.0 4.3 24.3 0.0 0.0 3.3 2.4 0.0 0.0 0.3 0.3 0.4 0.0 0.2 0.0 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.6 1.8 0.3 0.6 0.1 0.3 0.0 0.1 248.7 0.0 0.1 CD40 "Bp50, p50, TNFRSF5" ENSG00000101017 "CD40 molecule" P25942 20 46118278-46129863 "Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 127.5;Basal respiratory cells: 126.0;Langerhans cells: 191.4;monocytes: 242.0;Prostatic glandular cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 139.4;naive B-cell: 157.9" "Group enriched" "Detected in all" 6 "B-cells: 157.9;monocytes: 43.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 76.0;Daudi: 42.1;EFO-21: 131.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002495, HPA031567, HPA031568, CAB072868" Enhanced "Secreted to blood" NA NA 705000 "Cluster 19: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" "CAB002495: AB_563562, CAB072868: AB_2665719, HPA031567: AB_2673936, HPA031568: AB_2673937" "unprognostic (6.41e-2)" "unprognostic (1.55e-2)" "unprognostic (7.08e-3)" "unprognostic (6.21e-2)" "unprognostic (4.23e-3)" "unprognostic (1.25e-1)" "unprognostic (7.64e-3)" "unprognostic (1.34e-1)" "unprognostic (4.15e-2)" "unprognostic (7.16e-2)" "unprognostic (2.48e-2)" "unprognostic (7.04e-2)" "prognostic unfavorable (4.48e-4)" "unprognostic (1.22e-1)" "unprognostic (4.95e-2)" "unprognostic (1.60e-2)" "unprognostic (2.28e-2)" 25.9 8.4 6.7 34.9 7.0 2.7 20.5 7.6 7.7 19.4 9.4 11.8 12.6 14.4 7.6 12.4 19.7 14.3 16.3 6.6 7.2 26.1 18.3 34.4 57.8 8.0 7.1 24.5 21.9 46.5 9.9 12.4 7.6 23.6 9.6 1.1 24.5 15.4 8.6 17.0 21.8 14.0 7.8 35.1 15.6 3.8 7.3 17.3 20.4 7.1 57.7 32.9 21.0 8.0 26.6 4.1 0.0 12.8 4.7 2.7 5.0 4.9 1.4 3.8 3.6 0.0 76.0 42.1 131.8 0.8 18.7 3.1 2.3 16.2 3.9 29.0 0.0 10.0 0.0 7.5 36.6 0.0 13.0 16.2 6.2 15.3 0.0 0.0 28.3 0.0 3.5 0.0 0.8 0.0 0.0 0.2 1.8 9.3 0.1 1.1 1.0 4.5 32.7 0.3 0.0 0.0 23.1 12.6 0.0 0.0 2.7 14.5 0.0 0.0 41.2 0.0 0.1 0.1 0.1 29.2 9.6 5.0 0.1 4.0 28.0 0.4 4.8 43.3 3.5 139.4 2.6 2.0 16.1 157.9 5.0 3.7 2.8 2.9 32.1 8.3 4.1 20.0 6.7 7.0 7.6 7.7 6.6 7.2 8.0 7.1 7.6 7.8 7.3 8.0 68.8 12.8 15.0 6.5 127.5 43.6 63.3 126.0 30.1 1.2 3.8 10.0 3.9 30.0 32.9 14.7 0.0 0.4 7.3 1.5 0.0 68.4 9.0 1.3 2.4 61.5 1.2 5.2 0.9 29.7 3.2 37.9 11.7 3.3 3.8 0.6 55.3 17.0 40.5 0.0 0.9 6.2 14.2 13.0 191.4 14.6 25.7 48.1 28.4 12.2 242.0 9.0 6.2 0.5 0.2 37.9 8.8 22.6 25.1 130.2 6.1 4.3 12.2 0.4 32.9 28.0 31.6 1.9 5.7 13.2 34.1 0.4 4.8 2.3 6.8 64.4 CDC42EP5 "Borg3, CEP5" ENSG00000167617 "CDC42 effector protein 5" Q6NZY7 19 54465026-54473296 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.8;prostate: 60.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 435.6;Intestinal goblet cells: 547.3;Paneth cells: 288.4;Prostatic glandular cells: 193.3;Undifferentiated cells: 257.0;Urothelial cells: 385.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 8.4;BJ hTERT+: 5.9;CAPAN-2: 6.5;EFO-21: 9.6;HHSteC: 6.6;TIME: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043449 Approved NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA043449: AB_10961041" "unprognostic (7.67e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-1)" "unprognostic (3.36e-1)" "unprognostic (7.30e-3)" "unprognostic (1.63e-1)" "unprognostic (2.52e-2)" "unprognostic (6.49e-2)" "unprognostic (4.13e-2)" "prognostic unfavorable (2.79e-5)" "unprognostic (1.73e-2)" "unprognostic (5.41e-2)" "unprognostic (6.37e-3)" "prognostic favorable (1.36e-4)" 24.3 8.1 0.7 0.2 0.6 0.0 23.4 0.5 1.1 26.2 0.6 83.8 18.4 13.6 0.0 16.7 16.9 0.8 19.0 0.5 0.4 13.5 3.4 24.1 0.4 1.8 0.4 12.7 14.5 0.1 5.5 1.4 1.1 60.4 4.4 0.1 40.1 2.1 3.8 11.4 52.4 0.4 0.3 9.2 19.6 6.0 0.6 0.2 11.0 0.5 0.3 42.5 22.9 0.9 0.0 0.0 0.7 0.4 0.7 4.8 3.3 8.4 5.9 0.4 0.1 1.4 6.5 0.0 9.6 2.2 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 2.9 0.1 0.0 0.4 1.5 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.7 0.1 2.2 0.1 3.8 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 8.9 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.5 1.1 0.5 0.4 1.8 0.4 1.1 0.3 0.6 0.9 123.5 0.0 0.0 0.3 1.3 10.3 75.4 2.3 13.1 0.9 107.8 114.7 1.3 0.0 2.4 18.4 0.0 0.4 2.3 435.6 0.0 3.1 6.4 4.3 37.0 50.7 39.0 0.0 0.5 11.4 12.6 33.8 50.0 5.0 8.9 0.8 61.1 0.3 0.8 0.0 0.2 547.3 0.0 1.9 5.9 12.0 10.2 1.5 17.8 7.5 0.6 26.7 0.0 0.0 0.5 11.2 288.4 9.1 0.0 193.3 117.0 0.3 0.4 2.5 6.6 3.8 17.6 0.5 1.2 18.3 7.5 0.7 2.4 17.3 257.0 385.7 CDH6 ENSG00000113361 "Cadherin 6" P55285 5 31193686-31329146 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 14.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 48.6;Excitatory neurons: 67.1;Oligodendrocyte precursor cells: 60.8;Pancreatic endocrine cells: 63.8;Proximal tubular cells: 171.1;Sertoli cells: 46.0;Smooth muscle cells: 69.5" "Group enriched" "Detected in many" 5 "ovarian cancer: 15.0;renal cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 477.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007047, HPA007403, HPA007456, CAB025274" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 9600000 "Cluster 21: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane, Cell Junctions" "CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373" "unprognostic (3.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" "unprognostic (1.58e-2)" "unprognostic (7.61e-3)" "unprognostic (9.04e-2)" "unprognostic (2.68e-1)" "unprognostic (2.74e-2)" "unprognostic (5.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (8.29e-3)" "unprognostic (1.22e-3)" "unprognostic (2.67e-1)" "unprognostic (6.22e-2)" "unprognostic (2.09e-2)" 5.0 1.1 3.2 1.4 9.3 0.2 2.6 2.2 3.7 4.3 0.5 1.3 1.3 2.3 1.8 2.4 6.8 9.2 2.0 2.2 7.4 14.8 0.7 4.5 0.6 4.9 9.5 0.7 0.7 1.1 1.0 3.6 6.0 1.1 0.9 1.5 0.7 1.8 1.2 1.0 1.2 2.6 3.2 0.8 1.0 0.3 9.8 0.4 2.3 1.6 0.7 2.3 1.9 3.9 0.1 1.9 62.2 0.0 0.0 0.0 0.2 1.5 0.1 0.0 0.0 0.2 0.0 0.1 477.1 0.3 0.0 0.0 49.6 0.1 0.0 0.6 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 17.5 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.1 9.4 0.0 0.2 0.0 10.9 0.1 14.0 0.0 1.8 0.0 0.0 0.1 0.2 19.3 0.1 0.2 0.0 0.1 1.8 5.9 1.5 0.1 0.4 1.1 0.1 0.1 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 9.3 2.2 3.7 2.2 7.4 4.9 9.5 6.0 3.2 9.8 3.9 5.7 0.0 0.5 7.2 2.4 0.9 0.1 36.5 0.0 10.8 0.1 0.4 3.1 48.6 7.0 11.0 0.0 0.0 0.0 0.0 27.4 37.2 0.2 2.9 0.6 5.3 0.0 0.0 67.1 3.0 0.0 2.9 0.0 2.9 0.0 4.1 0.0 0.1 0.1 0.0 33.6 0.0 0.0 0.0 2.5 0.1 0.3 1.3 0.0 39.4 1.0 0.3 0.0 60.8 5.5 63.8 0.0 0.4 0.0 1.2 0.0 171.1 1.1 0.8 46.0 0.6 69.5 0.0 0.4 0.1 1.0 0.0 1.8 0.2 0.0 0.1 CFP PFC ENSG00000126759 "Complement factor properdin" P27918 X 47623172-47630305 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 83.9;lymphoid tissue: 58.4" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 108.1;Kupffer cells: 356.7;Langerhans cells: 164.1;Macrophages: 177.3;monocytes: 473.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in all" 8 "classical monocyte: 1167.5;intermediate monocyte: 1273.6;myeloid DC: 994.5;neutrophil: 730.3;non-classical monocyte: 868.9" "Group enriched" "Detected in all" 46 "dendritic cells: 994.5;granulocytes: 730.3;monocytes: 1273.6" "Cell line enhanced" "Detected in some" "EFO-21: 20.7;HEL: 5.0;HMC-1: 5.5;NB-4: 10.7;U-937: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA072644 Approved Vesicles "Secreted to blood" NA NA 6200000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 38: EFO-21 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "HPA072644: " "unprognostic (2.77e-3)" "unprognostic (2.21e-3)" "unprognostic (1.00e-1)" "unprognostic (2.15e-2)" "unprognostic (4.15e-2)" "unprognostic (9.66e-5)" "unprognostic (9.90e-3)" "unprognostic (1.30e-2)" "unprognostic (5.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (2.70e-1)" "unprognostic (1.97e-2)" "unprognostic (2.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.62e-2)" "unprognostic (2.17e-1)" 6.0 1.9 0.3 20.5 0.3 83.9 2.1 0.3 0.6 0.6 0.2 2.1 1.2 0.9 0.2 1.6 3.4 2.1 2.6 0.4 0.1 0.8 12.0 9.3 11.7 0.1 0.0 0.7 0.8 0.1 0.8 0.9 0.0 0.7 0.9 0.2 1.0 0.2 1.0 1.5 3.7 5.2 0.0 58.4 1.5 0.6 0.0 5.1 0.9 0.7 4.4 4.9 0.7 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 20.7 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.2 5.0 0.2 0.0 0.1 1.1 5.5 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.0 10.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.2 1.0 0.0 0.1 0.5 0.1 0.4 0.4 0.1 0.1 7.2 0.0 131.5 1167.5 39.9 3.0 1273.6 2.3 6.7 15.1 1.8 994.5 2.6 21.8 8.1 730.3 12.3 868.9 30.9 14.1 1071.9 0.3 0.3 0.3 0.6 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 9.1 1.0 5.8 4.0 0.1 0.3 1.2 3.4 0.7 0.4 0.9 1.5 2.8 0.0 0.0 0.3 1.7 0.3 0.0 0.2 0.2 0.4 0.4 7.4 0.0 2.5 1.4 0.7 0.5 2.0 1.1 0.6 1.3 4.0 108.1 2.0 17.3 1.7 1.1 0.0 0.0 356.7 164.1 0.3 0.9 177.3 5.4 0.0 473.7 0.3 4.1 2.0 0.3 0.3 0.1 1.2 1.2 0.3 0.1 0.5 7.5 1.9 0.0 1.5 1.2 0.0 0.2 0.5 3.0 0.4 4.8 3.1 0.6 0.0 CHST7 "C6ST-2, C6ST2" ENSG00000147119 "Carbohydrate sulfotransferase 7" Q9NS84 X 46573765-46598496 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 35.3" "Cell type enhanced" "Detected in many" "Langerhans cells: 45.4;monocytes: 55.5;Peritubular cells: 60.2;Sertoli cells: 52.6;Skeletal myocytes: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 18.5" "Group enriched" "Detected in many" 10 "granulocytes: 10.9;monocytes: 10.2;T-cells: 18.5" "Cell line enhanced" "Detected in many" "EFO-21: 22.8;NTERA-2: 20.5;PC-3: 17.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003919, HPA030503" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA 9800 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Vesicles" "HPA003919: AB_10601258, HPA030503: " "unprognostic (3.16e-1)" "prognostic favorable (7.20e-4)" "unprognostic (1.11e-1)" "unprognostic (2.66e-1)" "unprognostic (1.82e-2)" "unprognostic (7.85e-2)" "unprognostic (9.82e-3)" "unprognostic (3.52e-2)" "unprognostic (2.61e-1)" "unprognostic (2.81e-1)" "unprognostic (2.39e-3)" "unprognostic (6.71e-2)" "unprognostic (1.19e-1)" "unprognostic (8.85e-3)" "unprognostic (8.28e-2)" "unprognostic (1.50e-1)" "unprognostic (4.39e-2)" 13.2 3.4 5.4 1.7 7.3 2.5 7.5 6.4 7.0 11.2 3.7 3.7 0.8 5.8 0.4 2.5 4.9 1.9 17.4 5.4 7.1 4.0 7.5 3.6 1.8 6.1 7.3 35.3 2.0 1.2 4.2 2.0 6.0 4.1 0.8 0.9 3.5 1.4 4.4 7.3 4.0 1.4 4.7 10.2 3.4 2.1 8.0 1.4 5.8 3.9 0.7 4.5 7.7 4.0 5.5 4.7 3.9 3.5 10.8 7.5 0.2 7.6 5.4 2.0 2.6 1.2 2.1 0.0 22.8 3.1 1.3 4.1 3.8 1.3 1.7 3.2 8.1 1.1 0.3 4.1 16.6 1.9 0.1 2.5 1.1 3.8 3.1 3.4 6.2 2.5 0.0 4.7 1.5 2.6 0.7 2.4 20.5 0.4 17.0 3.6 3.2 10.3 5.5 0.2 8.8 3.4 1.1 0.2 0.9 9.6 1.3 0.4 1.4 6.1 0.6 3.3 3.5 11.0 2.4 1.7 6.8 0.1 0.4 2.4 2.2 0.7 1.5 7.1 1.4 1.2 5.8 2.8 1.2 0.6 1.2 1.1 10.9 0.6 10.2 0.8 18.5 1.9 5.4 7.3 6.4 7.0 5.4 7.1 6.1 7.3 6.0 4.7 8.0 4.0 33.8 0.0 3.1 22.9 2.5 12.4 2.0 4.8 1.2 0.8 2.2 3.7 7.4 10.0 2.6 1.8 0.0 5.3 11.5 1.7 1.9 2.8 0.0 3.6 20.8 16.3 0.0 0.0 0.9 2.5 4.3 23.6 0.0 1.6 0.0 19.7 15.7 4.5 11.5 3.3 4.1 2.9 0.0 14.2 45.4 0.3 19.0 14.1 14.2 4.7 55.5 5.2 4.1 13.0 1.0 1.8 1.5 60.2 4.7 6.7 0.7 2.1 1.9 0.8 52.6 43.1 11.2 0.5 1.3 1.3 13.2 1.4 9.9 11.4 0.9 3.3 CLCNKB hClC-Kb ENSG00000184908 "Chloride voltage-gated channel Kb" P51801 1 16043736-16057308 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Bartter syndrome, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 209.7" "Cell type enhanced" "Detected in some" "Collecting duct cells: 23.9;Distal tubular cells: 58.7;Early spermatids: 24.6;Ionocytes: 116.0;Late spermatids: 104.2" "Cancer enriched" "Detected in some" 9 "renal cancer: 24.9" "Region enriched" "Detected in some" 6 "cerebellum: 7.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.6;HeLa: 1.1" HPA057717 Uncertain NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "HPA057717: AB_2683509" "unprognostic (9.05e-4)" "unprognostic (1.72e-1)" "unprognostic (2.41e-2)" "unprognostic (2.68e-3)" "unprognostic (1.44e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-4)" "unprognostic (1.87e-1)" "unprognostic (3.61e-2)" "unprognostic (2.31e-1)" "unprognostic (4.57e-2)" "unprognostic (1.02e-1)" "prognostic favorable (1.27e-7)" "unprognostic (2.04e-2)" "unprognostic (4.62e-1)" "unprognostic (1.78e-2)" "unprognostic (5.14e-2)" 0.6 1.7 0.1 0.0 0.3 0.0 0.3 7.0 0.3 0.7 0.6 0.4 0.0 0.9 0.7 0.2 0.4 0.2 4.0 0.1 0.3 209.7 0.0 0.4 0.0 0.4 0.5 1.3 1.1 4.9 2.5 0.3 1.2 0.7 0.3 1.2 48.1 1.5 0.1 0.1 0.1 0.3 0.3 0.1 0.7 2.8 0.5 0.1 16.1 0.1 0.0 0.1 0.4 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.7 0.0 1.6 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 7.0 0.3 0.1 0.3 0.4 0.5 1.2 0.3 0.5 0.6 0.0 3.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.1 0.3 4.2 0.0 1.4 23.9 0.0 0.3 0.0 0.6 58.7 1.0 24.6 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.3 116.0 0.0 0.0 104.2 0.9 0.0 0.0 1.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 1.6 0.9 0.0 0.0 0.5 0.1 0.0 0.9 0.1 CLDN1 "ILVASC, SEMP1" ENSG00000163347 "Claudin 1" O95832 3 190305707-190322446 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 309.8;skin 1: 288.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 12 "spinal cord: 25.4" "CAB002602, HPA048319" Enhanced NA NA "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "CAB002602: , HPA048319: AB_2680355" "unprognostic (5.89e-2)" "unprognostic (4.58e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (7.92e-3)" "unprognostic (2.43e-1)" "unprognostic (3.54e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (3.06e-1)" "unprognostic (1.13e-1)" "unprognostic (4.43e-2)" "unprognostic (9.20e-2)" "unprognostic (1.09e-3)" "unprognostic (1.22e-1)" 40.8 47.9 1.5 1.2 1.1 0.2 22.7 0.8 1.3 17.7 20.7 1.7 1.1 64.2 31.9 40.9 56.6 15.5 2.5 1.5 1.2 10.5 309.8 9.1 0.5 1.2 2.8 6.3 34.3 0.4 2.4 5.3 1.7 13.6 1.6 0.9 34.0 46.0 1.1 288.2 0.7 126.6 0.7 1.5 1.0 4.3 1.1 9.4 36.2 4.9 44.2 40.4 35.9 1.0 34.0 29.7 0.2 0.1 0.0 0.1 0.0 2.5 52.7 1.1 2.1 17.7 69.1 0.0 658.6 0.3 58.5 236.5 1.5 77.7 6.2 0.9 1.4 0.1 9.3 41.5 49.6 0.4 0.2 0.5 288.6 6.0 87.0 2.4 0.6 0.0 0.1 0.1 0.1 6.5 0.1 0.1 1.5 2.3 5.5 0.0 0.6 0.2 414.9 267.0 0.2 0.0 31.0 5.7 18.4 3.5 53.5 0.5 12.9 0.6 9.9 0.2 1.4 0.7 0.6 1.2 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.8 1.3 1.5 1.2 1.2 2.8 1.7 0.7 1.1 1.0 0.4 12.8 34.7 0.0 0.5 440.1 291.1 217.3 84.2 0.0 35.6 2.0 1.0 170.1 143.2 31.3 0.0 2.4 0.6 0.6 0.0 203.3 0.1 44.4 10.0 7.0 1.8 0.0 0.7 56.3 0.3 29.2 2.0 100.0 1.3 0.4 1.4 188.2 1.0 0.0 1.6 0.3 54.9 3.8 66.5 1.7 15.5 8.5 32.0 0.0 5.7 0.0 0.0 24.6 0.0 139.9 0.0 35.3 0.0 501.6 0.1 4.1 144.6 0.0 0.0 0.3 11.2 0.3 0.8 298.2 836.1 33.8 2.6 5.0 1.0 562.9 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412138 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 63.6" "Cell type enriched" "Detected in some" 8 "Distal tubular cells: 187.9" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 153 "EFO-21: 691.6;RPTEC TERT1: 233.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA056020: AB_2683011" "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.1 0.7 0.3 0.2 0.4 0.0 0.2 0.0 0.5 0.1 1.5 0.0 0.0 0.3 0.6 0.5 2.9 0.7 0.0 0.2 0.2 63.6 2.2 0.4 1.5 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.4 0.9 0.0 3.2 0.0 0.4 0.1 0.1 0.1 0.1 0.3 0.3 9.7 0.0 1.0 0.3 0.2 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 691.6 0.0 0.3 0.7 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 233.2 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 2.2 0.0 0.3 1.4 1.2 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.5 0.2 0.2 0.2 0.1 0.2 0.1 0.3 0.6 0.1 0.0 0.0 0.3 0.0 7.0 5.8 2.6 0.6 0.3 0.8 0.3 0.4 4.3 1.6 9.2 0.0 0.4 0.0 0.0 187.9 3.4 2.0 3.0 0.1 0.2 0.0 0.0 5.0 0.4 0.2 0.9 0.0 0.5 1.3 0.3 0.0 1.6 0.1 3.3 3.6 0.0 0.0 0.3 1.2 0.2 0.0 0.4 5.4 2.8 0.0 0.2 0.0 4.0 0.1 0.5 0.0 0.4 0.0 6.7 0.0 0.9 22.1 0.2 0.0 0.8 0.6 0.3 0.3 0.9 12.6 6.2 0.2 0.2 0.0 3.1 COL18A1 "KNO, KNO1, KS" ENSG00000182871 "Collagen type XVIII alpha 1 chain" P39060 21 45405165-45513720 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 561.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 479.6;Sertoli cells: 223.5;Smooth muscle cells: 268.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 3.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 139.0;EFO-21: 309.4;NTERA-2: 170.6;RPTEC TERT1: 131.6;TIME: 186.0" "Region enriched" "Detected in all" 6 "cerebellum: 22.1" "Low region specificity" "Detected in all" "HPA030933, HPA036104" Supported Approved "Golgi apparatus" "Secreted to extracellular matrix" NA NA 290000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA030933: , HPA036104: AB_2674943" "unprognostic (4.32e-2)" "unprognostic (1.20e-1)" "unprognostic (1.76e-2)" "unprognostic (3.47e-2)" "unprognostic (3.25e-2)" "unprognostic (5.55e-2)" "prognostic favorable (6.16e-4)" "unprognostic (4.23e-3)" "unprognostic (9.93e-2)" "unprognostic (3.48e-1)" "unprognostic (2.77e-1)" "unprognostic (5.50e-2)" "unprognostic (1.70e-1)" "unprognostic (1.83e-2)" "unprognostic (9.44e-2)" "unprognostic (9.10e-3)" "unprognostic (2.25e-3)" 136.4 87.6 14.5 33.9 22.3 15.9 97.1 26.4 21.8 229.4 34.4 91.2 30.4 135.6 35.4 50.1 118.3 28.9 122.2 15.7 18.1 218.2 561.9 83.2 19.8 43.7 28.6 257.3 102.3 7.9 106.5 40.7 39.1 91.0 5.5 5.4 35.8 46.8 26.5 77.8 65.7 28.5 26.6 86.8 44.5 30.0 27.0 9.0 101.1 7.4 7.2 109.8 112.2 45.4 10.5 84.0 20.6 18.0 38.6 31.9 3.3 82.0 139.0 39.1 10.5 48.8 28.9 1.5 309.4 82.8 21.6 37.9 4.6 5.0 7.4 0.7 20.0 47.9 1.4 69.6 37.3 0.7 4.4 37.6 3.3 3.8 4.5 8.5 121.3 0.5 49.6 0.3 14.4 16.7 0.8 3.2 170.6 3.2 30.7 0.7 12.6 4.0 131.6 1.3 22.8 16.3 7.6 7.8 26.6 73.0 7.5 9.9 186.0 0.5 11.4 0.4 17.7 0.4 0.8 1.5 0.1 1.7 32.7 0.8 0.1 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 0.1 0.0 0.1 14.5 22.3 26.4 21.8 15.7 18.1 43.7 28.6 39.1 26.6 27.0 45.4 156.9 0.0 4.1 6.5 3.9 67.7 15.5 19.0 67.7 13.5 9.3 32.1 15.7 61.5 5.0 112.2 4.2 1.9 3.4 0.1 9.8 117.5 1.5 58.3 99.5 91.2 0.0 33.0 4.9 5.8 1.1 101.1 3.6 144.2 57.8 6.6 75.0 479.6 2.4 0.0 15.8 0.1 4.1 12.1 32.5 6.7 79.9 6.5 49.8 82.4 3.2 141.9 7.2 4.0 28.0 9.9 0.0 126.0 4.6 14.0 0.0 72.9 0.7 6.3 223.5 138.2 268.6 4.1 6.0 7.9 28.6 2.5 15.3 47.5 0.4 2.6 COL4A1 ENSG00000187498 "Collagen type IV alpha 1 chain" P02462 13 110148963-110307157 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 900.3" "Cell type enhanced" "Detected in many" "Adipocytes: 401.4;Endometrial stromal cells: 312.2;Endothelial cells: 385.9;Extravillous trophoblasts: 672.4;Sertoli cells: 506.2;Smooth muscle cells: 415.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Cell line enhanced" "Detected in many" "ASC diff: 501.6;EFO-21: 915.3;TIME: 331.3" "Low region specificity" "Detected in all" CAB001695 Approved "Secreted to extracellular matrix" NA NA 75000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 28: Placenta - Pregnancy" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "CAB001695: " "unprognostic (3.82e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (2.27e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-1)" "unprognostic (6.51e-3)" "unprognostic (1.06e-2)" "unprognostic (9.79e-2)" "unprognostic (1.73e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.47e-3)" "unprognostic (1.72e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-2)" 348.4 33.6 10.8 135.9 5.2 0.4 130.4 3.7 9.0 65.7 8.9 108.5 24.8 105.3 14.8 40.8 64.1 116.8 81.9 12.6 5.2 53.4 22.1 137.0 27.7 9.1 7.0 27.0 36.0 36.3 12.8 900.3 7.5 53.6 30.4 1.8 19.0 85.6 40.1 25.2 43.4 312.7 6.8 76.3 50.1 10.7 13.7 10.7 54.7 47.0 11.1 120.8 38.2 6.9 40.0 15.2 195.9 0.3 501.6 148.9 274.9 246.2 59.5 134.0 65.3 4.2 0.8 0.1 915.3 46.2 59.7 26.8 0.0 55.8 30.3 1.3 29.5 0.2 28.2 0.0 142.8 0.0 0.4 49.7 8.9 132.8 59.4 212.8 207.7 0.1 0.3 0.2 31.1 0.1 0.1 0.8 28.1 0.2 3.6 0.4 58.6 0.1 278.8 0.0 1.4 29.8 0.1 0.4 61.0 192.4 0.1 13.9 331.3 39.9 121.4 1.0 97.4 0.3 1.8 3.9 0.4 0.7 297.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 10.8 5.2 3.7 9.0 12.6 5.2 9.1 7.0 7.5 6.8 13.7 6.9 401.4 41.7 8.9 5.2 1.9 14.0 9.7 8.5 2.8 1.0 3.5 16.5 41.1 10.0 0.9 23.9 0.0 49.7 0.5 0.1 1.9 22.6 0.7 19.8 312.2 385.9 0.0 0.0 10.5 0.2 672.4 211.8 1.5 48.7 1.3 215.8 134.6 1.3 27.7 0.0 18.9 0.5 0.0 4.4 19.2 2.8 38.5 4.2 30.2 36.5 0.6 2.5 0.0 1.0 0.9 0.6 0.1 109.4 0.5 6.2 0.5 26.7 2.8 0.4 506.2 142.8 415.1 1.2 5.0 0.8 15.2 45.0 4.2 45.9 0.6 2.2 COL4A2 "DKFZp686I14213, FLJ22259" ENSG00000134871 "Collagen type IV alpha 2 chain" P08572 13 110305812-110513209 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 474.0" "Cell type enhanced" "Detected in many" "Adipocytes: 313.6;Endometrial stromal cells: 308.3;Endothelial cells: 278.2;Extravillous trophoblasts: 512.9;Granulosa cells: 223.8;Sertoli cells: 374.7;Smooth muscle cells: 338.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 1041.3;WM-115: 428.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010751, HPA029118, HPA069337" Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA 2700000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "CAB010751: AB_476828, HPA029118: , HPA069337: " "unprognostic (2.43e-1)" "unprognostic (4.13e-3)" "unprognostic (8.04e-2)" "unprognostic (6.03e-3)" "unprognostic (2.20e-1)" "unprognostic (2.64e-2)" "unprognostic (3.45e-2)" "unprognostic (1.15e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.33e-2)" "unprognostic (1.57e-2)" "unprognostic (6.95e-2)" "prognostic unfavorable (9.25e-4)" 240.5 51.2 15.1 103.5 2.3 0.6 153.5 1.7 5.9 111.6 3.4 282.0 29.5 219.4 10.4 51.8 122.9 84.2 113.0 19.3 1.8 71.7 19.1 181.7 22.8 4.3 7.8 51.9 32.6 25.6 17.5 474.0 6.0 121.3 18.9 2.8 35.0 95.8 44.7 45.2 84.1 226.8 2.6 121.5 96.4 15.7 11.5 7.9 74.9 21.5 7.1 186.2 74.4 2.9 88.9 45.7 218.7 0.6 213.7 99.0 312.8 307.9 97.4 167.3 76.1 2.5 0.7 0.6 1041.3 60.0 75.0 85.4 0.1 82.4 27.3 28.1 46.3 0.2 76.6 0.7 150.5 0.5 1.0 42.8 4.5 114.8 71.2 193.5 158.5 0.0 1.3 0.9 25.4 0.3 0.3 12.1 34.2 0.8 11.7 0.6 87.8 0.4 125.6 0.0 6.4 35.4 0.3 0.9 81.2 84.7 0.6 6.7 327.7 94.9 237.9 2.3 161.9 0.6 3.0 7.4 5.8 0.4 428.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 2.3 1.7 5.9 19.3 1.8 4.3 7.8 6.0 2.6 11.5 2.9 313.6 83.3 5.8 17.9 2.9 9.6 8.0 16.3 1.8 2.4 7.0 56.8 31.8 20.0 1.8 53.3 0.0 77.4 0.1 10.0 1.9 39.0 1.7 19.4 308.3 278.2 0.0 8.0 17.7 4.4 512.9 159.1 5.6 50.1 1.3 223.8 102.1 1.8 30.9 0.0 44.0 7.0 2.0 3.3 13.3 3.4 60.6 3.8 39.2 46.9 2.0 7.3 0.0 5.5 1.1 2.8 1.4 176.0 1.5 12.3 23.9 32.7 2.1 0.3 374.7 64.7 338.9 0.9 8.5 0.7 7.0 67.2 3.6 49.4 5.4 2.4 CP ENSG00000047457 Ceruloplasmin P00450 3 149162410-149221829 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Copper transport, Ion transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 1871.4" "Cell type enhanced" "Detected in many" "Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4" "Cancer enhanced" "Detected in many" "liver cancer: 98.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "EFO-21: 318.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001834, CAB008591" Supported "Secreted to blood" NA NA 160000000000 440000000000 "Cluster 62: Liver - Hemostasis" "Cluster 38: EFO-21 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "CAB008591: AB_1613734, HPA001834: AB_1078502" "unprognostic (3.58e-1)" "unprognostic (4.24e-1)" "unprognostic (9.61e-2)" "unprognostic (1.80e-2)" "unprognostic (4.14e-2)" "unprognostic (1.02e-2)" "unprognostic (1.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "unprognostic (6.03e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.68e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (2.70e-1)" 13.0 2.3 17.9 2.2 18.1 0.9 20.8 18.7 29.8 70.2 129.2 13.0 9.8 14.8 0.0 5.6 8.3 1.1 39.2 17.5 33.0 9.5 1871.4 13.4 18.9 28.1 20.3 0.8 6.5 3.9 28.6 3.4 24.9 7.9 16.4 246.5 39.9 0.9 2.6 13.0 20.8 2.4 19.2 23.1 3.0 1.5 20.1 0.5 16.1 8.3 20.0 23.9 2.3 29.0 0.2 18.8 15.6 0.0 3.3 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 318.8 0.0 29.4 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.4 32.7 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 2.5 5.4 0.0 0.0 0.0 0.4 6.7 16.2 0.0 0.2 0.3 1.0 0.1 0.4 0.0 0.4 0.0 0.2 1.7 0.2 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.9 18.1 18.7 29.8 17.5 33.0 28.1 20.3 24.9 19.2 20.1 29.0 2.3 19.2 76.6 3.3 10.6 3.3 8.3 28.6 0.6 6.9 14.0 0.6 0.6 65.8 558.1 9.2 6.2 0.1 0.3 0.1 0.0 83.4 0.9 190.5 51.0 12.6 0.0 34.7 1.5 21.4 0.2 16.3 0.0 406.0 2.5 0.1 34.6 1687.2 0.6 5.0 1.4 0.2 8.2 44.6 6.9 1.2 0.3 4.0 0.0 6.5 1.6 720.5 1.0 0.5 2.0 69.3 0.0 0.4 0.3 19.5 0.0 0.3 318.4 24.8 0.0 0.8 15.3 0.0 0.1 0.8 2.6 0.3 4.9 0.1 0.1 79.0 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 1113.7" "Cell type enhanced" "Detected in many" "Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6" "Group enriched" "Detected in all" 30 "B-cells: 109.9;T-cells: 115.6" "Cell line enhanced" "Detected in many" "EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 160000 "Cluster 26: Non-specific - Mitochondria" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 177.6 44.7 160.4 31.3 172.0 1.5 162.5 137.7 259.5 101.6 124.2 101.9 27.0 138.1 36.4 127.3 130.0 47.9 1113.7 172.7 186.4 205.1 52.7 185.7 30.0 157.3 158.7 51.2 46.1 19.2 175.0 49.6 158.6 89.0 8.3 4.1 100.0 72.9 52.5 128.9 82.8 32.0 145.0 104.1 66.1 92.8 191.9 10.4 155.6 42.7 16.5 121.4 100.4 140.8 2.5 201.2 37.9 98.3 4.3 19.9 10.0 17.5 1.9 2.8 1.0 7.1 44.2 0.2 321.9 73.8 4.5 166.8 3.6 50.8 0.1 2.3 1.9 0.2 132.5 73.8 24.3 0.0 25.5 10.5 4.4 5.2 26.2 38.4 192.7 0.2 0.5 1.4 26.8 306.5 0.5 0.6 10.0 45.7 143.4 0.4 7.7 9.9 140.1 0.6 61.6 175.3 30.0 303.7 1.9 4.9 266.4 0.1 259.3 82.7 38.8 2.3 50.5 0.7 0.6 0.9 24.3 0.3 179.3 0.2 1.9 0.0 7.5 0.9 6.8 52.1 80.4 17.2 3.6 109.9 17.8 4.5 1.0 3.7 0.5 0.5 115.6 10.4 160.4 172.0 137.7 259.5 172.7 186.4 157.3 158.7 158.6 145.0 191.9 140.8 459.4 157.0 33.7 17.9 15.0 153.2 96.7 206.4 29.0 2.7 110.0 140.7 863.3 107.2 127.1 189.4 4.2 2.6 8.2 0.9 154.6 106.8 37.9 125.1 28.8 510.4 25.2 9.7 16.4 87.6 30.5 132.9 32.1 126.6 7.6 0.4 346.3 30.4 3.0 94.2 3.0 0.3 81.4 11.8 92.6 84.0 28.0 9.3 156.5 27.2 2.5 57.2 1.0 4.5 3.1 48.9 0.1 14.7 7.0 37.4 0.2 17.0 155.7 4.0 276.1 108.1 339.5 27.8 46.1 20.1 196.8 32.0 32.5 5.9 0.2 103.2 CTRB1 CTRB ENSG00000168925 "Chymotrypsinogen B1" P17538 16 75218988-75226338 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Digestion "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 2384 "pancreas: 133851.7" "Cell type enriched" "Detected in some" 21 "Exocrine glandular cells: 31269.6" "Cancer enriched" "Detected in some" 1905 "pancreatic cancer: 962.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;HDLM-2: 1.6" "Secreted to digestive system" NA NA "Cluster 25: Pancreas - Digestion" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.76e-1)" "unprognostic (2.62e-1)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (5.22e-2)" "unprognostic (4.43e-3)" "unprognostic (2.96e-1)" "unprognostic (1.17e-2)" 25.5 5.1 0.2 2.1 0.2 1.0 9.5 0.5 0.3 10.4 0.0 4.3 16.6 4.2 0.5 6.8 3.0 0.0 22.3 0.0 0.0 4.4 13.2 2.9 2.6 0.1 0.1 56.1 133851.7 0.0 7.2 6.5 0.1 5.6 0.0 0.0 22.3 0.2 3.8 5.8 8.9 0.0 0.0 11.7 7.6 3.4 0.1 0.0 2.8 0.1 0.0 2.4 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.7 0.0 0.1 0.1 2.0 0.0 0.0 0.1 31269.6 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 151.9 0.0 0.0 0.0 0.1 1430.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 CXCL1 "FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1" ENSG00000163739 "C-X-C motif chemokine ligand 1" P09341 4 73869393-73871308 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Inflammatory response" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 102.2;lymphoid tissue: 196.6" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 16674.3;Club cells: 7384.0;Ionocytes: 4146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 243 "neutrophil: 47.3" "Lineage enriched" "Detected in single" 243 "granulocytes: 47.3" "Group enriched" "Detected in many" 6 "BJ hTERT+: 748.4;EFO-21: 1906.7;RPTEC TERT1: 682.0" "Secreted to blood" NA NA 384000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "prognostic favorable (7.83e-4)" "prognostic unfavorable (7.23e-4)" "unprognostic (5.24e-3)" "unprognostic (1.27e-1)" "unprognostic (1.33e-2)" "unprognostic (4.23e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (2.33e-1)" "unprognostic (5.45e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.17e-1)" "unprognostic (5.30e-2)" "unprognostic (7.41e-2)" "unprognostic (9.41e-2)" 38.0 6.2 4.3 49.0 4.9 41.6 3.8 3.6 8.1 102.2 4.8 14.6 10.6 2.3 0.1 38.7 14.9 25.7 28.3 3.5 3.7 18.7 10.2 45.2 2.4 4.0 3.7 2.4 25.7 0.4 2.0 5.1 4.3 18.7 16.0 0.4 23.7 9.5 1.7 2.2 26.9 3.0 4.1 196.6 9.1 0.2 5.4 2.9 1.9 1.9 23.6 75.5 25.5 4.2 3.7 4.4 0.0 0.0 4.4 11.7 0.0 20.6 748.4 17.7 18.8 0.2 13.4 0.0 1906.7 1.3 72.5 38.6 0.0 3.5 94.2 2.8 0.0 0.0 1.3 0.0 4.4 0.0 0.0 9.7 1.3 133.2 10.6 1.4 144.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 7.7 5.4 0.0 0.0 0.0 682.0 16.7 0.1 0.0 1.5 0.3 40.4 2.0 0.5 1.9 173.9 0.0 6.6 37.8 1.5 0.0 1.6 3.7 1.9 0.1 26.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 0.0 0.0 0.0 0.0 0.0 4.3 4.9 3.6 8.1 3.5 3.7 4.0 3.7 4.3 4.1 5.4 4.2 7.9 44.8 273.3 0.0 2.9 126.6 991.1 16674.3 131.5 0.0 61.3 42.9 4.1 413.2 7384.0 5.5 0.0 0.3 1.4 40.3 0.0 1073.2 0.0 152.2 21.5 106.7 635.7 0.0 0.0 42.5 0.7 449.0 20.9 199.0 15.8 1.4 3.9 2.1 26.7 0.0 0.0 31.1 4146.2 10.4 467.3 0.0 0.0 110.8 124.5 0.0 56.9 0.0 0.0 0.0 0.0 232.8 7.6 0.0 0.1 2062.0 19.6 3.1 1219.7 0.0 0.0 152.9 217.7 0.4 0.2 48.7 105.1 0.4 27.8 0.1 66.0 1251.3 CXCL6 "CKA-3, GCP-2, SCYB6" ENSG00000124875 "C-X-C motif chemokine ligand 6" P80162 4 73836640-73849064 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 36.0;lymphoid tissue: 100.8;urinary bladder: 26.5" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 241.2;Basal respiratory cells: 509.4;Cholangiocytes: 317.4;Club cells: 361.3;Ductal cells: 1120.6;Prostatic glandular cells: 245.5;Urothelial cells: 328.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebral cortex: 5.3" "Immune cell enriched" "Detected in single" 104 "neutrophil: 10.4" "Lineage enriched" "Detected in single" 104 "granulocytes: 10.4" "Cell line enhanced" "Detected in some" "BJ hTERT+: 53.2;EFO-21: 136.5;hTEC/SVTERT24-B: 28.8;HUVEC TERT2: 84.5;RPTEC TERT1: 98.4" "Region enhanced" "Detected in many" "basal ganglia: 9.6" "Not detected" "Not detected" "Secreted to blood" NA NA 108000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (4.35e-4)" "unprognostic (4.47e-2)" "unprognostic (6.09e-2)" "unprognostic (4.60e-2)" "unprognostic (1.98e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-3)" "unprognostic (2.62e-1)" "unprognostic (2.05e-1)" "unprognostic (2.02e-2)" "unprognostic (3.75e-2)" "unprognostic (9.02e-2)" "prognostic unfavorable (4.82e-4)" "unprognostic (2.47e-1)" "unprognostic (4.88e-1)" "unprognostic (2.72e-1)" "unprognostic (4.48e-2)" 6.0 0.1 0.5 14.1 0.8 2.1 0.6 0.2 5.3 4.6 2.7 0.9 8.0 0.0 0.1 2.5 2.4 36.0 3.2 0.3 0.6 3.7 6.6 2.7 0.3 0.4 0.4 0.1 5.3 0.0 0.2 0.1 0.6 3.5 0.6 0.0 3.8 10.8 0.0 0.0 10.3 0.3 0.2 100.8 1.2 0.3 0.9 2.6 0.0 0.3 2.8 26.5 5.6 0.3 0.0 0.0 0.5 0.0 4.4 16.6 0.0 3.3 53.2 0.4 0.7 0.0 0.0 0.0 136.5 0.2 5.3 11.8 0.0 0.0 8.1 1.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 10.1 0.3 28.8 0.0 0.4 84.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 0.0 3.9 0.0 0.0 0.0 98.4 1.9 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 1.4 0.9 0.5 0.0 0.6 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.2 5.3 0.3 0.6 0.4 0.4 0.6 0.2 0.9 0.3 0.0 3.2 2.0 0.0 0.1 0.4 241.2 509.4 0.0 0.0 2.9 1.3 0.2 317.4 361.3 0.0 0.0 0.0 0.0 0.2 0.0 1120.6 0.0 0.7 0.1 2.0 78.1 0.0 0.0 3.9 0.0 13.2 0.0 1.3 0.0 0.3 0.0 0.6 0.2 0.0 0.0 0.2 97.6 0.3 0.8 0.1 0.0 1.1 0.0 0.0 7.8 0.0 0.0 0.0 0.0 43.5 0.0 0.0 0.0 245.5 0.0 0.3 75.7 0.0 0.0 1.5 18.4 0.0 1.2 0.3 0.1 0.0 0.1 0.0 0.1 328.4 DCAF12L1 "KIAA1892L, WDR40B" ENSG00000198889 "DDB1 and CUL4 associated factor 12 like 1" Q5VU92 X 126549383-126552814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 4.9;testis: 6.2" "Group enriched" "Detected in some" 4 "Early spermatids: 20.7;Late spermatids: 44.4;Spermatogonia: 14.4" "Cancer enhanced" "Detected in some" "renal cancer: 1.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "EFO-21: 15.2;U-2 OS: 8.4" "HPA044737, HPA048981, HPA053138" Approved Uncertain Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054" "unprognostic (2.62e-5)" "unprognostic (2.88e-1)" "unprognostic (1.19e-1)" "unprognostic (3.40e-1)" "unprognostic (1.39e-3)" "unprognostic (1.34e-1)" "unprognostic (2.34e-1)" "unprognostic (1.74e-1)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 4.9 0.0 2.5 1.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.0 0.8 6.2 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.7 3.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.3 3.8 14.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 DEFB4A "DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1" ENSG00000171711 "Defensin beta 4A" O15263 8 7894677-7896716 "Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial, Defensin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "esophagus: 124.1" "Group enriched" "Detected in some" 8 "Basal respiratory cells: 79.5;Club cells: 38.3;Exocrine glandular cells: 37.4;Pancreatic endocrine cells: 41.0" "Group enriched" "Detected in many" 6 "head and neck cancer: 32.2;melanoma: 9.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "EFO-21: 1.4" "Secreted in other tissues" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (6.96e-2)" "unprognostic (1.17e-2)" "unprognostic (2.72e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.75e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 124.1 0.1 3.6 0.0 0.0 0.0 0.1 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 3.2 0.4 0.0 0.0 0.0 7.3 0.0 0.0 5.0 0.0 0.0 7.6 0.2 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.5 0.0 0.0 0.0 0.0 0.0 0.0 38.3 0.0 0.0 0.1 0.0 5.6 0.0 4.3 0.0 5.3 0.2 0.0 0.0 0.0 0.0 37.4 0.0 0.0 3.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 1.1 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.6 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299330 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 422.9;Oligodendrocytes: 1542.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 20.7 14.5 26.4 14.7 57.0 16.2 18.4 33.2 36.4 23.8 15.4 24.2 24.0 19.7 11.6 37.6 16.1 17.1 19.4 25.4 29.3 27.6 25.9 18.0 14.7 36.9 43.3 23.3 17.2 31.7 14.4 21.3 34.8 15.9 26.3 38.8 20.2 18.6 25.2 18.8 25.4 21.2 19.9 13.0 22.9 15.5 50.3 27.1 43.3 28.2 20.6 20.3 20.5 73.5 128.0 20.0 40.3 75.7 34.2 36.2 40.7 52.2 46.2 49.2 59.0 60.4 59.8 41.5 127.1 47.7 95.7 86.4 39.3 76.4 97.7 10.9 22.5 35.2 31.1 40.5 35.2 35.0 33.3 27.8 43.3 49.1 101.3 163.1 64.8 32.2 26.7 51.4 125.6 41.5 51.3 12.9 35.3 71.1 35.4 26.7 51.6 26.8 51.9 55.3 19.7 32.3 72.9 49.5 49.4 46.7 108.8 26.0 62.5 127.5 33.5 36.1 79.9 76.0 50.6 50.6 50.3 51.8 40.0 2.5 0.7 1.2 0.8 0.7 1.3 1.6 1.3 0.9 0.8 1.2 1.3 1.3 2.4 1.1 0.4 1.1 1.0 0.8 26.4 57.0 33.2 36.4 25.4 29.3 36.9 43.3 34.8 19.9 50.3 73.5 24.0 25.6 25.7 113.3 28.5 53.3 52.3 45.5 40.5 42.0 29.6 23.0 25.6 35.8 44.6 49.7 95.9 48.9 25.2 72.4 5.9 22.8 12.9 51.8 37.4 28.1 28.9 17.5 422.9 20.2 19.5 27.7 51.5 68.5 12.0 29.9 27.8 54.6 14.9 37.0 117.8 34.4 28.5 26.4 26.0 19.2 28.6 19.2 37.4 165.8 18.3 71.9 43.3 257.3 1542.2 30.3 48.0 25.6 34.1 52.3 50.6 20.8 66.3 101.7 13.1 40.5 25.5 31.2 37.9 66.7 70.8 25.0 30.6 29.3 38.8 106.8 DNAJB6 "LGMD1D, MRJ" ENSG00000105993 "DnaJ heat shock protein family (Hsp40) member B6" O75190 7 157335381-157417439 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004670, HPA024258, HPA058593" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767" "unprognostic (4.37e-1)" "unprognostic (1.62e-2)" "unprognostic (3.22e-2)" "unprognostic (9.26e-3)" "unprognostic (6.66e-3)" "unprognostic (4.68e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.01e-2)" "unprognostic (8.41e-2)" "unprognostic (3.19e-1)" "unprognostic (6.33e-2)" "unprognostic (2.24e-1)" "unprognostic (1.54e-1)" "unprognostic (6.45e-2)" "unprognostic (1.52e-1)" 82.7 66.0 112.4 55.9 119.0 183.2 87.0 124.0 219.8 76.0 125.6 103.7 43.5 81.5 109.4 117.0 73.8 50.5 121.0 119.5 122.2 73.3 49.8 69.9 54.8 122.8 122.8 76.6 43.6 57.6 65.2 73.7 123.7 58.1 49.2 87.4 74.8 70.5 328.3 132.7 56.9 73.3 120.3 59.3 62.1 118.2 118.5 81.1 52.6 177.5 68.0 92.7 90.8 139.5 179.8 106.7 127.0 130.9 126.3 113.1 117.6 196.2 159.8 179.1 194.4 146.4 176.0 68.7 359.2 146.9 162.4 111.9 87.3 137.8 275.3 138.3 119.6 123.1 61.7 104.6 116.1 92.4 99.4 100.2 130.7 136.1 64.2 178.9 135.6 72.2 203.8 66.9 232.5 121.7 232.4 181.0 255.7 126.1 141.2 122.7 91.1 96.0 148.9 108.1 76.5 201.2 153.5 119.3 151.2 259.6 87.2 129.8 170.0 113.0 85.4 270.6 172.0 126.1 193.1 80.9 160.1 208.7 146.4 345.1 160.8 201.9 133.8 168.2 135.2 134.8 120.8 138.4 120.2 124.0 152.0 141.7 287.8 148.0 206.3 109.9 159.6 247.0 112.4 119.0 124.0 219.8 119.5 122.2 122.8 122.8 123.7 120.3 118.5 139.5 225.2 48.1 62.7 41.1 150.9 756.7 640.9 632.6 182.7 100.4 281.8 175.9 115.0 62.9 206.8 97.5 81.3 276.9 287.0 143.0 193.7 134.9 105.8 225.6 125.2 178.8 193.5 131.1 49.4 69.4 241.8 159.8 66.8 296.3 212.7 70.5 101.4 46.7 164.7 94.2 56.4 149.8 223.8 133.7 803.5 126.4 151.0 339.2 282.8 60.9 313.6 122.7 173.0 37.2 73.5 138.5 132.4 202.3 132.9 413.2 82.4 196.1 253.8 104.0 98.6 146.0 198.8 319.4 504.8 204.1 960.5 508.1 288.0 111.4 155.1 876.8 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 3.3" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 12.0;Spermatogonia: 14.5" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 6.0;EFO-21: 11.4;SuSa: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036134 Uncertain Approved Nucleoplasm NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.4 0.0 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 1.6 0.0 0.1 0.0 0.0 DYNC1I1 "DNCI1, DNCIC1" ENSG00000158560 "Dynein cytoplasmic 1 intermediate chain 1" O14576 7 95772506-96110322 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 457.5;Inhibitory neurons: 374.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 213.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 14.0;SH-SY5Y: 10.3;U-266/84: 9.5;WM-115: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061689 Enhanced Supported NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA061689: AB_2684586" "unprognostic (2.61e-1)" "unprognostic (4.58e-2)" "unprognostic (3.83e-2)" "prognostic favorable (3.79e-4)" "unprognostic (6.27e-2)" "unprognostic (2.11e-4)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (2.18e-2)" "unprognostic (1.85e-1)" "unprognostic (1.84e-3)" "unprognostic (5.86e-2)" "unprognostic (2.24e-4)" "unprognostic (2.25e-4)" "unprognostic (1.63e-1)" "unprognostic (7.81e-4)" "unprognostic (1.10e-2)" 2.5 12.7 27.0 1.5 30.2 1.1 2.7 36.3 53.8 2.4 18.5 19.1 1.4 2.7 5.0 3.4 2.6 2.0 19.0 30.9 34.2 2.2 0.3 1.0 0.8 36.1 41.6 7.8 2.0 0.6 19.6 0.8 52.5 7.4 3.0 27.4 1.4 8.2 9.6 2.6 2.3 3.6 7.6 1.4 5.5 2.4 13.4 3.8 2.9 12.4 0.6 19.8 3.5 31.0 0.4 0.3 0.1 1.3 0.2 0.1 0.5 0.2 0.0 0.7 0.2 1.7 1.1 0.5 14.0 1.9 1.0 0.6 4.9 0.3 0.3 0.1 1.1 3.5 0.6 0.0 0.1 0.4 4.6 0.2 0.3 0.3 0.5 0.6 0.3 2.1 0.6 0.5 2.2 3.2 0.4 0.6 0.9 0.3 2.9 0.8 0.4 2.0 1.8 1.6 1.8 10.3 0.1 0.2 2.3 7.5 1.0 0.9 0.4 4.0 2.8 2.2 2.2 7.3 9.5 0.4 4.6 0.5 9.2 0.5 0.3 0.2 0.3 0.2 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.2 1.4 0.6 0.1 0.8 0.2 0.2 27.0 30.2 36.3 53.8 30.9 34.2 36.1 41.6 52.5 7.6 13.4 31.0 1.6 0.0 0.0 21.5 0.2 0.8 1.3 0.0 1.2 49.6 3.6 1.3 30.9 0.0 0.0 0.0 50.1 1.3 0.0 0.0 0.0 0.3 6.8 22.3 1.7 4.2 1.8 0.0 457.5 1.1 0.1 6.7 0.0 24.4 0.0 3.8 15.0 0.5 0.5 1.7 374.1 0.0 0.0 0.3 0.8 5.2 19.0 3.0 21.4 30.9 0.1 83.5 0.0 91.0 213.8 0.9 0.0 11.7 1.4 0.7 0.0 0.3 0.0 24.8 6.6 19.4 9.1 1.2 4.0 0.4 1.1 0.1 0.4 1.2 0.0 0.6 EDN1 ET1 ENSG00000078401 "Endothelin 1" P05305 6 12290361-12297194 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 44.6" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "non-classical monocyte: 4.9" "Lineage enriched" "Detected in single" 6 "monocytes: 4.9" "Cell line enhanced" "Detected in many" "EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031976, CAB032500, CAB037291" Approved Approved "Nucleoplasm,Nucleoli,Golgi apparatus" "Secreted to blood" NA Yes 9740 "Cluster 14: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli, Golgi apparatus" Nucleoplasm "CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (3.95e-2)" "unprognostic (9.72e-2)" "unprognostic (3.40e-1)" "unprognostic (1.91e-1)" "unprognostic (6.24e-2)" "unprognostic (2.94e-3)" "unprognostic (1.42e-1)" "unprognostic (8.92e-2)" "unprognostic (4.19e-2)" "unprognostic (3.17e-1)" "unprognostic (8.02e-3)" "unprognostic (2.09e-1)" "unprognostic (1.71e-1)" "unprognostic (1.34e-1)" "unprognostic (3.47e-1)" 44.6 1.8 14.7 7.3 13.8 4.7 23.6 13.6 18.2 6.2 9.7 10.6 10.4 7.0 6.3 12.1 9.4 13.5 7.8 12.6 12.2 7.7 3.1 36.6 5.6 15.1 13.6 2.6 9.6 1.4 1.1 18.5 15.2 5.5 14.5 1.0 12.1 8.9 7.6 11.8 9.8 11.3 13.1 12.3 10.4 4.7 15.7 1.7 3.4 6.4 2.4 9.9 5.9 14.2 10.3 57.6 1.1 0.1 0.3 0.2 0.2 18.2 16.0 15.0 12.4 74.6 8.6 0.0 660.4 7.2 9.2 5.4 0.0 10.6 11.0 0.8 0.0 0.0 2.1 2.3 0.8 0.0 0.0 0.4 6.2 3.0 2.1 4.7 446.8 0.0 0.0 0.0 56.8 1.6 0.2 0.3 0.6 10.4 0.7 0.2 5.1 0.1 35.3 9.4 0.6 0.0 1.8 53.1 0.1 117.2 137.5 0.8 334.3 37.1 30.1 0.7 23.5 0.3 0.4 1.3 0.3 0.0 1.6 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 4.9 0.1 0.0 0.0 14.7 13.8 13.6 18.2 12.6 12.2 15.1 13.6 15.2 13.1 15.7 14.2 190.7 173.1 23.8 2.9 0.8 189.9 749.7 99.9 151.4 0.2 68.7 26.8 2.2 8.6 110.6 38.6 0.0 1.8 0.8 189.7 3.9 316.3 13.3 187.2 16.3 236.8 15.6 2.7 3.6 218.9 0.4 9.0 22.4 289.7 1.3 0.8 169.2 1.8 1.8 1.7 3.0 43.8 12.2 5.0 6.7 19.8 5.6 5.3 8.8 6.5 10.9 0.3 0.0 3.5 0.6 268.5 145.7 0.4 0.4 185.8 119.6 8.3 27.4 0.4 6.6 1.8 21.8 1.0 0.6 53.7 64.5 0.8 9.7 0.1 196.6 141.8 EDN2 ET2 ENSG00000127129 "Endothelin 2" P20800 1 41478775-41484683 "Predicted secreted proteins" "Vasoactive, Vasoconstrictor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 26.1;esophagus: 20.8;vagina: 32.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 239.7;Basal respiratory cells: 137.3;Club cells: 146.1;Collecting duct cells: 69.9;Prostatic glandular cells: 62.5;Proximal enterocytes: 91.7" "Cancer enhanced" "Detected in many" "cervical cancer: 24.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;EFO-21: 35.9;HeLa: 13.0;SCLC-21H: 16.8;SK-BR-3: 41.2;U-2 OS: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA028459 Uncertain Approved Cytosol "Secreted to blood" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "HPA028459: AB_10602490" "unprognostic (2.71e-2)" "unprognostic (5.64e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.47e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.04e-1)" "unprognostic (5.44e-2)" "unprognostic (5.61e-2)" "prognostic unfavorable (5.81e-4)" "unprognostic (5.59e-2)" "unprognostic (1.28e-2)" "unprognostic (8.47e-2)" "unprognostic (1.76e-1)" "unprognostic (6.14e-2)" "unprognostic (3.85e-1)" 0.3 0.1 0.0 0.0 0.0 0.1 3.1 0.0 0.0 26.1 1.0 1.9 3.9 3.1 4.7 20.8 1.6 0.2 1.4 0.1 0.0 7.4 1.2 3.7 0.0 0.1 0.1 0.1 2.4 0.0 2.1 0.0 0.1 7.5 0.9 0.2 8.0 0.5 0.2 15.0 17.4 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.5 0.0 0.3 2.4 32.7 0.1 0.2 0.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 13.8 0.0 35.9 0.0 0.0 1.7 0.0 0.1 0.0 4.2 0.0 0.0 13.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.8 0.4 0.0 0.0 1.3 8.4 9.4 0.9 16.8 0.0 0.3 41.2 0.0 0.9 0.8 0.0 0.0 0.0 15.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 6.4 1.5 0.0 0.0 30.3 239.7 137.3 8.6 0.1 2.5 1.3 0.7 2.8 146.1 69.9 0.0 0.2 0.1 23.3 0.0 8.8 0.0 36.9 0.5 0.6 1.8 0.0 0.0 1.0 0.0 1.8 3.1 6.5 0.0 0.3 0.0 0.2 0.0 0.0 0.0 4.2 38.7 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 10.9 2.7 0.0 0.1 62.5 91.7 1.6 20.9 0.0 0.0 0.4 3.5 0.0 0.2 2.4 29.1 0.0 0.7 0.8 8.2 45.2 ENAH "FLJ10773, MENA, NDPP1" ENSG00000154380 "ENAH actin regulator" Q8N8S7 1 225486835-225653142 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028448, HPA028696" Enhanced Enhanced "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 15000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Focal adhesion sites, Cytosol" "HPA028448: AB_10600766, HPA028696: AB_10611249" "unprognostic (2.56e-2)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.61e-3)" "unprognostic (2.85e-1)" "unprognostic (1.21e-3)" "unprognostic (2.30e-1)" "unprognostic (2.23e-1)" "unprognostic (9.22e-2)" "unprognostic (4.71e-3)" "unprognostic (2.14e-1)" "unprognostic (2.24e-3)" "unprognostic (8.84e-2)" "unprognostic (5.83e-2)" "unprognostic (7.92e-2)" "unprognostic (2.93e-2)" 26.3 20.2 30.3 16.5 25.9 0.5 13.4 21.1 20.3 13.5 2.0 30.9 12.5 23.6 13.7 16.2 15.0 23.6 25.2 27.2 35.7 7.0 7.5 17.3 4.7 35.5 34.2 22.6 22.3 17.9 6.5 18.2 28.1 21.4 10.1 8.1 20.9 30.6 20.4 10.6 10.8 57.6 22.4 24.8 23.3 25.0 40.9 9.0 7.3 11.5 4.6 30.1 13.8 28.7 91.6 71.9 87.1 79.0 33.3 43.7 111.9 99.1 47.3 58.4 43.9 46.4 33.0 38.7 256.8 153.9 52.5 79.0 102.7 37.4 55.2 0.6 63.4 40.3 62.4 63.1 99.4 4.8 1.5 67.9 44.2 75.9 96.2 47.8 47.0 10.7 2.7 1.9 58.6 17.7 18.5 4.7 146.8 23.9 64.3 27.6 122.9 1.1 26.9 69.5 85.3 68.9 194.6 73.3 63.3 66.1 87.5 5.9 92.2 150.4 109.8 126.8 198.6 4.2 11.4 25.7 82.7 5.0 78.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 30.3 25.9 21.1 20.3 27.2 35.7 35.5 34.2 28.1 22.4 40.9 28.7 117.0 12.8 37.3 81.9 3.8 129.0 172.5 64.4 26.2 11.2 96.2 57.9 119.3 54.3 56.5 22.0 62.6 65.0 1.7 14.8 3.9 84.7 74.8 127.2 60.5 79.3 41.4 0.0 86.3 100.5 18.5 71.6 63.2 75.0 5.1 194.2 23.9 12.9 11.2 16.8 155.0 27.3 26.4 1.6 29.7 24.3 58.1 4.3 83.6 41.2 3.8 32.6 3.1 160.4 151.3 61.5 16.5 168.9 1.6 133.1 3.5 19.6 137.8 19.0 92.1 69.4 166.1 13.4 37.2 25.6 134.1 60.5 4.8 220.7 31.3 100.3 ERLIN2 "C8orf2, Erlin-2, NET32, SPFH2, SPG18" ENSG00000147475 "ER lipid raft associated 2" O94905 8 37736601-37758422 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002025, CAB014894" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Endoplasmic reticulum" "CAB014894: , HPA002025: AB_1080077" "unprognostic (5.82e-3)" "unprognostic (2.45e-1)" "prognostic favorable (5.16e-4)" "unprognostic (1.08e-2)" "prognostic unfavorable (4.51e-4)" "unprognostic (3.39e-2)" "unprognostic (1.89e-1)" "unprognostic (3.77e-2)" "unprognostic (6.67e-2)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.78e-3)" "prognostic favorable (6.67e-6)" "unprognostic (4.78e-2)" "unprognostic (2.83e-1)" "unprognostic (3.43e-1)" "unprognostic (2.33e-1)" 20.3 17.8 15.7 14.6 17.3 14.4 25.0 16.5 16.8 20.0 27.2 24.2 17.7 21.2 32.3 17.9 30.1 19.8 17.8 14.2 16.3 40.4 40.8 15.5 11.5 18.0 18.5 30.8 26.2 41.4 8.3 21.2 17.7 25.4 25.0 21.6 29.4 23.8 18.9 15.3 23.6 19.5 17.9 14.6 24.9 17.0 15.6 14.7 46.5 14.1 12.6 16.8 10.3 18.6 39.0 38.5 43.0 31.4 47.3 33.9 47.2 59.1 51.9 31.8 33.2 20.1 50.8 18.9 95.8 63.4 30.3 41.4 31.2 48.4 46.8 11.2 24.2 27.8 22.7 22.7 31.5 17.8 34.1 43.3 49.1 46.3 48.1 39.6 30.7 17.2 51.1 17.7 47.4 18.3 25.8 14.7 45.9 53.8 17.7 17.9 29.9 15.2 42.8 41.9 7.7 20.7 39.3 12.6 35.6 50.1 62.0 27.1 31.1 30.9 26.4 56.8 31.1 24.3 41.0 24.2 55.0 28.4 40.7 1.3 6.5 13.4 4.4 7.0 3.6 4.5 2.7 3.5 5.4 2.3 4.1 3.8 6.1 2.5 9.6 7.6 5.5 3.1 15.7 17.3 16.5 16.8 14.2 16.3 18.0 18.5 17.7 17.9 15.6 18.6 14.7 12.8 14.3 21.5 7.1 9.7 10.0 18.5 13.1 25.2 24.9 20.7 30.2 25.8 22.8 33.1 20.9 17.9 6.0 19.0 9.8 23.8 21.3 31.3 18.5 13.6 11.4 8.0 3.7 22.1 27.0 18.8 17.3 27.8 3.8 14.4 17.5 41.0 20.6 16.8 6.4 24.3 20.3 23.9 6.6 16.8 11.8 16.1 14.2 7.5 12.3 23.5 5.2 11.6 16.7 18.8 17.4 17.7 16.8 15.2 25.4 19.8 47.6 18.7 19.7 19.1 14.8 47.4 18.5 21.9 7.4 15.7 7.1 12.9 25.4 12.8 EXTL3 "botv, REGR" ENSG00000012232 "Exostosin like glycosyltransferase 3" O43909 8 28600469-28755599 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 5.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025387 Approved NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 38: Heart - Muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "CAB025387: " "unprognostic (1.35e-1)" "unprognostic (1.31e-1)" "unprognostic (5.53e-2)" "unprognostic (1.19e-3)" "unprognostic (9.83e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.14e-5)" "unprognostic (4.25e-2)" "unprognostic (9.29e-3)" "unprognostic (1.05e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-3)" "prognostic favorable (2.47e-5)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (8.91e-2)" "unprognostic (1.39e-2)" 10.8 16.5 11.3 7.2 12.0 3.8 6.3 7.6 13.7 8.9 5.8 11.1 5.5 13.8 5.4 12.3 11.3 7.9 31.1 14.7 10.4 7.0 6.2 8.6 5.4 10.7 14.3 10.0 11.9 18.9 10.3 13.8 7.2 8.5 5.4 11.2 8.1 11.8 20.8 11.1 6.7 17.9 8.9 8.6 9.0 10.3 23.4 6.4 7.7 22.7 4.8 10.6 7.2 12.7 45.3 33.6 70.1 37.0 18.8 18.5 15.6 33.7 32.6 20.3 16.4 28.9 15.9 12.2 46.6 40.1 28.2 29.7 34.5 55.1 22.4 8.9 18.9 17.2 15.7 14.3 9.8 8.6 46.9 22.2 36.7 15.9 14.6 16.9 44.3 17.4 16.2 15.4 16.5 8.5 15.5 4.7 49.2 13.3 13.6 18.4 31.3 7.1 31.2 29.0 15.2 26.6 14.3 8.6 17.3 22.0 8.4 9.4 34.9 26.6 62.7 25.4 28.9 7.9 17.9 13.5 22.5 10.3 23.7 3.0 1.3 2.0 1.7 0.9 0.8 0.3 0.7 0.9 1.3 0.4 0.5 0.4 5.7 0.5 1.4 1.1 0.3 0.8 11.3 12.0 7.6 13.7 14.7 10.4 10.7 14.3 7.2 8.9 23.4 12.7 6.3 3.2 4.4 10.4 2.4 5.0 2.9 8.7 6.8 17.5 4.8 4.2 26.8 7.2 5.0 1.8 25.0 3.7 7.1 4.9 3.9 9.7 32.0 4.2 7.0 7.3 4.2 1.3 20.0 10.6 16.9 6.5 4.1 5.9 5.7 3.0 8.2 9.0 4.4 8.4 19.0 2.4 2.0 6.6 2.5 10.1 9.9 6.1 5.4 16.9 5.7 6.7 23.7 13.0 16.6 12.3 2.4 14.3 4.2 6.3 2.1 3.5 4.9 16.2 26.3 8.4 9.6 4.3 9.1 4.3 3.0 2.2 4.5 8.6 3.1 3.1 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "FAM3 metabolism regulating signaling molecule A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 109.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" "Secreted to blood" Yes No 15000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "CAB025016: , HPA035268: , HPA056991: AB_2683303" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 28.4 37.3 43.5 11.3 49.1 11.3 27.6 50.8 51.3 44.6 38.8 35.3 28.0 36.0 7.7 41.3 38.9 8.4 58.7 40.6 45.8 38.6 63.1 26.8 9.4 52.2 47.6 51.5 52.0 14.8 40.9 10.1 47.8 39.1 6.8 6.1 28.5 12.7 36.8 31.1 33.8 7.4 46.9 28.2 36.1 10.0 46.4 12.1 39.9 13.7 5.5 35.8 35.3 58.1 44.4 41.1 10.3 34.5 30.3 15.4 28.8 22.3 15.1 14.8 17.6 19.1 26.2 28.5 109.2 36.8 29.0 31.6 16.2 19.3 3.6 23.4 21.7 11.2 36.9 13.8 47.2 7.6 17.6 19.0 17.5 30.7 21.4 17.7 10.5 18.1 21.6 20.5 17.3 46.3 14.2 32.7 4.6 47.8 52.4 17.3 10.4 79.6 16.6 18.0 20.4 15.6 10.3 24.4 37.3 7.4 18.7 11.8 12.0 19.9 12.0 54.7 30.6 77.6 46.5 36.0 36.4 19.6 20.8 23.4 10.8 15.2 13.4 12.7 13.2 6.1 8.6 9.6 11.0 8.7 10.0 12.0 5.8 10.6 11.3 14.6 9.1 10.1 43.5 49.1 50.8 51.3 40.6 45.8 52.2 47.6 47.8 46.9 46.4 58.1 23.5 12.8 16.7 13.1 16.9 16.3 23.4 29.2 22.8 25.4 21.9 24.9 21.9 22.8 16.3 22.0 14.6 47.0 19.3 60.2 27.4 27.6 1.0 13.4 18.3 18.3 17.5 29.9 7.1 42.5 50.0 28.4 50.0 15.0 5.7 34.8 23.6 30.3 29.8 21.9 9.4 58.9 18.3 16.4 15.3 2.8 33.5 18.0 33.8 6.5 17.6 28.9 24.7 11.1 14.3 28.2 57.5 29.3 32.5 28.7 116.2 33.1 12.7 20.4 6.6 26.7 24.5 5.2 10.1 32.1 21.2 71.3 19.3 23.7 39.7 22.9 FGF18 "FGF-18, ZFGF5" ENSG00000156427 "Fibroblast growth factor 18" O76093 5 171419647-171457626 "Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 16.1" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 19.8;Cardiomyocytes: 24.4;Endometrial ciliated cells: 13.0;Glandular and luminal cells: 24.9" "Group enriched" "Detected in many" 6 "endometrial cancer: 19.0;ovarian cancer: 21.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 55 "EFO-21: 188.2" "Low region specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" HPA018795 Uncertain "Secreted in other tissues" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA018795: AB_1848523" "unprognostic (3.01e-1)" "unprognostic (2.38e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-3)" "unprognostic (6.62e-3)" "unprognostic (1.50e-1)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (2.98e-3)" "unprognostic (3.65e-2)" "unprognostic (3.18e-2)" "unprognostic (2.29e-1)" "unprognostic (1.37e-8)" "unprognostic (7.33e-2)" "unprognostic (2.58e-1)" "unprognostic (3.19e-1)" "unprognostic (2.76e-2)" 4.2 0.3 1.1 0.3 1.2 0.0 2.1 1.1 2.1 1.0 1.1 0.9 0.6 0.9 0.1 0.3 1.5 0.7 16.1 1.1 1.2 0.7 0.1 2.6 0.3 1.4 1.3 0.4 0.5 0.1 1.6 0.5 1.6 1.2 0.1 0.1 1.1 0.3 3.8 1.6 0.7 0.4 1.1 0.5 0.6 0.8 1.5 0.3 1.9 0.4 0.2 0.8 0.5 1.2 0.0 0.3 0.3 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.1 3.4 0.4 0.2 188.2 0.0 0.2 0.2 0.0 0.1 0.0 3.1 0.3 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.5 0.0 0.9 0.1 3.4 0.0 0.1 0.0 0.3 2.1 0.1 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 1.5 0.1 0.5 0.0 0.2 0.6 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.1 2.1 1.1 1.2 1.4 1.3 1.6 1.1 1.5 1.2 6.9 6.4 0.0 0.0 2.0 2.4 2.6 0.5 6.2 0.1 6.6 19.8 24.4 1.5 1.3 1.8 0.0 0.1 3.4 0.5 0.0 0.0 6.2 13.0 3.1 4.2 1.8 0.0 0.8 0.0 0.3 9.4 0.5 24.9 0.0 0.0 2.9 0.0 0.1 0.0 2.1 1.0 0.0 0.0 2.1 0.7 0.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.4 3.2 1.1 0.0 0.0 0.0 0.0 5.4 4.6 0.7 1.6 5.6 3.1 0.0 2.4 0.5 1.8 0.9 FLNA "ABP-280, FLN, FLN1, OPD1, OPD2" ENSG00000196924 "Filamin A" P21333 X 154348524-154374634 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Cilium biogenesis/degradation" Actin-binding "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 1203.7;intestine: 1462.2" "Cell type enhanced" "Detected in many" "Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000356, HPA000368, HPA001016, HPA001115, HPA002925" Enhanced Approved Enhanced "Plasma membrane,Actin filaments,Cytosol" NA NA 730000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane, Actin filaments, Cytosol" "CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869" "unprognostic (1.39e-1)" "unprognostic (9.40e-3)" "prognostic unfavorable (7.37e-4)" "unprognostic (3.68e-2)" "unprognostic (2.55e-1)" "unprognostic (6.05e-3)" "unprognostic (5.08e-2)" "unprognostic (1.08e-1)" "unprognostic (6.02e-2)" "unprognostic (1.30e-1)" "unprognostic (3.23e-2)" "unprognostic (9.58e-2)" "prognostic unfavorable (1.54e-6)" "unprognostic (5.49e-3)" "unprognostic (1.78e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.88e-4)" 267.4 55.9 14.4 223.2 18.5 157.9 164.2 15.2 43.0 392.1 54.7 1462.2 89.9 1203.7 35.5 454.7 609.4 137.9 108.4 14.8 23.0 70.5 21.2 238.9 65.0 39.9 19.9 236.7 50.5 13.4 30.5 79.2 24.4 369.2 86.9 9.0 80.3 617.2 49.7 124.7 354.6 706.6 21.1 102.7 508.0 33.7 34.0 48.1 85.6 31.2 38.1 1053.9 286.4 21.5 947.2 719.2 246.7 316.1 209.8 278.4 400.9 614.0 680.1 552.5 489.8 469.2 169.4 80.5 1551.4 966.4 970.1 528.3 224.0 538.1 152.7 333.6 77.8 262.2 914.9 159.7 375.9 309.3 324.9 266.1 126.1 825.5 327.0 533.8 417.1 94.9 74.7 538.7 401.3 210.7 148.5 93.1 258.3 97.9 470.9 147.8 221.2 71.6 197.2 193.4 52.9 119.7 515.8 80.2 381.1 187.3 79.1 96.3 1016.6 625.2 586.8 640.0 1147.1 333.7 212.8 162.3 580.3 202.4 638.7 7.6 24.9 11.8 32.6 23.1 21.2 10.2 15.6 29.2 22.4 4.6 6.0 14.3 3.6 10.5 34.2 2.7 20.7 56.2 14.4 18.5 15.2 43.0 14.8 23.0 39.9 19.9 24.4 21.1 34.0 21.5 105.1 57.7 38.7 30.0 76.9 124.3 85.9 127.8 85.4 3.5 40.9 153.5 34.5 38.6 26.1 35.0 0.0 24.6 257.7 2.6 1.9 272.0 2.1 33.8 186.3 107.0 1.8 39.7 11.8 133.1 90.9 137.9 13.3 55.8 26.0 334.5 81.8 4.3 120.3 11.8 8.6 2.5 22.4 141.0 263.0 13.7 122.4 227.7 88.9 30.9 207.9 39.4 270.8 8.0 2.6 347.4 1.5 500.6 98.7 96.1 1.9 3.0 9.1 4.3 420.7 118.3 459.3 4.1 8.9 48.8 73.6 20.0 172.3 134.7 3.3 35.3 FNDC3B "DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421" ENSG00000075420 "Fibronectin type III domain containing 3B" Q53EP0 3 172039578-172401669 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 283.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 29.4;hypothalamus: 8.2;pons: 9.4;thalamus: 14.4" "Immune cell enhanced" "Detected in many" "neutrophil: 37.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007859 Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA007859: AB_1078900" "unprognostic (7.18e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (6.03e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (3.25e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (2.17e-3)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (3.50e-2)" "prognostic unfavorable (5.65e-7)" "unprognostic (4.35e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-2)" 34.4 25.5 1.1 26.3 1.1 37.0 16.6 0.6 29.4 26.0 11.9 19.8 13.0 21.9 18.2 9.2 12.5 19.4 24.4 3.5 8.2 17.5 28.5 21.8 8.9 3.3 3.4 22.8 28.3 15.0 8.5 52.7 9.4 12.9 19.6 4.4 21.3 15.6 21.2 7.0 11.4 25.4 0.7 14.7 20.6 9.3 14.4 6.8 32.4 18.5 11.0 38.6 9.5 1.9 47.4 55.9 36.0 43.5 107.6 73.6 87.6 68.3 73.1 43.3 58.3 30.5 100.5 4.2 178.9 99.0 85.6 27.4 12.4 53.2 74.9 27.5 9.2 6.0 34.8 78.6 109.2 62.1 100.1 75.5 24.9 80.8 75.9 102.8 116.7 8.1 10.9 32.6 44.3 14.8 2.4 24.9 20.8 18.0 22.0 5.4 37.5 21.9 44.8 42.1 2.2 10.8 62.2 30.6 53.9 49.3 31.1 28.5 182.6 60.5 28.5 78.9 52.2 67.3 84.0 9.3 63.5 32.7 61.0 13.5 8.3 20.4 4.2 5.3 1.8 1.1 1.3 2.3 4.7 0.1 1.4 2.5 37.5 4.6 2.7 0.7 1.2 3.4 1.1 1.1 0.6 29.4 3.5 8.2 3.3 3.4 9.4 0.7 14.4 1.9 54.8 86.6 49.0 115.2 19.2 63.9 51.4 61.1 39.3 7.5 27.4 31.9 51.0 41.5 47.9 46.0 12.5 41.4 29.2 53.1 15.6 69.8 16.2 73.7 73.4 61.5 16.8 16.4 37.9 45.6 99.6 103.7 32.6 179.5 15.2 95.2 58.2 68.9 47.1 0.0 43.9 30.7 12.2 59.2 53.3 9.3 57.5 65.1 69.4 155.5 52.2 17.4 39.1 115.6 31.4 78.5 44.8 54.5 283.6 67.8 16.1 35.7 33.6 11.5 52.6 89.4 69.1 2.3 3.2 18.6 33.5 34.8 23.1 26.0 26.2 88.4 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868588-90883564 "Enzymes, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 305.6;salivary gland: 220.5" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 130000 "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 54.5 24.4 12.8 36.4 10.5 73.8 42.4 10.6 14.5 26.4 11.7 32.8 27.6 32.3 9.8 33.7 30.4 19.4 58.5 14.9 9.0 56.8 305.6 63.2 13.0 12.5 10.8 22.4 108.6 27.3 45.9 40.6 11.3 60.1 12.1 12.9 220.5 17.7 61.3 62.7 35.5 14.3 10.4 51.4 34.0 8.6 15.6 11.8 56.1 25.3 11.2 30.2 33.3 9.3 50.8 31.2 6.8 29.8 49.4 32.1 77.5 64.4 48.1 26.3 18.1 45.4 54.3 1.9 148.8 47.5 46.1 91.5 14.0 32.5 5.4 148.0 35.2 90.9 52.8 57.7 26.2 13.0 141.2 35.6 35.3 29.5 13.2 62.4 84.7 14.6 70.5 8.5 17.8 32.3 5.0 29.2 21.5 44.2 9.3 7.9 26.6 10.9 35.2 39.1 13.1 9.2 54.5 28.5 42.5 31.9 10.7 31.4 125.9 29.4 60.1 43.7 95.5 15.2 93.4 3.4 55.8 40.1 60.7 2.0 0.9 1.5 0.7 0.1 0.2 0.4 0.2 0.3 0.6 0.1 0.0 0.1 0.7 0.4 0.0 0.3 0.0 1.1 12.8 10.5 10.6 14.5 14.9 9.0 12.5 10.8 11.3 10.4 15.6 9.3 44.1 3.2 27.4 4.2 7.3 19.4 10.0 10.4 2.8 12.8 12.0 9.0 16.3 21.5 8.5 22.0 25.0 20.9 26.9 49.5 0.0 47.1 0.5 15.2 9.7 29.4 37.8 26.5 7.9 117.5 16.5 11.4 21.9 32.3 15.8 7.0 23.9 131.8 24.8 8.4 7.5 31.7 10.2 35.3 42.1 1.4 11.1 33.6 16.0 5.6 14.0 13.6 24.7 2.0 4.4 108.3 26.4 10.9 7.2 24.3 28.7 7.8 2.0 28.0 26.3 10.5 18.6 2.8 3.6 8.5 23.0 84.3 19.6 4.7 17.9 16.4 GABRE ENSG00000102287 "Gamma-aminobutyric acid type A receptor subunit epsilon" P78334 X 151953124-151974680 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 52.3" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 30.7;Syncytiotrophoblasts: 61.4;Urothelial cells: 42.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.4;EFO-21: 11.6;HeLa: 6.1;SiHa: 5.6" "Region enriched" "Detected in many" 4 "hypothalamus: 18.4" "Region enhanced" "Detected in many" "hypothalamus: 32.3" HPA045918 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "HPA045918: AB_10961281" "unprognostic (1.33e-2)" "unprognostic (6.75e-2)" "unprognostic (3.50e-3)" "unprognostic (1.39e-3)" "unprognostic (2.43e-1)" "unprognostic (7.52e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (3.58e-2)" "unprognostic (1.55e-1)" "unprognostic (6.44e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (4.05e-11)" "unprognostic (1.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (5.28e-2)" 9.7 0.4 6.3 0.3 4.5 0.0 4.4 0.0 9.7 1.7 0.9 0.4 0.7 0.6 1.8 1.0 0.7 0.5 9.5 0.8 52.3 1.1 0.1 0.6 0.2 5.1 38.0 0.8 0.8 0.9 2.2 3.3 33.0 1.8 0.3 0.1 0.8 3.4 0.3 3.2 0.4 0.3 0.2 0.2 0.3 0.1 14.0 0.1 1.0 0.0 0.2 0.6 2.3 0.2 0.2 0.0 0.1 0.0 3.4 0.0 0.0 0.5 0.0 0.8 0.4 1.9 0.6 0.0 11.6 2.5 0.0 1.9 0.0 0.6 0.5 0.0 0.4 1.3 6.1 0.7 0.2 0.0 0.1 0.8 0.5 0.9 0.2 1.1 0.4 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.7 0.0 0.8 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 4.5 0.0 9.7 0.8 52.3 5.1 38.0 33.0 0.2 14.0 0.2 7.7 16.0 9.3 0.7 0.7 17.2 22.9 18.6 30.7 0.0 6.8 4.6 7.3 11.5 25.2 1.8 0.0 25.0 0.5 10.0 0.0 4.1 2.0 7.6 12.8 9.0 1.8 0.0 0.0 0.4 3.5 9.2 0.0 29.2 0.0 0.1 4.2 0.9 3.0 0.0 0.0 2.3 4.1 0.6 4.6 3.5 1.5 0.3 1.8 2.8 0.7 0.6 1.0 0.0 0.0 6.1 7.4 2.2 0.0 19.2 21.6 0.2 5.6 0.3 0.0 19.6 5.7 1.2 2.1 22.5 10.9 61.4 1.3 0.1 3.6 42.2 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor subunit pi" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 152.3;esophagus: 171.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6" "Group enriched" "Detected in many" 4 "breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 11.8" "Group enriched" "Detected in many" 8 "granulocytes: 11.8;monocytes: 5.7" "Cell line enhanced" "Detected in many" "A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "CAB014883: " "unprognostic (3.98e-3)" "prognostic favorable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 4.5 3.6 10.4 7.3 10.5 9.9 152.3 15.8 16.2 13.1 5.4 4.2 15.4 48.6 19.0 171.5 12.9 27.3 5.4 7.6 23.0 6.1 7.1 14.7 5.7 12.5 6.1 3.9 23.8 2.0 2.0 9.1 10.6 12.7 4.9 42.1 35.8 16.6 13.7 19.0 16.2 2.6 2.7 7.4 27.4 8.3 10.4 4.7 6.1 2.7 42.2 5.4 29.4 17.9 215.1 9.9 10.1 7.0 0.7 4.3 23.8 3.8 1.5 0.5 0.6 38.1 23.6 3.3 236.8 1.1 2.3 75.7 6.4 0.5 0.6 3.5 7.6 14.1 166.8 5.7 0.8 5.1 11.2 1.6 3.0 2.8 1.8 8.0 1.4 13.4 57.6 26.5 0.4 6.7 9.5 4.7 84.5 3.7 331.3 13.7 6.6 8.2 13.8 11.6 8.2 4.0 76.5 3.9 2.2 418.8 4.2 2.4 8.8 19.1 69.3 15.7 15.7 10.0 6.7 6.3 2.6 13.9 2.9 11.8 1.9 6.1 0.4 1.5 1.1 0.3 0.4 0.3 0.6 0.7 0.5 0.5 4.5 0.2 5.7 0.9 0.6 2.3 10.4 10.5 15.8 16.2 7.6 23.0 12.5 6.1 10.6 2.7 10.4 17.9 1.1 3.2 0.6 0.0 0.9 0.0 14.9 44.4 0.0 0.0 169.0 113.2 0.7 51.5 83.1 1.8 0.0 5.2 2.3 0.0 0.0 10.4 0.0 146.0 48.8 3.8 0.0 0.0 0.3 13.8 0.6 2.4 2.0 464.0 0.0 0.0 0.0 0.1 2.3 0.0 0.2 0.3 12.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 56.6 0.1 0.0 0.0 24.2 0.1 0.1 34.0 0.0 0.0 0.2 5.9 0.0 0.0 4.5 0.0 5.7 2.7 0.0 0.6 146.6 GCNT2 "bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3" ENSG00000111846 "Glucosaminyl (N-acetyl) transferase 2 (I blood group)" Q8N0V5 6 10492223-10629368 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4" "Region enriched" "Detected in all" 4 "basal ganglia: 61.1" "Low region specificity" "Detected in all" HPA026776 Approved Approved "Golgi apparatus" No No 750000 "Cluster 41: Basophils - Cellular respiration" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA026776: AB_1849573" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (3.12e-1)" "unprognostic (1.42e-2)" "unprognostic (9.31e-2)" "unprognostic (2.51e-1)" "unprognostic (4.11e-2)" "unprognostic (2.39e-1)" "unprognostic (1.27e-1)" "unprognostic (2.11e-2)" "unprognostic (6.28e-4)" "unprognostic (3.96e-2)" "unprognostic (1.58e-3)" "unprognostic (6.54e-2)" "unprognostic (6.32e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" 0.6 0.3 0.7 1.0 0.6 0.3 10.1 2.5 1.1 4.2 4.5 3.6 5.2 1.4 0.2 1.4 0.8 1.5 6.6 0.8 1.1 5.7 5.1 3.9 1.8 1.2 1.0 0.3 1.3 0.4 1.4 2.6 1.4 13.5 2.0 0.3 4.2 0.3 0.7 1.4 5.8 1.6 0.9 1.5 5.9 2.5 0.9 0.5 1.2 1.8 2.4 1.0 0.7 1.0 6.3 4.9 1.5 4.8 0.0 0.0 9.6 0.0 4.1 1.1 0.5 11.0 5.2 3.5 44.2 0.0 3.2 0.3 0.4 5.1 2.9 3.1 1.8 0.5 2.6 19.7 0.0 1.7 4.7 0.0 0.0 0.5 0.0 2.4 9.1 0.0 0.4 0.0 0.4 0.0 0.0 4.0 4.4 0.0 3.6 0.2 3.8 6.0 16.0 2.9 4.0 1.2 0.0 14.4 17.1 21.4 0.3 0.8 6.4 0.8 0.5 0.0 5.0 0.1 0.0 2.4 0.8 0.3 2.3 1.9 1.1 0.5 0.1 0.8 0.0 0.7 0.1 0.1 0.8 0.4 0.1 0.2 0.1 0.2 0.2 0.2 0.0 0.3 0.7 0.6 2.5 1.1 0.8 1.1 1.2 1.0 1.4 0.9 0.9 1.0 1.4 76.9 32.4 1.0 9.5 4.6 6.6 15.5 9.6 5.1 30.5 16.1 18.4 2.8 28.6 7.3 0.0 27.9 6.4 15.5 11.7 2.9 4.3 79.1 5.5 11.0 2.4 25.9 0.7 24.7 2.1 2.0 16.8 105.5 2.5 0.0 12.8 32.0 15.8 3.3 11.8 5.6 6.1 7.7 9.4 8.2 0.3 7.8 49.8 52.5 11.1 2.4 0.0 18.6 1.1 12.0 11.9 0.0 1.0 16.6 44.3 13.4 27.9 0.6 0.0 0.7 2.2 6.2 27.6 11.2 1.7 10.9 3.1 0.0 16.3 8.1 GDF1 ENSG00000130283 "Growth differentiation factor 1" P27539 19 18868545-18896158 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.7;pituitary gland: 1.5;skeletal muscle: 3.9;testis: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.8;SH-SY5Y: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 38: EFO-21 - Unknown function" 0.0 0.1 1.5 0.0 2.1 0.0 0.1 1.4 3.6 0.3 0.5 0.7 0.0 0.1 0.0 0.0 0.1 0.0 0.6 1.7 1.1 0.0 0.0 0.0 0.0 3.0 2.0 0.4 0.1 0.0 1.5 0.0 2.3 0.2 0.0 0.0 0.1 0.0 3.9 0.0 0.1 0.0 1.9 0.0 0.2 4.9 3.7 0.0 0.1 0.0 0.0 0.3 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.1 1.4 3.6 1.7 1.1 3.0 2.0 2.3 1.9 3.7 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GJA4 CX37 ENSG00000187513 "Gap junction protein alpha 4" P35212 1 34792999-34795747 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hepatic stellate cells: 234.2;Sertoli cells: 664.0;Smooth muscle cells: 306.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 74.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047981 Approved NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "HPA047981: AB_2680228" "unprognostic (2.22e-2)" "unprognostic (2.05e-1)" "unprognostic (1.12e-2)" "unprognostic (2.67e-2)" "unprognostic (4.48e-1)" "unprognostic (5.24e-3)" "prognostic favorable (3.28e-4)" "unprognostic (2.01e-2)" "unprognostic (2.23e-1)" "unprognostic (8.17e-2)" "unprognostic (6.83e-2)" "unprognostic (8.81e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.47e-2)" "unprognostic (3.74e-2)" "unprognostic (3.82e-3)" "unprognostic (7.96e-3)" 79.4 20.4 10.1 9.3 11.0 0.3 61.5 9.8 15.1 26.6 9.0 14.7 2.8 33.8 5.5 7.5 40.0 17.3 83.6 10.5 9.6 35.8 17.3 40.7 11.3 10.3 10.2 18.0 7.0 10.6 6.4 61.6 10.6 18.8 3.8 0.8 10.1 10.7 34.7 14.8 13.9 15.2 10.2 9.9 12.9 5.4 10.2 2.7 39.8 35.2 5.4 28.1 22.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.1 11.0 9.8 15.1 10.5 9.6 10.3 10.2 10.6 10.2 10.2 9.9 90.4 0.0 0.0 0.3 0.6 9.7 1.9 0.2 1.2 0.2 1.1 1.5 9.0 1.5 0.6 3.7 0.0 0.2 0.7 0.0 0.0 11.0 0.1 3.1 0.5 81.4 15.6 2.7 0.0 0.0 0.1 7.7 2.6 4.9 0.0 0.5 234.2 1.8 0.3 0.0 0.0 0.0 0.0 6.3 10.7 1.1 0.9 2.2 19.6 1.0 0.6 0.1 0.0 0.0 0.0 1.0 0.0 12.8 0.2 3.0 0.0 0.1 1.2 0.7 664.0 4.4 306.3 0.2 1.2 0.7 8.7 0.0 1.3 1.6 0.1 5.2 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149930-228159826 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 51.3" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 12.5;Oligodendrocytes: 26.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.4;SCLC-21H: 2.9;TIME: 2.7" "Region enhanced" "Detected in all" "white matter: 105.5" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.9 0.9 13.6 0.6 31.2 0.2 1.7 39.0 20.2 4.2 5.2 5.8 0.2 4.7 0.9 1.4 5.4 0.7 1.7 13.9 19.5 1.3 0.5 2.9 0.6 43.9 31.6 3.8 0.5 0.7 1.4 0.5 38.1 3.0 0.3 0.5 0.8 1.7 0.8 1.7 1.7 1.8 28.1 1.4 2.4 1.2 27.6 0.4 2.0 0.8 0.3 4.2 3.5 51.3 0.2 0.2 0.1 0.3 0.8 0.4 1.0 0.8 0.2 0.3 0.4 0.5 0.7 0.1 5.4 1.5 0.4 0.5 0.2 0.2 0.1 0.2 0.9 0.2 1.4 1.2 1.4 0.0 0.0 0.2 0.1 0.5 0.3 0.7 0.1 1.0 0.6 0.1 0.2 0.3 1.1 0.3 0.3 0.0 1.1 0.2 0.1 0.0 0.4 0.0 2.9 1.7 0.2 0.0 0.2 0.1 0.1 0.2 2.7 0.7 2.1 2.5 0.9 0.1 0.4 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 13.6 31.2 39.0 20.2 13.9 19.5 43.9 31.6 38.1 28.1 27.6 51.3 2.8 0.0 0.6 0.7 0.2 3.4 1.3 0.6 1.8 2.6 1.3 0.6 1.8 0.0 0.0 0.0 12.5 0.0 0.4 0.2 0.0 0.1 0.2 1.0 1.1 4.3 0.0 0.0 0.8 0.5 0.0 2.2 0.0 1.6 0.0 0.3 3.6 0.0 0.1 3.3 1.1 0.3 0.0 0.6 3.8 0.0 2.5 1.3 1.8 0.0 0.0 0.3 0.0 0.0 26.9 1.1 0.0 4.1 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.6 1.8 0.0 0.0 0.5 1.7 0.0 0.8 0.6 0.3 1.0 GLS "GLS1, KIAA0838" ENSG00000115419 Glutaminase O94925 2 190880821-190965552 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Cataract, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 316.8" "Cell type enhanced" "Detected in all" "Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 907.3;RPTEC TERT1: 419.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036223 Enhanced Supported Mitochondria "Intracellular and membrane" No No 92000 "Cluster 44: Non-specific - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA036223: AB_10669984" "unprognostic (7.45e-2)" "unprognostic (3.42e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (3.45e-4)" "unprognostic (1.17e-1)" "unprognostic (2.08e-3)" "unprognostic (2.51e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-1)" "unprognostic (2.40e-1)" "unprognostic (8.01e-2)" "unprognostic (9.06e-2)" "unprognostic (5.41e-2)" "unprognostic (1.62e-1)" "unprognostic (5.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.12e-1)" 37.0 77.4 38.5 45.7 50.5 28.7 32.0 40.5 74.6 31.0 35.6 32.0 92.2 28.8 26.6 16.8 25.1 41.8 34.7 55.5 35.9 316.8 11.7 55.6 68.0 44.7 19.8 28.9 36.9 62.0 19.9 35.8 52.5 20.8 30.1 81.8 20.4 31.2 15.8 28.5 103.4 36.9 12.0 49.3 18.7 16.2 24.1 41.7 35.7 23.6 57.9 36.5 23.6 44.8 43.6 47.2 32.4 43.1 99.7 68.9 84.0 126.8 95.7 90.6 103.1 58.1 42.1 88.5 907.3 269.3 46.1 55.6 58.0 50.0 131.5 219.8 37.7 147.3 69.1 72.2 90.8 87.2 66.5 62.9 51.0 71.2 48.4 90.1 119.3 36.7 69.3 175.2 203.3 22.8 59.2 83.7 86.9 25.7 76.7 74.2 83.7 77.4 419.2 78.9 44.9 46.8 172.8 37.9 169.2 115.1 14.9 53.0 85.3 129.4 94.5 65.9 156.8 56.2 138.9 122.1 46.7 70.6 105.5 6.4 1.0 1.9 3.7 1.5 6.5 3.4 4.4 4.8 1.6 3.8 4.5 5.5 2.1 2.8 1.1 3.6 4.1 1.1 38.5 50.5 40.5 74.6 55.5 35.9 44.7 19.8 52.5 12.0 24.1 44.8 81.0 189.1 122.5 61.0 89.3 174.5 44.7 15.6 60.9 93.5 51.8 49.5 38.2 35.8 28.4 391.8 210.6 4.4 128.0 100.6 50.9 21.4 6.6 33.7 66.8 68.3 59.2 17.9 427.1 24.5 15.6 66.0 46.4 97.9 36.8 48.2 63.5 4.3 29.1 26.9 270.5 36.7 14.2 31.2 230.0 7.3 28.6 84.3 88.9 143.4 68.4 11.9 55.6 163.3 146.9 29.8 92.9 43.2 118.4 70.1 165.9 539.1 17.0 111.9 19.7 71.6 76.0 11.3 12.9 61.7 162.8 4.0 114.0 97.8 43.6 56.7 GNGT1 GNG1 ENSG00000127928 "G protein subunit gamma transducin 1" P63211 7 93591573-93911265 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 644 "retina: 1902.1" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 3097.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.4;HeLa: 3.4;SK-BR-3: 3.0;SuSa: 4.3;T-47d: 5.3;U-266/84: 4.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA042721 Enhanced NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 79: Retina - Phototransduction" "Cluster 38: EFO-21 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA042721: AB_10806370" "unprognostic (1.30e-1)" "unprognostic (2.55e-4)" "unprognostic (3.32e-4)" "unprognostic (5.01e-2)" "unprognostic (2.54e-2)" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (4.55e-1)" "unprognostic (2.23e-4)" "unprognostic (1.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.9 0.2 0.0 0.0 1902.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.3 0.0 0.5 1.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.0 3.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.4 0.1 1.4 0.1 0.0 1.5 0.1 0.1 0.0 0.0 0.4 0.2 1.3 2.6 1.0 0.1 3.0 0.0 4.3 5.3 0.1 0.1 0.0 2.7 0.1 0.0 2.8 4.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 0.1 0.6 0.1 0.0 0.2 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 371.1 0.0 0.0 0.1 0.0 0.7 0.0 385.7 0.5 0.0 0.1 1.9 0.4 0.1 0.2 0.0 21.7 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.2 198.5 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 619.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.3 0.8 3097.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.1 0.0 0.1 0.0 0.0 GPR20 ENSG00000204882 "G protein-coupled receptor 20" Q99678 8 141356470-141367286 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 72.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "intermediate monocyte: 2.6;non-classical monocyte: 4.3" "Lineage enriched" "Detected in single" 22 "monocytes: 4.3" "Cell line enriched" "Detected in single" 6 "EFO-21: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA071337 Supported "Plasma membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" Cytosol "HPA071337: " "unprognostic (4.47e-2)" "unprognostic (2.64e-3)" "unprognostic (5.18e-2)" "unprognostic (2.00e-2)" "unprognostic (7.47e-2)" "unprognostic (2.28e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (3.54e-1)" "unprognostic (2.13e-2)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (7.41e-2)" "unprognostic (5.50e-2)" "unprognostic (6.23e-2)" "unprognostic (4.07e-1)" 0.8 0.2 0.0 0.2 0.0 0.0 0.6 0.0 0.4 2.0 0.0 1.4 0.4 1.9 0.7 0.6 1.5 0.7 1.1 0.0 0.0 0.6 0.2 1.5 0.0 0.0 0.0 1.2 0.2 0.1 0.2 1.2 0.1 0.9 0.3 0.0 0.2 0.8 0.3 0.4 2.1 1.8 0.0 0.2 1.7 0.1 0.0 0.0 0.5 0.4 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.1 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.3 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.2 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 72.3 0.3 16.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 GPRC5B RAIG-2 ENSG00000167191 "G protein-coupled receptor class C group 5 member B" Q9NZH0 16 19856691-19886167 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 490.3" "Cell type enhanced" "Detected in many" "Early spermatids: 197.7;Late spermatids: 269.9;Oligodendrocytes: 171.0" "Cancer enhanced" "Detected in all" "glioma: 52.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 2.8" "Lineage enhanced" "Detected in single" "T-cells: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 92.5;HHSteC: 60.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015247 Enhanced Supported Nucleoplasm,Nucleoli,Vesicles NA NA "Cluster 32: T-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 34: Spermatids - Unknown function" Vesicles "Nucleoplasm, Nucleoli" "HPA015247: AB_1849323" "unprognostic (1.26e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.60e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (3.97e-2)" "unprognostic (5.70e-2)" "unprognostic (1.42e-1)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.30e-4)" "unprognostic (4.73e-2)" "unprognostic (1.06e-1)" "unprognostic (4.42e-3)" "unprognostic (6.78e-3)" 25.3 7.0 249.1 4.4 428.3 0.1 19.6 365.2 263.4 12.8 13.1 8.1 5.7 13.1 14.8 8.1 20.1 15.3 40.7 245.8 278.4 22.4 3.2 5.8 7.8 379.4 327.1 22.6 21.7 45.9 14.1 15.7 333.0 9.6 2.4 17.4 40.1 17.7 72.7 7.5 11.1 7.5 262.7 2.5 41.3 34.0 315.0 3.2 13.8 73.8 3.4 12.8 8.6 490.3 1.2 29.9 29.0 5.2 29.3 2.0 5.3 0.3 7.4 2.9 1.8 28.0 1.0 0.0 92.5 1.0 18.9 1.6 21.6 0.2 1.7 0.2 8.6 0.0 0.1 0.0 60.3 0.0 0.0 2.5 0.0 4.9 0.0 7.9 14.3 0.7 6.6 0.6 6.7 1.5 0.1 0.1 31.8 0.0 15.6 8.9 0.0 0.2 1.1 13.8 22.9 1.9 3.6 1.9 27.2 9.1 0.1 0.6 2.9 0.0 3.5 14.4 0.8 0.4 0.1 0.3 1.4 0.3 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 0.0 0.5 249.1 428.3 365.2 263.4 245.8 278.4 379.4 327.1 333.0 262.7 315.0 490.3 71.4 0.0 3.0 75.4 1.2 1.3 5.3 2.6 9.1 30.7 22.5 16.3 15.7 40.0 7.2 31.3 0.0 5.0 0.3 0.2 1.9 65.3 197.7 4.1 20.7 44.8 0.0 0.0 2.4 64.5 1.4 14.8 31.6 13.7 0.0 0.4 9.3 0.2 4.1 0.0 13.5 0.0 38.7 1.6 2.6 269.9 23.9 2.2 16.0 7.5 1.0 24.8 0.0 51.8 171.0 72.8 0.0 26.7 1.3 12.3 0.0 0.3 3.3 6.0 13.1 3.3 13.0 4.9 1.6 2.4 1.7 2.5 0.8 7.0 0.2 1.6 HDAC7 "DKFZP586J0917, HDAC7A" ENSG00000061273 "Histone deacetylase 7" Q8WUI4 12 47782722-47833132 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 6.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004775 Supported Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "HPA004775: AB_1850548" "unprognostic (3.83e-1)" "unprognostic (9.49e-3)" "unprognostic (1.37e-2)" "unprognostic (4.46e-2)" "unprognostic (6.56e-3)" "unprognostic (2.22e-2)" "unprognostic (2.50e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.28e-1)" "unprognostic (2.07e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (6.24e-2)" "unprognostic (4.38e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.65e-4)" 52.5 41.8 7.7 28.5 8.1 23.6 45.3 3.2 9.7 46.2 24.6 44.2 8.9 51.4 13.6 23.5 50.3 16.8 31.6 4.1 4.8 29.3 6.0 55.0 27.3 17.2 7.1 44.9 14.5 20.1 20.6 19.5 10.2 34.4 4.8 2.8 30.6 17.1 16.2 40.1 28.6 16.9 3.4 38.4 27.2 7.9 10.7 80.0 39.2 9.4 15.2 44.3 38.5 7.6 41.6 28.1 28.6 46.9 21.9 60.2 25.3 39.4 30.7 28.3 18.8 37.4 38.4 80.5 126.8 37.1 13.9 37.8 6.7 31.4 10.5 38.8 13.6 27.6 29.9 8.6 23.6 9.1 1.2 39.4 10.8 28.6 15.4 51.6 58.6 45.9 29.9 33.4 18.6 18.0 83.2 21.8 39.4 9.1 29.1 64.2 14.7 29.6 12.1 26.9 8.1 18.8 30.6 14.1 14.4 18.4 13.4 12.0 66.6 56.9 61.0 47.6 28.9 70.8 58.8 67.4 23.8 41.9 19.1 0.0 1.4 0.0 0.8 0.5 0.9 0.8 0.7 0.7 0.4 0.5 0.8 0.6 6.5 0.9 0.5 0.3 0.3 1.5 7.7 8.1 3.2 9.7 4.1 4.8 17.2 7.1 10.2 3.4 10.7 7.6 80.6 41.7 32.1 34.9 32.7 13.8 26.8 28.7 8.6 20.3 22.5 17.4 13.4 28.6 28.6 36.8 0.0 4.8 18.6 5.3 1.9 31.6 15.5 26.2 39.4 79.3 7.3 40.4 19.9 23.0 3.5 37.8 25.5 58.4 8.8 20.2 101.7 2.0 15.6 28.6 17.5 9.6 24.4 32.7 14.1 6.9 55.0 13.3 14.2 46.9 20.5 11.7 28.8 10.6 13.6 66.8 7.3 33.1 42.9 69.1 0.6 3.8 31.8 4.0 26.3 18.3 26.9 1.1 3.7 10.3 21.6 2.9 28.2 9.3 8.1 46.8 HLA-C "D6S204, HLA-JY3, PSORS1" ENSG00000204525 "Major histocompatibility complex, class I, C" P10321 6 31268749-31272130 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 1445.7" "Cell type enhanced" "Detected in all" "NK-cells: 3899.1;Proximal enterocytes: 3582.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 760.0;EFO-21: 795.5;RPTEC TERT1: 462.7;U-266/70: 481.6;U-266/84: 401.0;U-698: 289.3" "Intracellular and membrane" NA NA 240000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (2.17e-1)" "unprognostic (3.38e-1)" "unprognostic (3.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.56e-1)" "unprognostic (2.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.90e-3)" "unprognostic (3.23e-3)" "unprognostic (1.17e-1)" "unprognostic (2.39e-1)" "unprognostic (2.34e-1)" "unprognostic (2.00e-1)" "unprognostic (8.12e-2)" "unprognostic (1.87e-2)" "unprognostic (7.16e-2)" 538.6 417.5 0.7 274.6 2.4 122.3 507.4 0.8 0.9 464.4 1.5 594.3 1.6 434.8 259.5 277.6 411.7 103.9 424.3 0.3 1.1 561.0 485.7 1078.3 334.0 1.6 0.9 266.3 245.3 0.2 269.6 34.5 0.9 344.2 27.7 13.7 389.5 0.4 190.6 449.6 750.0 51.0 1.3 1445.7 419.4 62.3 1.2 2.4 382.9 0.3 0.7 372.7 377.5 0.8 760.0 1.1 0.0 0.0 120.1 94.1 1.7 3.1 0.9 1.1 2.3 0.9 0.0 0.4 795.5 190.8 208.7 0.5 0.0 188.1 0.0 1.4 170.4 0.8 8.1 0.1 0.8 0.5 0.5 80.5 0.2 0.5 0.0 272.4 0.0 92.5 0.4 0.0 0.0 0.0 7.8 4.8 0.5 0.0 0.8 1.9 0.3 1.9 462.7 0.0 0.9 1.5 0.2 0.1 2.2 0.3 0.3 3.3 0.6 196.4 65.8 2.3 2.5 481.6 401.0 289.3 0.3 8.2 0.2 1.9 2.8 2.3 0.7 0.8 0.6 0.4 0.4 0.6 0.4 0.4 0.4 0.5 2.8 0.8 0.3 0.1 0.9 46.1 0.7 2.4 0.8 0.9 0.3 1.1 1.6 0.9 0.9 1.3 1.2 0.8 1903.4 227.6 328.1 13.1 1576.5 729.1 757.8 1082.3 236.8 33.4 457.0 342.8 61.2 807.8 662.7 483.7 10.4 39.5 2429.1 1994.0 84.1 1966.4 25.6 233.7 343.8 1466.2 482.2 301.2 3.9 1511.3 1010.7 608.5 648.8 557.2 344.1 256.3 1390.0 469.2 1579.0 99.3 5.8 1375.7 923.7 2050.7 1492.7 32.1 507.3 1595.9 836.0 76.8 2570.1 207.3 3899.1 18.6 3.8 1272.7 2195.7 333.6 2482.6 1038.0 3582.3 232.5 548.5 24.0 1203.0 336.7 558.8 142.0 43.5 192.6 651.7 121.6 2212.1 786.8 1003.1 1160.6 HYOU1 "Grp170, HSP12A, ORP150" ENSG00000149428 "Hypoxia up-regulated 1" Q9Y4L1 11 119044188-119057227 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Stress response" Chaperone "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 201.9" "Cell type enhanced" "Detected in all" "Plasma cells: 118.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 35.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 418.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049296 Approved "Intracellular and membrane" NA NA 130000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA049296: AB_2680702" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "unprognostic (8.46e-2)" "prognostic favorable (2.58e-4)" "unprognostic (2.19e-1)" "unprognostic (1.35e-2)" "unprognostic (1.61e-3)" "unprognostic (1.81e-1)" "unprognostic (8.98e-2)" "unprognostic (7.93e-2)" "unprognostic (2.01e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (5.10e-5)" "unprognostic (3.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.38e-2)" 38.2 48.5 30.7 27.1 32.2 18.6 31.0 28.3 34.1 37.2 25.5 40.9 18.1 44.6 51.2 47.4 40.8 14.0 56.5 32.9 41.0 63.0 201.9 47.7 17.4 32.6 34.5 36.1 165.9 18.8 100.1 19.9 34.2 47.9 21.3 11.9 46.3 20.7 19.1 25.0 39.0 19.0 28.5 47.6 60.3 85.7 35.2 21.7 87.2 8.4 20.9 39.9 31.7 32.9 40.5 34.5 77.2 224.4 41.2 19.7 107.7 56.1 38.0 63.1 47.2 105.0 103.0 85.3 418.9 40.7 122.1 59.5 71.5 69.3 53.8 92.8 26.1 151.8 32.6 76.7 187.7 88.6 73.5 23.9 91.1 55.2 185.3 57.9 100.2 57.2 53.5 136.8 33.9 97.8 59.4 49.6 55.5 83.2 33.6 63.1 55.9 144.3 48.6 67.8 45.7 70.0 80.4 103.8 53.3 65.5 78.8 82.9 75.0 59.9 46.4 27.2 77.5 88.1 64.0 61.2 53.8 76.2 135.6 4.4 4.5 2.2 11.7 6.1 12.6 5.4 6.4 8.7 5.0 4.0 4.0 6.1 1.3 7.6 4.4 35.9 5.5 4.7 30.7 32.2 28.3 34.1 32.9 41.0 32.6 34.5 34.2 28.5 35.2 32.9 16.4 9.6 14.1 6.2 22.7 17.8 18.5 17.5 14.2 11.5 28.5 21.1 12.4 15.7 16.8 25.8 43.8 11.2 36.6 35.3 9.8 20.7 74.0 20.4 29.1 20.0 35.8 17.0 12.0 18.8 26.6 21.0 39.8 38.1 15.8 43.1 13.9 49.9 22.2 25.2 13.7 52.1 18.3 8.2 21.6 38.8 13.1 17.8 23.2 5.6 15.5 8.7 17.5 4.5 9.3 31.4 24.2 13.5 118.7 44.4 14.9 17.6 16.7 14.5 13.1 16.4 15.6 27.8 29.1 16.2 19.9 19.3 20.8 14.8 27.3 24.7 ID1 "bHLHb24, dJ857M17.1.2" ENSG00000125968 "Inhibitor of DNA binding 1, HLH protein" P41134 20 31605283-31606515 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025915, HPA051456, HPA058518" Approved Enhanced Nucleoplasm "Intracellular and membrane" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740" "unprognostic (3.89e-2)" "unprognostic (3.45e-2)" "unprognostic (2.62e-2)" "unprognostic (3.19e-2)" "unprognostic (1.27e-2)" "unprognostic (1.74e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (2.29e-1)" "unprognostic (1.58e-1)" "unprognostic (2.14e-2)" "unprognostic (7.83e-2)" "unprognostic (1.67e-2)" "unprognostic (1.71e-3)" "unprognostic (2.97e-1)" "unprognostic (6.17e-3)" "unprognostic (3.41e-3)" 242.2 88.5 53.0 20.2 43.1 9.0 141.3 50.1 57.1 125.7 60.9 136.7 78.4 116.0 4.7 340.4 146.3 35.0 291.9 45.3 56.8 218.1 154.1 204.7 14.0 69.3 56.0 66.8 42.4 8.1 167.8 45.7 62.3 202.5 26.4 5.1 58.5 149.6 53.8 129.6 154.3 12.2 53.3 79.7 162.5 16.4 79.1 5.9 266.8 37.8 6.2 351.1 206.9 47.1 76.1 245.3 2.7 49.3 31.2 14.1 187.6 314.1 12.6 56.9 6.2 130.5 111.4 0.6 509.6 84.3 67.2 500.2 40.1 17.9 8.6 6.2 25.6 41.5 229.2 425.3 42.3 0.9 2.2 57.4 69.7 0.3 4.3 93.5 35.0 27.6 94.0 2.3 110.4 99.8 11.4 1.8 172.7 336.5 515.3 0.9 200.8 4.2 11.1 206.1 93.5 87.4 261.3 91.9 2.4 128.8 57.0 7.6 188.5 151.3 300.0 49.0 216.1 5.6 6.3 5.2 176.2 39.5 21.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 1.1 0.1 0.2 0.0 0.0 0.1 53.0 43.1 50.1 57.1 45.3 56.8 69.3 56.0 62.3 53.3 79.1 47.1 1667.3 237.2 171.7 88.2 25.1 102.3 992.2 1443.4 406.3 2.7 98.6 114.3 35.1 112.9 685.1 228.1 4.2 129.9 46.3 594.3 37.2 584.1 5.7 794.1 450.1 907.7 572.7 49.9 0.6 535.5 493.7 195.3 675.3 707.6 22.2 8.9 2131.4 109.1 25.6 0.0 0.5 557.4 321.4 72.2 52.4 8.7 28.6 38.9 90.7 92.8 8.2 85.0 1.0 4.0 0.3 257.4 924.9 0.4 26.7 519.7 579.8 7.1 168.1 8.3 13.1 229.7 206.1 3.2 53.7 455.8 87.9 89.1 39.8 15.9 389.1 591.6 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928790 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 58.7;placenta: 110.9" "Cell type enriched" "Detected in many" 11 "monocytes: 2612.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 14 "eosinophil: 465.0" "Lineage enriched" "Detected in many" 18 "granulocytes: 465.0" "Cell line enriched" "Detected in some" 7 "EFO-21: 61.8" "Region enriched" "Detected in many" 12 "basal ganglia: 34.1" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 38: EFO-21 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favorable (5.27e-4)" "prognostic favorable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 9.8 0.7 0.6 40.5 0.4 0.7 2.0 0.4 0.8 7.2 1.0 5.3 10.3 10.2 1.2 1.3 2.6 6.2 1.8 0.4 0.6 1.7 2.4 25.9 58.7 0.7 0.3 1.2 1.2 0.2 0.1 110.9 0.5 2.0 8.2 1.3 1.9 3.0 8.1 1.3 8.4 2.4 0.4 23.0 5.8 1.1 0.8 31.2 4.0 0.6 31.5 9.1 0.5 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 7.6 4.8 0.3 0.8 0.0 61.8 0.0 3.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.1 8.4 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 9.1 0.2 0.2 0.0 0.3 0.0 32.5 1.3 465.0 0.1 1.4 0.1 0.2 0.1 0.0 26.4 0.3 0.1 0.2 4.9 0.1 0.1 0.3 0.1 1.2 0.6 0.4 0.4 0.8 0.4 0.6 0.7 0.3 0.5 0.4 0.8 0.6 24.9 0.0 0.5 0.7 4.4 0.4 0.2 18.3 0.0 0.0 0.5 0.1 0.3 0.0 76.0 0.0 0.0 0.0 0.3 8.3 0.0 4.4 3.7 70.1 23.0 6.9 0.0 0.0 0.2 8.1 0.0 0.3 0.0 223.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 2.0 3.7 28.1 1.8 0.0 13.6 0.0 0.0 2612.3 3.0 0.0 0.0 0.1 0.4 0.0 0.4 2.4 0.5 0.0 0.0 33.3 0.2 0.0 1.2 8.4 0.0 0.1 0.1 0.6 0.0 1.3 0.0 1.3 2.0 KNDC1 "bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND" ENSG00000171798 "Kinase non-catalytic C-lobe domain containing 1" Q76NI1 10 133160219-133226412 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.0;pituitary gland: 27.5" "Cell type enhanced" "Detected in many" "Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039624, HPA056143" Uncertain Approved "Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane, Cytosol" Vesicles "HPA039624: AB_10671045, HPA056143: " "unprognostic (2.32e-1)" "unprognostic (1.11e-1)" "unprognostic (6.35e-4)" "unprognostic (1.59e-3)" "unprognostic (1.96e-2)" "unprognostic (2.76e-1)" "unprognostic (5.61e-2)" "unprognostic (2.75e-2)" "unprognostic (6.77e-2)" "unprognostic (1.15e-1)" "unprognostic (6.80e-3)" "unprognostic (2.46e-3)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (2.53e-1)" "unprognostic (1.94e-1)" "unprognostic (9.41e-2)" 1.5 13.7 31.1 0.1 17.9 0.0 0.2 8.4 44.0 2.3 0.0 0.3 0.0 2.8 0.7 0.2 9.0 0.2 0.3 19.8 9.1 0.8 6.5 2.8 0.0 17.3 13.3 8.5 0.5 0.4 27.5 0.4 10.3 1.1 0.0 0.9 0.6 0.9 0.0 0.2 0.2 0.4 3.0 0.5 0.3 1.8 22.7 0.0 2.5 0.0 0.0 0.2 0.9 13.1 0.2 0.3 0.2 1.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.2 0.0 1.2 0.1 0.5 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 1.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 31.1 17.9 8.4 44.0 19.8 9.1 17.3 13.3 10.3 3.0 22.7 13.1 0.0 0.0 9.0 93.4 0.2 0.0 0.1 0.4 0.0 1.6 0.2 0.0 2.4 1.5 4.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 14.2 1.5 0.2 3.0 0.0 41.9 0.0 0.1 1.4 0.0 0.3 0.0 1.5 0.4 4.6 0.2 1.7 36.3 0.0 0.0 1.0 0.4 1.0 3.7 1.2 0.0 5.6 0.3 4.5 0.0 6.6 2.1 0.0 0.0 1.2 0.0 0.1 0.0 0.0 25.9 1.0 0.0 0.1 0.5 0.0 1.7 0.0 0.3 0.1 0.4 1.2 0.0 0.0 KNOP1 "101F10.1, C16orf88, FAM191A, TSG118" ENSG00000103550 "Lysine rich nucleolar protein 1" Q1ED39 16 19701937-19718235 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 166.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041079, HPA066169" Uncertain Enhanced "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim" Cytosol "HPA041079: AB_10962350, HPA066169: AB_2685628" "unprognostic (6.55e-3)" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (2.42e-2)" "unprognostic (8.57e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (3.75e-6)" "unprognostic (2.50e-2)" "unprognostic (2.03e-2)" "unprognostic (1.18e-3)" "unprognostic (5.84e-2)" "unprognostic (2.14e-2)" "unprognostic (7.91e-2)" "unprognostic (3.75e-2)" "unprognostic (3.62e-1)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" 7.5 6.8 14.3 6.9 16.9 4.0 11.5 14.6 22.5 9.1 9.7 8.3 7.1 7.0 8.8 10.4 7.4 6.3 7.3 15.5 15.1 9.9 7.9 5.7 9.0 15.9 15.8 11.4 8.6 13.5 6.4 8.8 17.3 7.3 9.1 8.8 12.5 6.8 14.4 13.0 7.3 4.8 13.2 6.4 8.1 8.9 15.6 5.9 6.2 5.4 6.7 7.2 8.8 22.9 30.2 45.4 49.7 37.9 12.1 11.3 25.5 18.3 9.9 17.1 17.2 32.2 25.5 35.7 72.6 11.1 15.0 27.4 38.9 25.1 16.6 24.2 27.2 21.1 25.3 42.7 21.9 33.5 15.9 7.2 35.1 22.4 18.4 15.0 18.3 25.0 66.1 15.6 16.2 39.3 29.7 27.6 96.8 29.7 17.9 63.0 26.7 41.4 18.0 28.4 44.4 37.4 22.7 29.0 31.2 28.1 33.8 22.4 21.3 26.7 27.4 16.5 24.5 23.0 51.3 44.7 14.4 25.2 26.6 0.4 3.0 1.5 4.0 7.1 5.9 5.8 5.6 3.9 3.6 7.1 10.1 5.7 0.8 4.4 6.7 4.6 3.8 3.5 14.3 16.9 14.6 22.5 15.5 15.1 15.9 15.8 17.3 13.2 15.6 22.9 40.3 6.4 17.8 108.7 19.8 12.2 29.9 47.9 17.6 39.2 37.9 31.9 8.9 38.6 29.5 38.6 87.6 57.1 13.6 43.0 46.9 98.2 2.8 33.8 79.8 47.2 15.0 21.7 9.7 66.3 45.4 26.0 26.5 42.1 6.3 66.9 26.0 53.4 36.5 35.3 12.7 41.7 61.1 24.9 12.6 8.5 60.6 17.9 12.4 16.9 27.2 25.8 33.0 15.1 166.6 77.8 19.0 53.8 14.8 46.4 32.3 34.5 21.3 64.1 46.0 18.7 38.9 67.8 125.3 31.5 16.1 24.6 16.8 53.6 64.4 23.3 KRT27 KRT25C ENSG00000171446 "Keratin 27" Q7Z3Y8 17 40776808-40782550 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "skin 1: 71.5" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.0;Endothelial cells: 1.5;Hepatic stellate cells: 2.2;Melanocytes: 8.8;Muller glia cells: 3.0;Spermatogonia: 2.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.9;thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "EFO-21: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in all" 5 "hippocampal formation: 80.6" HPA055114 Enhanced NA NA "Cluster 61: Skin - Cornification" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA055114: AB_2682700" "unprognostic (1.13e-1)" "unprognostic (1.87e-1)" "unprognostic (2.18e-1)" "unprognostic (5.75e-4)" "unprognostic (5.11e-2)" "unprognostic (3.08e-2)" "unprognostic (8.41e-2)" "unprognostic (4.16e-1)" "unprognostic (1.53e-1)" "unprognostic (4.90e-1)" "unprognostic (1.56e-1)" "unprognostic (5.64e-3)" 1.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.5 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.0 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 8.8 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 2.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 KRT78 K5B ENSG00000170423 "Keratin 78" Q8N1N4 12 52837804-52849092 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "esophagus: 972.7" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 2.4;Glandular and luminal cells: 1.9;Spermatocytes: 2.1;Spermatogonia: 8.0;Squamous epithelial cells: 6.7;Suprabasal keratinocytes: 4.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 16.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "EFO-21: 5.5;RT4: 1.6;SK-BR-3: 3.6;U-87 MG: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA039724 Enhanced NA NA 70000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA039724: AB_10795255" "unprognostic (5.36e-2)" "unprognostic (5.89e-2)" "unprognostic (2.95e-2)" "unprognostic (3.25e-2)" "unprognostic (1.88e-1)" "unprognostic (2.18e-2)" "unprognostic (3.01e-3)" "unprognostic (8.88e-16)" "unprognostic (3.50e-2)" "unprognostic (6.92e-1)" "unprognostic (7.55e-2)" "unprognostic (1.25e-1)" 0.4 0.2 0.0 0.0 0.0 0.1 3.4 0.0 0.5 227.1 0.0 0.1 0.0 0.1 0.0 972.7 0.1 0.9 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.7 0.0 0.0 0.1 0.0 0.0 141.7 0.0 0.3 126.7 0.2 0.0 0.0 0.1 1.0 1.5 0.3 0.4 0.3 0.0 134.2 0.4 221.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 5.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.5 0.6 0.0 0.8 2.4 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 8.0 6.7 4.4 0.3 0.0 0.0 0.2 0.5 LAMC3 DKFZp434E202 ENSG00000050555 "Laminin subunit gamma 3" Q9Y6N6 9 131009174-131094473 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 48.7" "Group enriched" "Detected in many" 4 "Leydig cells: 118.4;Peritubular cells: 364.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.0;EFO-21: 17.3;Hep G2: 6.1;SiHa: 6.7;U-2 OS: 5.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022814 Enhanced "Secreted to extracellular matrix" NA NA 1100000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 28: Placenta - Pregnancy" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA022814: AB_2670960" "unprognostic (9.77e-2)" "unprognostic (1.90e-1)" "unprognostic (9.55e-3)" "unprognostic (2.09e-1)" "unprognostic (2.15e-1)" "unprognostic (1.22e-2)" "unprognostic (1.38e-2)" "unprognostic (2.28e-3)" "unprognostic (6.27e-2)" "unprognostic (1.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.38e-1)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (1.63e-1)" "unprognostic (3.34e-1)" "unprognostic (7.83e-2)" 1.5 13.5 1.3 0.3 1.8 0.0 1.5 1.3 2.4 22.3 1.9 1.6 0.4 3.3 3.5 1.7 1.1 2.7 1.2 1.4 1.2 9.2 4.9 23.3 0.0 1.4 1.3 1.7 3.5 0.9 11.6 48.7 1.2 4.2 0.1 0.0 1.4 3.8 0.3 8.6 0.3 0.3 1.2 11.3 0.5 19.0 1.7 0.2 1.2 1.1 0.0 15.0 8.2 2.0 0.0 0.5 4.0 0.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 2.2 0.0 1.5 6.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.2 2.2 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.4 0.1 6.7 0.0 2.6 0.4 0.0 0.7 0.0 0.0 5.3 0.4 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 1.3 1.8 1.3 2.4 1.4 1.2 1.4 1.3 1.2 1.2 1.7 2.0 1.5 0.0 0.0 1.0 0.0 6.8 0.0 0.0 0.0 0.0 0.4 0.4 1.3 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.1 1.9 1.6 48.5 1.7 0.0 0.0 1.7 0.0 0.8 20.7 0.0 1.1 0.0 27.8 3.6 0.1 1.5 0.0 4.1 0.2 0.0 0.0 10.2 12.6 118.4 0.5 10.6 36.5 0.1 0.0 0.0 0.0 1.0 0.1 0.0 364.1 0.0 0.2 0.0 0.2 0.0 0.0 46.0 0.1 10.0 1.0 3.5 0.0 4.4 1.0 0.8 38.1 0.0 0.1 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122215-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lung: 219.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 486.7;monocytes: 339.6" "Cancer enhanced" "Detected in many" "lung cancer: 27.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 5.6" "Group enriched" "Detected in many" 8 "granulocytes: 5.6;T-cells: 4.8" "Group enriched" "Detected in many" 4 "EFO-21: 169.5;HDLM-2: 46.6;HHSteC: 60.4;hTCEpi: 59.1;JURKAT: 52.7" "CAB025133, HPA051467" Enhanced Enhanced Vesicles NA NA 59000 "Cluster 13: T-cells - Unknown function" "Cluster 19: Lung - Lung function" "Cluster 38: EFO-21 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" Vesicles "CAB025133: , HPA051467: AB_2681495" "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.7 0.6 0.2 33.1 0.4 0.8 1.3 0.3 0.2 1.4 0.0 3.2 2.7 0.7 2.6 4.4 1.1 3.9 0.3 0.2 0.1 0.6 0.9 219.7 16.1 0.2 0.1 0.3 7.8 1.9 0.5 1.9 0.1 2.7 6.8 0.6 27.2 2.5 0.2 7.0 3.1 4.3 0.2 9.0 4.1 22.7 0.3 28.1 7.5 0.2 21.5 11.2 0.9 0.0 10.7 0.3 0.2 1.7 0.1 0.1 8.7 0.2 2.8 1.8 0.5 2.8 5.3 0.1 169.5 0.9 18.9 1.5 3.7 6.4 0.2 46.6 5.9 0.0 0.3 0.4 60.4 0.0 1.4 0.9 59.1 0.1 7.4 0.0 7.6 52.7 0.4 9.9 0.2 0.2 2.5 0.4 0.3 0.9 2.7 0.0 0.0 0.8 0.2 3.4 0.7 0.4 0.8 0.3 5.0 2.1 3.4 0.4 8.3 0.0 3.0 0.4 0.2 3.5 13.2 0.5 0.0 0.1 0.1 0.3 0.0 5.6 0.2 0.0 2.4 0.1 1.8 1.1 0.0 0.2 2.3 1.3 1.3 0.6 0.0 0.0 4.8 0.7 0.2 0.4 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.3 0.0 0.2 64.1 486.7 0.0 2.0 6.0 2.9 2.4 8.6 0.0 0.3 0.6 1.2 1.5 9.5 1.8 0.0 2.9 0.1 0.1 0.0 0.6 34.3 1.3 0.2 0.5 0.0 0.4 0.7 6.1 0.4 1.0 1.5 0.8 18.9 0.4 0.0 0.0 1.3 0.0 0.6 0.2 0.0 0.0 41.1 84.9 0.6 4.8 1.8 0.0 339.6 0.0 0.0 0.0 0.1 0.6 0.0 0.0 4.1 1.6 0.1 0.0 11.5 0.0 0.0 0.4 0.3 14.0 0.5 4.0 5.7 1.2 2.3 0.0 0.5 2.2 LYNX1-SLURP2 ENSG00000284505 "LYNX1-SLURP2 readthrough" 8 142764334-142778224 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 6.3;intestine: 7.0" "Cell type enriched" "Detected in single" 12 "Pancreatic endocrine cells: 10.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 8 "monocytes: 1.4" "Cell line enhanced" "Detected in single" "BJ: 1.0" "Intracellular and membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" 1.5 1.0 0.3 0.2 0.4 0.0 0.5 1.1 2.5 2.1 0.3 7.0 0.3 2.0 0.3 6.3 1.3 0.3 1.5 0.7 0.2 0.5 0.9 0.4 0.1 1.4 0.3 0.6 0.2 0.5 1.0 0.1 1.4 1.8 0.2 0.2 0.7 1.7 0.8 3.4 1.0 0.3 0.6 0.3 2.2 0.6 0.6 0.0 0.4 0.2 0.3 3.8 2.5 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.4 1.1 2.5 0.7 0.2 1.4 0.3 1.4 0.6 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LYPD2 "LYPDC2, RGTR430, UNQ430" ENSG00000197353 "LY6/PLAUR domain containing 2" Q6UXB3 8 142750150-142752532 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "esophagus: 347.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 97.0;Club cells: 378.7;Ionocytes: 71.2;Respiratory ciliated cells: 77.4" "Cancer enhanced" "Detected in many" "cervical cancer: 45.9;ovarian cancer: 46.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 13 "non-classical monocyte: 440.1" "Lineage enriched" "Detected in many" 22 "monocytes: 440.1" "Cell line enhanced" "Detected in some" "EFO-21: 10.2;HaCaT: 2.8;OE19: 1.9" "Low region specificity" "Detected in many" HPA028599 Uncertain "Intracellular and membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA028599: AB_10603777" "prognostic favorable (2.00e-4)" "unprognostic (3.10e-2)" "prognostic favorable (2.63e-4)" "unprognostic (3.85e-3)" "unprognostic (3.75e-2)" "unprognostic (2.49e-1)" "unprognostic (1.57e-2)" "unprognostic (3.11e-3)" "unprognostic (1.53e-1)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.12e-1)" "unprognostic (2.04e-1)" 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.4 15.0 0.0 0.0 0.0 0.0 0.0 347.8 0.3 0.2 2.9 0.0 0.0 0.1 1.3 1.5 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 27.0 0.0 0.1 28.8 0.1 0.0 0.0 0.2 23.2 0.0 0.1 2.5 0.0 0.0 26.3 0.0 48.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 33.7 0.4 2.0 0.1 0.2 20.1 0.0 0.2 0.1 0.0 0.0 440.1 1.6 0.1 10.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 97.0 0.0 0.0 0.1 0.0 0.0 0.0 378.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.0 5.7 0.4 0.4 0.0 0.0 0.0 71.2 1.3 0.0 0.1 0.0 25.3 0.0 0.0 11.2 0.0 2.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 77.4 0.0 0.0 0.0 22.3 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.2 MRAS "M-RAs, R-RAS3, RRAS3" ENSG00000158186 "Muscle RAS oncogene homolog" O14807 3 138347648-138405534 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 202.3;heart muscle: 132.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "non-classical monocyte: 25.0" "Lineage enriched" "Detected in many" 9 "monocytes: 25.0" "Cell line enhanced" "Detected in many" "BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042728 Approved Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Vesicles "HPA042728: AB_10796582" "unprognostic (1.96e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.69e-1)" "unprognostic (5.32e-2)" "unprognostic (8.96e-2)" "unprognostic (3.85e-3)" "unprognostic (1.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (3.18e-3)" "unprognostic (1.78e-2)" "unprognostic (6.25e-2)" "unprognostic (2.21e-1)" "unprognostic (4.23e-2)" 91.9 67.7 112.7 10.8 130.6 1.7 46.7 118.2 105.5 17.3 48.9 24.2 3.3 28.7 7.1 7.9 26.4 12.0 132.9 105.6 132.8 22.9 5.5 18.4 5.2 126.1 135.9 48.6 5.7 8.2 17.7 10.6 112.9 15.3 4.1 15.9 13.4 15.0 80.4 12.2 8.7 23.2 110.3 12.2 12.0 9.6 202.3 4.9 26.4 48.0 3.3 29.1 12.1 97.8 0.8 7.9 15.8 24.5 59.6 29.2 40.0 92.9 16.0 7.3 8.2 3.3 3.1 0.3 113.7 70.4 18.6 0.1 9.0 1.8 6.1 7.7 3.1 0.5 4.8 20.1 15.9 0.0 1.9 41.5 5.9 0.7 1.4 13.6 1.3 0.0 10.7 0.8 31.4 3.7 0.0 20.4 19.1 0.0 2.7 1.1 33.8 0.2 30.4 2.0 18.6 42.0 62.8 0.7 45.9 10.9 16.1 37.7 0.6 23.7 25.3 24.3 2.4 0.1 1.0 1.2 21.4 0.1 11.4 0.2 2.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.8 25.0 0.1 0.0 0.8 112.7 130.6 118.2 105.5 105.6 132.8 126.1 135.9 112.9 110.3 202.3 97.8 8.9 9.6 1.5 54.2 0.8 2.2 3.0 3.4 1.2 5.6 28.8 34.8 121.7 2.8 3.5 9.2 10.4 20.1 0.2 0.0 58.7 8.6 11.6 1.0 21.4 14.5 1.8 0.0 25.5 3.2 3.2 23.0 2.0 1.5 6.3 35.2 12.8 1.6 26.3 28.6 20.6 0.0 2.0 15.1 18.4 40.0 23.3 18.2 28.4 20.6 12.2 24.3 0.0 28.6 11.0 3.8 0.0 34.3 0.1 3.3 0.0 27.5 1.3 9.6 6.6 20.8 18.9 7.3 18.6 0.4 1.0 14.4 0.8 59.1 0.0 0.6 NBDY "LINC01420, NoBody" ENSG00000204272 "Negative regulator of P-body association" A0A0U1RRE5 X 56729241-56819179 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 336.5;Extravillous trophoblasts: 257.1;Proximal tubular cells: 262.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (8.38e-3)" "unprognostic (2.46e-1)" "unprognostic (1.96e-3)" "prognostic unfavorable (3.14e-5)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.01e-2)" "unprognostic (2.23e-1)" "unprognostic (2.83e-1)" "unprognostic (2.59e-2)" "unprognostic (2.77e-1)" "unprognostic (2.09e-1)" "unprognostic (2.01e-2)" "unprognostic (2.18e-3)" "unprognostic (2.38e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-2)" 27.5 39.3 36.3 20.9 36.2 18.8 25.8 34.5 48.0 29.0 32.7 25.2 17.8 27.6 47.5 25.8 31.9 27.5 27.5 34.9 42.2 43.9 13.8 29.6 26.9 34.6 39.9 29.6 15.6 34.6 41.4 24.7 39.4 28.7 22.4 23.4 20.3 27.9 11.1 30.5 21.2 30.3 35.1 27.9 22.5 13.0 39.1 35.9 41.5 18.2 24.9 35.1 27.9 34.5 34.2 52.1 63.6 53.7 74.2 66.4 15.5 46.6 75.4 25.7 42.1 25.0 67.4 14.7 111.1 54.2 52.8 23.0 59.0 58.0 32.9 0.2 73.5 43.6 49.6 6.4 76.7 49.5 44.4 80.2 68.9 45.3 81.0 77.8 68.8 48.7 17.7 36.7 50.4 59.0 62.3 14.3 84.2 55.5 92.2 30.2 42.8 53.0 68.8 49.3 27.7 43.1 100.8 47.1 46.7 113.7 60.7 22.7 59.3 42.9 35.3 75.5 29.0 40.7 26.3 39.8 36.2 26.9 34.6 66.4 54.7 6.0 70.5 62.5 73.1 86.1 89.1 78.6 98.7 86.7 85.6 82.1 5.0 103.4 66.9 175.9 93.2 68.2 36.3 36.2 34.5 48.0 34.9 42.2 34.6 39.9 39.4 35.1 39.1 34.5 128.6 28.9 34.5 0.0 24.6 0.0 0.0 0.0 0.0 0.0 83.2 88.9 0.0 0.0 18.0 117.7 0.0 143.1 40.5 0.0 336.5 110.8 0.0 71.9 60.4 55.2 0.0 0.0 0.0 95.5 257.1 31.0 0.0 68.5 39.1 67.2 0.0 0.0 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.4 0.0 0.0 91.5 0.0 0.0 0.0 0.0 126.2 0.0 0.0 5.4 0.0 0.0 262.5 29.9 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 148.9 25.6 119.5 0.0 0.0 NEDD9 "CAS-L, CASS2, HEF1" ENSG00000111859 "Neural precursor cell expressed, developmentally down-regulated 9" Q14511 6 11183298-11382348 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 137.3;HSkMC: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009689, CAB009720, HPA038768, HPA039270, HPA072955" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: " "unprognostic (2.83e-3)" "unprognostic (2.33e-2)" "unprognostic (1.08e-2)" "unprognostic (6.93e-2)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.62e-1)" "unprognostic (9.54e-2)" "unprognostic (3.05e-2)" "unprognostic (2.09e-1)" "unprognostic (2.90e-1)" "unprognostic (1.64e-1)" "unprognostic (5.59e-3)" "unprognostic (2.25e-2)" "unprognostic (2.37e-1)" "unprognostic (2.41e-1)" "unprognostic (1.05e-1)" 94.7 8.6 8.3 23.3 8.1 8.6 64.2 6.4 12.3 26.6 14.4 30.7 15.5 19.2 17.5 14.5 22.7 31.4 32.7 7.7 6.4 33.8 20.7 91.9 25.8 8.3 7.3 8.3 17.1 9.5 8.1 69.2 8.5 22.4 30.2 9.8 26.7 29.8 27.2 20.6 38.1 25.8 7.4 25.2 23.5 6.9 9.7 22.2 25.6 12.0 22.2 34.5 15.3 7.9 4.4 29.0 26.4 0.4 17.7 2.3 27.7 6.6 8.2 12.2 22.4 9.3 1.9 9.2 137.3 14.7 1.5 12.6 36.0 13.5 15.8 4.1 1.0 0.8 4.4 62.3 8.3 10.1 0.4 67.7 4.0 7.9 1.3 4.4 21.0 0.8 0.1 7.6 27.7 1.3 5.8 4.0 4.1 34.6 2.9 1.6 0.7 5.4 6.1 39.8 0.6 4.8 1.1 31.2 55.5 29.3 2.3 7.7 53.8 8.2 14.3 0.8 16.5 7.8 34.8 11.4 0.2 7.9 36.6 24.2 13.3 37.3 18.3 28.5 14.7 10.9 12.2 17.5 14.1 12.3 6.4 9.9 80.9 12.3 50.6 8.7 12.1 17.1 8.3 8.1 6.4 12.3 7.7 6.4 8.3 7.3 8.5 7.4 9.7 7.9 323.2 471.1 135.1 11.1 34.9 60.5 235.6 83.5 98.4 4.7 43.1 38.0 14.2 50.1 89.0 44.1 25.0 56.3 45.9 103.4 9.8 62.0 8.2 244.8 24.8 148.1 108.3 2.5 18.2 19.8 42.6 37.2 107.6 337.0 64.5 15.7 86.7 21.6 14.7 10.1 11.3 108.4 12.2 29.8 28.9 4.3 7.5 51.4 24.9 34.7 15.4 84.1 64.9 8.0 4.9 69.1 43.6 29.0 34.8 66.1 100.5 26.7 64.4 12.4 26.3 8.8 30.0 2.1 1.1 11.4 20.6 42.8 59.4 37.2 46.6 90.3 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 101.2;monocytes: 57.7;Prostatic glandular cells: 90.5;Urothelial cells: 80.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 14.3;neutrophil: 15.6" "Group enriched" "Detected in many" 4 "dendritic cells: 4.1;granulocytes: 15.6;monocytes: 7.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;EFO-21: 29.5;HUVEC TERT2: 27.8;TIME: 16.3;U-937: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049771, HPA075115" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA049771: AB_2680872, HPA075115: " "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 4.7 1.3 8.1 3.0 9.6 2.2 3.2 11.8 6.6 3.2 12.3 4.9 0.8 3.2 1.4 3.1 2.3 4.3 2.2 6.6 5.9 1.1 0.9 3.4 0.8 1.5 9.1 1.6 0.6 1.6 2.6 2.2 4.6 3.5 1.9 0.3 1.5 4.8 0.8 1.4 1.7 6.9 0.8 2.8 1.9 2.4 6.9 1.0 2.7 2.4 0.9 3.7 2.3 0.0 0.4 0.6 25.2 0.1 0.3 1.0 0.2 0.9 4.7 0.1 0.4 0.1 0.0 0.2 29.5 2.6 0.1 0.0 1.6 0.0 0.6 0.1 0.6 0.1 0.1 0.0 0.1 0.1 1.4 0.5 0.0 0.9 0.0 0.1 27.8 0.1 0.0 4.1 0.2 0.2 0.1 2.1 4.8 0.0 0.0 0.1 1.4 0.0 0.1 2.9 0.6 5.7 0.0 0.0 0.0 7.1 0.1 1.7 16.3 0.0 1.6 2.0 0.0 0.1 0.0 0.1 1.1 20.5 0.0 5.0 7.1 14.3 2.0 4.7 1.9 0.0 1.0 1.7 4.1 0.0 0.1 0.2 15.6 1.0 3.7 0.0 0.1 2.3 8.1 9.6 11.8 6.6 6.6 5.9 1.5 9.1 4.6 0.8 6.9 0.0 29.2 0.0 1.9 1.0 7.3 0.5 101.2 0.0 0.6 0.9 5.0 3.7 19.6 21.5 0.0 1.8 0.0 17.9 10.1 2.0 0.0 0.2 4.7 3.3 2.8 32.9 1.2 17.3 7.8 0.7 24.3 15.2 0.5 9.0 7.6 0.9 51.0 19.0 19.1 0.0 5.8 3.7 0.0 49.0 0.5 7.4 31.7 19.7 1.8 19.7 57.7 1.5 32.0 5.5 1.1 0.6 3.1 21.4 2.8 90.5 7.8 2.9 0.0 0.5 26.3 39.7 12.6 2.7 3.7 0.3 0.3 24.9 17.0 2.9 3.8 80.7 NMUR2 NMU2R ENSG00000132911 "Neuromedin U receptor 2" Q9GZQ4 5 152391546-152433368 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 6.2" "Group enriched" "Detected in some" 13 "Gastric mucus-secreting cells: 5.1;Oligodendrocytes: 8.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8;stomach cancer: 2.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "EFO-21: 9.6" "Region enhanced" "Detected in single" "hypothalamus: 1.7" "Low region specificity" "Detected in all" "HPA027800, HPA045836" Enhanced Supported "Plasma membrane" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "HPA027800: , HPA045836: AB_10968856" "unprognostic (1.82e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-1)" "unprognostic (9.29e-2)" "unprognostic (5.87e-2)" "unprognostic (6.44e-3)" "unprognostic (3.13e-1)" "unprognostic (6.47e-2)" "unprognostic (5.63e-2)" "unprognostic (8.20e-3)" "unprognostic (8.90e-5)" "unprognostic (1.48e-2)" "unprognostic (9.24e-2)" "unprognostic (9.56e-2)" "unprognostic (2.29e-1)" 0.0 0.1 1.0 0.0 3.5 0.0 0.0 1.4 1.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.7 3.0 0.4 0.0 0.3 0.0 4.5 2.1 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 3.8 0.0 1.0 1.5 3.0 0.6 0.5 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 9.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.5 1.4 1.8 0.7 3.0 4.5 2.1 4.1 3.8 3.0 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 5.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 NOG "SYM1, SYNS1" ENSG00000183691 Noggin Q13253 17 56593699-56595611 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.2;placenta: 10.6" "Cell type enriched" "Detected in some" 4 "Extravillous trophoblasts: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 72.8;naive CD8 T-cell: 34.9" "Lineage enriched" "Detected in single" 78 "T-cells: 72.8" "Cell line enhanced" "Detected in many" "EFO-21: 123.3;LHCN-M2: 38.1;NB-4: 28.8;PC-3: 37.9;U-2 OS: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061318 Approved "Secreted to blood" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 32: Non-specific - Translation" "HPA061318: AB_2684478" "unprognostic (1.49e-1)" "unprognostic (1.17e-2)" "unprognostic (1.49e-5)" "prognostic favorable (6.66e-4)" "unprognostic (4.69e-2)" "unprognostic (5.23e-3)" "unprognostic (1.26e-2)" "unprognostic (3.06e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (6.86e-5)" "unprognostic (2.88e-1)" "unprognostic (1.14e-6)" "unprognostic (8.39e-2)" "unprognostic (1.40e-1)" "unprognostic (5.00e-1)" "unprognostic (1.65e-1)" 0.7 0.1 6.1 0.6 4.8 0.2 0.3 1.7 4.2 4.7 0.3 0.3 0.1 0.3 0.1 0.2 0.5 0.0 0.5 4.0 3.6 0.4 0.1 0.7 1.8 2.1 5.0 0.0 0.1 0.0 0.7 10.6 1.8 0.8 0.0 0.0 0.3 1.4 3.5 0.3 0.5 0.1 2.4 0.7 0.9 0.7 8.2 0.6 0.4 0.8 0.4 0.8 2.7 2.0 6.3 0.2 0.2 0.0 0.2 0.0 0.0 3.2 3.5 1.2 1.3 0.4 1.2 0.0 123.3 1.5 4.8 0.5 2.2 0.3 3.4 0.1 2.2 0.0 5.2 0.0 0.0 0.9 0.0 0.5 0.7 0.0 0.5 0.4 0.1 0.1 0.0 0.0 38.1 0.2 1.1 28.8 2.6 0.0 37.9 17.0 11.6 0.0 2.9 0.0 0.2 0.0 6.5 0.1 0.0 9.9 0.1 0.5 0.7 2.3 38.5 0.2 2.7 0.0 0.1 0.4 0.0 3.2 0.0 0.9 0.1 0.2 0.6 0.2 0.2 0.1 4.3 0.5 0.1 0.1 72.8 34.9 0.8 0.4 0.3 0.3 3.4 3.1 6.1 4.8 1.7 4.2 4.0 3.6 2.1 5.0 1.8 2.4 8.2 2.0 0.4 0.0 0.0 2.0 0.3 0.0 0.4 0.0 0.6 0.0 0.1 0.9 1.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.5 0.1 0.6 1.5 0.3 0.0 2.5 0.2 0.0 12.2 1.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.0 1.5 0.1 0.6 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.0 0.0 2.3 0.4 0.0 1.7 0.4 0.1 0.8 2.0 0.0 0.0 0.1 NOMO2 "NOMO, PM5" ENSG00000185164 "NODAL modulator 2" Q5JPE7 16 18417325-18562211 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 300.4" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 124.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA046697, HPA061174" Approved NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 22: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA046697: AB_2679758, HPA061174: AB_2684444" "unprognostic (2.58e-3)" "unprognostic (4.11e-3)" "unprognostic (2.58e-2)" "unprognostic (9.10e-2)" "unprognostic (1.74e-1)" "unprognostic (2.85e-2)" "unprognostic (4.80e-2)" "unprognostic (9.37e-2)" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (1.09e-2)" "unprognostic (1.78e-1)" "unprognostic (1.78e-3)" "unprognostic (2.22e-1)" "unprognostic (3.42e-2)" "unprognostic (8.39e-2)" "unprognostic (1.54e-2)" 55.9 66.1 119.0 27.6 128.5 31.1 54.7 106.5 141.4 54.0 108.0 65.4 34.8 59.8 53.5 57.2 48.2 22.4 191.7 133.8 124.9 76.7 96.6 73.8 23.9 112.0 108.8 48.4 300.4 76.8 104.2 49.1 112.6 59.5 35.6 42.3 63.3 31.7 126.2 60.5 56.7 41.5 100.3 61.8 88.5 50.4 112.7 23.1 55.9 52.2 29.6 61.3 50.5 116.5 71.1 101.3 37.5 104.5 141.0 85.9 110.3 122.1 144.6 101.5 125.4 87.7 108.6 83.0 433.3 213.4 71.0 80.5 81.2 84.8 88.1 67.7 64.5 37.0 98.2 313.5 195.5 88.7 252.1 91.2 112.6 117.2 106.8 107.9 113.1 70.3 52.3 185.4 120.6 213.9 33.2 197.2 72.9 107.0 42.3 71.1 50.8 230.1 150.9 63.6 52.6 44.2 94.4 128.5 82.4 75.2 99.6 185.8 106.1 60.7 47.0 127.4 86.8 95.6 112.0 44.6 135.3 92.9 85.1 21.8 12.6 11.8 14.3 11.9 11.6 10.8 14.0 14.5 14.1 9.8 9.3 11.8 13.8 8.3 15.4 22.8 22.4 17.5 119.0 128.5 106.5 141.4 133.8 124.9 112.0 108.8 112.6 100.3 112.7 116.5 0.5 6.4 2.8 2.0 3.8 0.4 0.4 0.6 2.8 0.9 0.5 0.3 124.4 0.0 1.4 0.0 4.2 0.4 1.3 0.4 1.9 0.2 0.2 0.3 0.8 3.2 0.0 2.5 6.4 0.7 0.3 9.1 4.1 0.6 0.0 0.7 0.7 0.8 0.1 0.0 5.1 0.2 0.0 0.8 0.2 0.4 0.0 1.2 0.0 5.6 0.2 0.3 2.1 8.5 7.6 0.4 0.1 0.4 22.7 0.4 0.6 0.1 1.9 0.6 6.6 0.6 4.8 1.2 1.3 3.3 0.6 0.4 3.2 1.1 0.4 0.1 NOMO3 ENSG00000103226 "NODAL modulator 3" P69849 16 16232506-16300806 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 30.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 9.3" "HPA046697, HPA061174" Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA046697: AB_2679758, HPA061174: AB_2684444" "unprognostic (1.21e-1)" "unprognostic (1.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.31e-1)" "unprognostic (3.99e-2)" "unprognostic (1.33e-1)" "unprognostic (9.81e-2)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (8.02e-2)" "unprognostic (6.25e-2)" "unprognostic (8.43e-2)" "unprognostic (7.86e-3)" "unprognostic (1.82e-1)" "unprognostic (1.65e-1)" "unprognostic (1.10e-2)" "unprognostic (1.22e-1)" 5.7 5.8 3.1 0.7 3.2 2.7 5.2 4.4 4.6 5.2 1.6 6.5 0.7 7.7 0.8 4.8 5.5 0.3 20.3 3.4 3.0 4.3 4.4 6.7 0.4 3.0 2.8 5.4 30.0 0.5 4.3 0.8 3.3 3.8 1.0 3.1 5.5 0.4 22.1 5.1 5.1 0.4 2.4 4.0 8.7 3.5 3.5 0.5 4.9 0.1 0.7 6.6 4.5 4.3 1.3 2.9 0.8 2.8 0.6 2.6 1.2 1.9 1.8 2.4 1.3 1.1 1.5 1.3 9.3 1.0 0.4 1.0 2.7 1.7 1.9 1.3 1.9 1.3 3.5 6.6 0.9 1.6 7.0 1.0 6.1 3.4 0.8 1.5 0.8 2.0 1.1 2.1 1.0 5.9 0.5 3.0 0.8 0.4 1.9 2.2 2.6 4.7 0.7 1.1 1.1 1.8 1.3 2.0 1.3 1.5 1.8 1.3 1.5 1.1 1.8 1.9 1.1 2.4 1.9 1.7 2.4 3.0 1.7 0.0 0.2 0.3 0.2 0.3 0.1 0.4 0.3 0.4 0.4 0.1 0.1 0.3 0.2 0.3 0.1 0.2 0.3 0.3 3.1 3.2 4.4 4.6 3.4 3.0 3.0 2.8 3.3 2.4 3.5 4.3 1.3 3.2 4.1 2.9 3.3 10.5 3.7 3.0 2.2 5.7 2.8 1.8 8.2 8.6 4.3 3.7 12.5 2.0 5.2 2.0 0.0 1.2 1.8 2.2 2.2 3.6 3.5 4.0 4.4 1.5 1.4 3.1 5.1 2.2 4.5 8.7 5.3 2.9 1.6 6.7 5.4 1.5 2.0 4.9 4.4 2.2 2.1 2.7 1.8 2.8 3.3 1.1 7.2 5.0 7.2 1.8 1.6 1.2 3.2 2.9 2.1 1.0 6.1 5.2 6.6 4.3 2.3 8.2 6.6 1.5 11.2 2.5 3.5 5.2 1.9 3.2 PAX2 ENSG00000075891 "Paired box 2" Q02962 10 100735396-100829944 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 29.6;kidney: 85.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 145.3;Distal tubular cells: 49.0;Endometrial ciliated cells: 129.5;Glandular and luminal cells: 246.0" "Group enriched" "Detected in some" 19 "endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "AN3-CA: 14.4;EFO-21: 22.6;RPTEC TERT1: 16.0" "Group enriched" "Detected in some" 9 "cerebellum: 1.3;pons and medulla: 3.4" "Group enriched" "Detected in some" 7 "cerebellum: 3.6;medulla oblongata: 5.6;spinal cord: 4.9" "CAB013024, HPA047704, HPA070751" Enhanced Supported Nucleoplasm "Intracellular and membrane" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305" "unprognostic (3.98e-2)" "unprognostic (9.55e-2)" "unprognostic (1.48e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (4.85e-2)" "unprognostic (5.54e-1)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.24e-2)" "unprognostic (6.59e-2)" "unprognostic (9.18e-2)" "unprognostic (3.30e-3)" "unprognostic (3.67e-1)" "unprognostic (1.97e-1)" "unprognostic (6.34e-2)" "unprognostic (8.26e-2)" 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.4 5.4 0.2 0.0 0.0 1.8 29.6 0.0 8.4 0.0 0.0 0.5 0.4 85.3 0.1 0.0 0.0 6.8 1.6 0.2 0.4 5.9 0.8 0.0 3.3 0.2 0.0 1.2 0.0 11.5 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 14.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.6 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 16.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 2.2 0.4 0.5 0.4 6.8 1.6 3.3 6.3 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 5.9 0.0 0.0 145.3 0.0 0.0 0.0 0.0 49.0 0.0 9.4 129.5 14.8 0.6 0.0 0.0 0.5 0.2 0.0 0.2 0.0 246.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 1.5 0.0 1.1 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 27.6 0.0 0.5 0.0 0.0 0.6 1.1 1.2 0.0 0.0 0.0 1.2 0.0 0.1 0.0 PCDHA10 "CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10" ENSG00000250120 "Protocadherin alpha 10" Q9Y5I2 5 140855883-141012347 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 6.3;pancreas: 4.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.3;Cone photoreceptor cells: 8.4;Horizontal cells: 8.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 16.2" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "unprognostic (4.24e-2)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (4.70e-2)" "unprognostic (4.19e-1)" "unprognostic (2.36e-1)" "unprognostic (6.46e-2)" "unprognostic (8.24e-2)" "unprognostic (8.10e-2)" "unprognostic (5.28e-2)" "unprognostic (2.65e-1)" "unprognostic (6.14e-3)" "unprognostic (1.93e-2)" "unprognostic (3.57e-3)" "unprognostic (5.21e-2)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" 0.8 0.5 1.3 0.3 1.8 0.1 0.7 6.3 2.4 0.9 0.0 0.2 0.3 1.8 2.0 0.0 1.0 1.2 0.1 1.6 0.7 1.5 0.0 0.8 0.2 2.1 1.0 1.1 4.1 0.7 1.5 0.0 2.0 0.4 0.1 2.4 0.5 0.2 0.1 0.1 0.7 1.6 1.5 0.1 0.3 1.3 1.1 0.0 2.1 0.1 0.0 0.2 0.1 2.7 0.0 0.2 0.5 3.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 16.2 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.3 1.2 0.8 0.0 0.1 0.0 2.4 0.3 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 1.8 6.3 2.4 1.6 0.7 2.1 1.0 2.0 1.5 1.1 2.7 0.9 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 7.3 1.2 1.4 0.6 1.5 0.1 0.0 8.4 0.0 0.0 0.2 0.0 0.2 3.2 0.6 2.7 0.6 1.8 0.0 0.0 0.9 0.0 0.6 0.0 0.5 0.0 0.3 0.4 0.0 0.0 8.4 0.0 0.0 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.9 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.4 0.0 3.2 0.0 2.5 2.3 2.2 0.3 0.0 0.0 0.0 0.2 0.3 0.1 0.3 PCDHA4 "CNR1, CNRN1, CRNR1, PCDH-ALPHA4" ENSG00000204967 "Protocadherin alpha 4" Q9UN74 5 140806929-141012347 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;granulocytes: 3.8;Respiratory ciliated cells: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.6;AF22: 5.6;EFO-21: 5.1;T-47d: 5.4" "Not detected" "Not detected" "HPA043180, HPA073478" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 6: Brain - Smell perception" "Cluster 38: EFO-21 - Unknown function" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Plasma membrane" Cytosol "HPA043180: AB_10806381, HPA073478: AB_2686608" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (2.85e-1)" "unprognostic (5.32e-2)" "unprognostic (1.93e-1)" "unprognostic (3.14e-2)" "unprognostic (2.56e-1)" "unprognostic (7.90e-3)" "unprognostic (7.14e-3)" "unprognostic (7.00e-2)" "unprognostic (5.06e-3)" "unprognostic (6.94e-5)" "unprognostic (5.01e-3)" "unprognostic (6.21e-2)" "unprognostic (3.98e-1)" "unprognostic (6.29e-3)" "unprognostic (4.79e-2)" 0.2 0.2 0.9 0.2 1.2 0.9 0.4 2.9 1.1 0.5 0.0 0.3 0.3 0.6 0.4 0.1 0.3 1.3 0.1 0.9 0.5 0.4 0.1 0.4 0.3 0.6 0.5 0.2 1.2 0.1 0.4 0.1 0.6 0.4 0.2 0.9 0.2 0.3 0.3 0.5 0.2 0.3 0.3 0.3 0.3 0.4 0.4 0.1 0.3 0.1 0.2 0.2 0.1 1.5 0.1 6.6 5.6 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 1.1 0.1 5.1 0.1 0.3 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.4 0.2 0.1 0.2 0.3 0.3 1.1 0.1 0.1 0.3 0.3 0.2 0.1 0.7 0.1 0.1 0.1 0.2 1.7 1.2 0.9 0.1 0.1 0.2 0.1 0.2 0.2 2.3 0.0 1.4 0.5 0.8 5.4 0.1 0.6 1.2 0.8 0.5 0.1 0.3 0.1 0.1 0.2 0.2 0.5 0.3 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.9 1.2 2.9 1.1 0.9 0.5 0.6 0.5 0.6 0.3 0.4 1.5 0.1 3.2 2.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.2 0.0 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.6 1.3 0.6 0.7 0.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.3 3.8 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.2 2.9 1.1 0.0 0.4 0.5 1.0 0.5 0.0 0.0 0.0 0.2 0.1 0.1 0.4 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 4.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.0;EFO-21: 8.4;hTERT-RPE1: 2.2;U-2 OS: 3.4;WM-115: 5.2" "Low region specificity" "Detected in many" "HPA059326, HPA078110" Enhanced Approved Vesicles "Secreted in brain" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 38: EFO-21 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA059326: AB_2683980, HPA078110: AB_2732371" "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 0.2 0.3 0.8 0.1 0.9 0.0 0.3 4.1 1.1 0.4 0.0 0.1 0.2 0.6 0.3 0.0 0.3 0.3 0.1 1.0 0.7 0.4 0.0 0.2 0.1 0.4 0.3 0.4 1.0 1.5 1.5 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.9 0.0 0.1 2.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.5 1.0 0.1 0.4 0.0 1.3 0.0 3.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 4.1 1.1 1.0 0.7 0.4 0.3 0.5 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB10 ENSG00000120324 "Protocadherin beta 10" Q9UN67 5 141192353-141195647 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.9;Endometrial stromal cells: 3.4;Endothelial cells: 3.2;Enteroendocrine cells: 4.2;granulocytes: 4.5;Peritubular cells: 4.1" "Cancer enhanced" "Detected in many" "glioma: 4.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 6.6;ASC TERT1: 6.4;EFO-21: 14.1;U-2197: 7.0" HPA013445 Uncertain NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" "HPA013445: AB_1855054" "unprognostic (1.08e-1)" "unprognostic (8.41e-2)" "unprognostic (4.03e-2)" "unprognostic (1.51e-2)" "unprognostic (1.94e-1)" "unprognostic (7.30e-2)" "unprognostic (1.81e-2)" "unprognostic (2.74e-1)" "unprognostic (2.61e-2)" "unprognostic (3.96e-3)" "unprognostic (2.16e-1)" "unprognostic (3.25e-1)" "unprognostic (5.40e-3)" "unprognostic (4.56e-2)" "unprognostic (3.11e-2)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" 1.4 1.8 2.1 0.5 1.9 0.0 1.7 1.1 2.7 2.3 0.0 2.6 0.5 3.4 1.6 0.8 1.8 1.5 1.6 2.4 0.9 0.7 0.2 1.4 0.3 1.6 2.5 2.5 0.7 1.3 3.6 0.7 1.5 1.6 0.7 1.5 1.1 1.5 0.5 0.9 0.8 3.1 1.2 0.6 0.9 0.7 2.6 0.2 0.9 0.7 0.1 1.6 1.4 2.1 0.0 0.0 3.9 3.7 6.6 6.4 0.2 0.4 3.6 0.1 0.3 0.0 0.3 0.1 14.1 1.0 2.9 0.1 0.7 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.7 2.5 0.0 0.0 3.5 0.3 0.0 0.0 4.3 1.3 0.1 0.1 0.1 0.1 0.0 0.2 0.8 2.4 0.0 0.5 0.0 2.6 5.4 4.4 0.1 0.6 0.4 2.9 0.2 1.4 3.6 2.0 7.0 1.0 0.0 0.0 0.0 4.4 0.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.9 1.1 2.7 2.4 0.9 1.6 2.5 1.5 1.2 2.6 2.1 2.6 0.0 0.5 0.0 0.0 0.0 0.1 1.5 0.0 8.9 0.5 0.9 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.1 3.4 3.2 4.2 0.0 0.0 0.9 0.0 2.1 0.0 0.2 4.5 0.2 1.4 0.0 0.1 0.0 0.0 0.3 2.0 0.0 0.4 0.6 1.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.2 0.1 0.2 0.0 2.9 1.6 1.9 0.6 0.2 0.4 0.1 0.1 0.3 0.0 0.3 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199610-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 4.9;Endometrial stromal cells: 3.5;Fibroblasts: 4.8;Peritubular cells: 3.4;Sertoli cells: 6.6;Skeletal myocytes: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.6;EFO-21: 8.9;U-2 OS: 3.0" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 1.3 0.6 0.2 0.5 0.5 0.2 0.9 0.9 1.2 1.2 0.0 1.0 0.2 1.5 0.5 0.7 0.9 0.9 0.8 0.5 0.0 0.7 0.2 0.8 0.1 0.3 0.3 1.6 2.6 2.6 0.7 0.6 0.1 0.9 0.3 0.6 0.8 1.0 0.4 0.8 0.4 1.2 0.4 0.6 0.6 0.4 0.0 0.3 0.6 0.6 0.1 0.9 0.6 0.4 0.0 0.1 1.8 5.6 0.1 0.1 1.1 0.1 0.5 0.0 0.0 0.0 0.1 0.0 8.9 0.5 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.8 0.0 0.1 0.0 1.4 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.0 2.2 0.0 0.0 0.2 2.2 0.3 1.3 0.1 0.7 0.3 1.3 0.0 0.3 0.1 3.0 2.4 0.0 0.1 0.0 0.0 1.4 0.1 1.5 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.2 0.5 0.9 1.2 0.5 0.0 0.3 0.3 0.1 0.4 0.0 0.4 1.9 3.2 0.5 0.0 0.0 0.0 0.7 0.0 0.0 4.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 3.5 1.9 2.4 0.0 0.0 1.8 0.0 4.8 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 3.4 0.1 0.9 0.0 0.9 0.0 0.2 6.6 4.1 1.7 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.7 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 4.0;Endometrial stromal cells: 2.8;Fibroblasts: 2.8;Melanocytes: 3.6;Peritubular cells: 2.6;Skeletal myocytes: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.7;ASC diff: 2.5;EFO-21: 3.0;RH-30: 3.2;U-2 OS: 2.3;U-2197: 2.4" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 1.3 0.6 0.1 0.4 0.7 0.0 1.2 0.9 1.1 1.9 0.0 1.3 0.2 2.7 0.8 0.4 1.9 1.0 1.4 0.8 0.1 0.6 0.3 1.4 0.1 0.3 0.3 2.2 1.3 1.0 2.0 0.4 0.0 0.9 0.4 0.8 0.6 0.9 0.7 0.5 0.6 1.8 0.1 0.7 0.6 1.1 0.1 0.1 0.6 0.9 0.1 1.2 1.1 0.7 0.0 0.0 0.7 2.7 2.5 1.4 0.4 0.0 1.9 0.1 0.2 0.0 0.0 0.0 3.0 0.3 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.7 0.1 0.0 0.0 0.1 0.0 0.5 0.5 3.2 0.0 0.0 0.0 1.5 0.9 0.0 0.0 0.6 0.2 2.1 0.4 0.2 0.4 2.3 2.4 0.0 0.0 0.0 0.0 1.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.9 1.1 0.8 0.1 0.3 0.3 0.0 0.1 0.1 0.7 1.9 0.0 1.1 0.0 0.0 0.4 0.0 0.2 0.0 4.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.8 0.1 2.8 1.3 1.8 0.0 0.0 0.9 0.0 2.8 0.5 0.1 0.0 0.1 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.0 3.6 0.0 0.0 1.2 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.1 0.0 0.2 0.0 0.3 0.0 2.2 1.6 1.2 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 PCDHB6 PCDH-BETA6 ENSG00000113211 "Protocadherin beta 6" Q9Y5E3 5 141150057-141153287 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 16.6;SH-SY5Y: 7.1;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5" "Low region specificity" "Detected in many" "HPA029566, HPA075308" Uncertain Approved Nucleoplasm NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA029566: AB_10601385, HPA075308: " "unprognostic (3.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.81e-1)" "unprognostic (8.05e-2)" "unprognostic (7.65e-3)" "unprognostic (2.82e-1)" "unprognostic (1.73e-3)" "unprognostic (9.64e-3)" "unprognostic (8.62e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (6.33e-2)" "prognostic unfavorable (5.52e-4)" "unprognostic (8.60e-4)" "unprognostic (2.31e-2)" "unprognostic (7.08e-3)" "unprognostic (6.52e-2)" 0.8 0.7 0.9 0.2 0.9 0.0 1.1 0.4 1.6 1.2 0.0 0.7 0.0 1.9 1.1 0.2 1.0 0.3 0.7 1.4 0.3 0.6 0.1 0.7 0.1 0.8 0.7 1.2 0.5 1.8 1.0 0.4 0.8 0.5 0.1 0.9 0.7 0.3 0.4 0.7 0.3 0.9 0.6 0.2 0.4 1.9 0.8 0.1 0.4 0.3 0.1 0.7 0.7 1.3 0.0 0.4 0.3 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 16.6 0.2 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 7.1 0.0 0.1 3.7 0.4 5.4 2.3 0.0 0.6 1.2 7.6 0.0 0.0 0.0 0.0 3.8 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.4 1.6 1.4 0.3 0.8 0.7 0.8 0.6 0.8 1.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.6 0.4 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 1.0 0.7 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.2 0.0 1.5 0.8 7.6 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 PCYT1A "CT, CTPCT, PCYT1" ENSG00000161217 "Phosphate cytidylyltransferase 1, choline, alpha" P49585 3 196214222-196287957 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Cone-rod dystrophy, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 215.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035428 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA035428: AB_10602045" "unprognostic (8.58e-3)" "unprognostic (2.63e-1)" "unprognostic (8.45e-2)" "unprognostic (8.61e-3)" "unprognostic (2.87e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (8.52e-2)" "unprognostic (5.99e-2)" "unprognostic (1.65e-2)" "unprognostic (6.72e-3)" "unprognostic (1.74e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.47e-2)" "unprognostic (7.16e-3)" "unprognostic (2.41e-2)" 31.4 24.4 15.2 30.0 16.0 45.3 21.0 16.6 15.8 16.7 17.8 25.7 60.3 19.1 13.9 31.0 15.6 20.7 46.4 15.5 21.1 18.3 20.7 22.5 22.9 18.8 18.0 15.8 16.8 22.7 12.9 20.1 18.5 16.6 22.9 14.4 19.3 18.6 73.8 43.0 49.1 23.0 17.5 25.9 24.2 22.4 18.1 18.1 17.2 42.1 26.8 21.0 19.8 17.1 92.6 36.6 25.8 37.2 52.2 53.9 37.0 68.2 47.1 59.2 51.8 92.3 32.8 23.9 215.2 78.1 60.2 71.4 40.5 52.1 50.4 42.1 28.6 68.6 40.6 39.5 45.2 34.3 56.7 47.4 40.0 55.9 39.6 35.4 63.0 21.0 38.3 53.3 58.1 79.6 19.9 17.3 21.4 55.7 53.0 34.5 31.0 37.5 35.7 53.6 25.4 18.3 44.5 79.5 44.2 32.8 114.1 37.2 88.5 45.5 25.2 61.8 92.7 45.8 101.1 44.1 69.6 43.8 56.9 9.6 9.2 10.4 8.8 9.3 7.5 7.2 6.5 9.7 9.1 6.3 4.2 6.3 21.0 9.4 11.0 5.9 14.9 5.2 15.2 16.0 16.6 15.8 15.5 21.1 18.8 18.0 18.5 17.5 18.1 17.1 24.7 16.0 25.7 15.3 19.9 14.5 9.4 19.7 14.2 15.9 14.1 9.4 70.1 20.0 17.5 14.7 25.0 11.9 27.3 36.4 13.7 24.8 76.3 17.8 22.9 23.2 22.1 12.2 20.4 22.9 17.7 17.0 23.4 15.6 20.8 16.1 26.7 35.6 37.4 8.4 22.7 24.2 6.1 34.6 27.1 67.6 19.9 33.9 19.6 20.6 39.4 13.1 39.1 16.1 17.6 24.6 21.1 28.2 27.2 12.0 67.2 23.2 33.9 12.8 26.3 15.0 19.0 46.0 13.2 30.0 21.5 18.6 25.6 25.5 23.8 12.2 PDE9A ENSG00000160191 "Phosphodiesterase 9A" O76083 21 42653621-42775509 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 74.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 90.8;Paneth cells: 105.3;Proximal enterocytes: 233.5" "Cancer enriched" "Detected in all" 5 "prostate cancer: 31.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 29.7;EFO-21: 30.0;MCF7: 23.2;NB-4: 34.7;NTERA-2: 41.2;SCLC-21H: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011380, HPA011978" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 45: Enterocytes - Digestion" Cytosol "Nucleoplasm, Plasma membrane" "HPA011380: AB_1855132, HPA011978: " "unprognostic (5.75e-2)" "unprognostic (9.92e-3)" "unprognostic (3.50e-1)" "unprognostic (1.08e-1)" "unprognostic (1.44e-1)" "unprognostic (1.40e-1)" "unprognostic (5.06e-2)" "unprognostic (3.99e-2)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (1.25e-2)" "unprognostic (5.01e-2)" "unprognostic (1.90e-2)" "unprognostic (4.01e-3)" "unprognostic (1.97e-1)" "unprognostic (6.55e-2)" "unprognostic (1.79e-1)" 9.4 11.1 12.3 3.9 15.1 0.5 10.8 14.0 12.9 7.2 8.6 74.7 2.9 5.1 19.4 3.7 10.6 6.8 4.3 10.6 12.6 29.8 4.2 4.9 4.8 12.4 14.4 3.5 4.1 6.5 9.9 10.3 12.7 38.5 16.4 10.7 12.7 15.8 2.4 7.0 47.3 8.8 11.0 18.3 13.4 1.9 15.0 7.8 6.5 4.8 3.1 18.9 6.2 12.0 0.0 2.8 29.7 3.7 0.0 0.8 0.5 0.0 0.0 0.0 0.0 3.2 18.2 0.0 30.0 0.0 2.2 0.0 2.7 9.8 0.0 0.0 10.4 0.0 0.0 6.4 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 23.2 1.5 34.7 41.2 14.6 0.0 0.0 0.0 1.2 20.4 7.6 22.5 13.5 5.2 0.0 0.5 7.0 0.2 19.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.1 0.2 3.1 0.6 0.4 0.9 0.0 0.4 1.0 0.3 12.3 15.1 14.0 12.9 10.6 12.6 12.4 14.4 12.7 11.0 15.0 12.0 18.6 3.2 5.0 43.4 1.6 1.0 10.9 4.2 6.2 26.4 13.4 12.6 1.6 5.7 2.4 18.4 0.0 0.0 1.0 90.8 29.4 7.3 0.6 18.1 8.5 11.9 13.1 3.2 5.6 2.4 0.1 5.9 1.5 26.8 1.3 6.1 5.7 0.9 7.5 35.3 10.8 25.8 8.2 1.3 0.8 2.2 11.8 1.6 28.4 31.9 1.1 11.0 0.0 29.1 16.6 5.3 105.3 6.0 0.2 28.1 233.5 8.9 1.3 2.8 13.1 0.5 6.4 0.4 2.3 0.5 0.6 0.4 3.8 16.9 24.4 15.0 PDGFB "SIS, SSV" ENSG00000100311 "Platelet derived growth factor subunit B" P01127 22 39223359-39244982 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 75.0;Endothelial cells: 60.6;Langerhans cells: 44.3;Macrophages: 25.5;Pancreatic endocrine cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 10.0" "Lineage enriched" "Detected in many" 7 "T-cells: 10.0" "Cell line enhanced" "Detected in many" "A-431: 33.8;EFO-21: 69.2;HUVEC TERT2: 52.6;SK-BR-3: 53.5;TIME: 68.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011604, HPA011972, CAB018341" Supported Approved Vesicles "Secreted to blood" NA NA 4390000 950000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134" "unprognostic (4.96e-2)" "unprognostic (8.94e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (9.84e-2)" "unprognostic (4.46e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (3.67e-5)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (8.68e-2)" "unprognostic (1.84e-3)" "unprognostic (5.12e-3)" "unprognostic (7.47e-2)" "unprognostic (6.50e-2)" "unprognostic (1.03e-1)" 32.6 6.4 14.7 7.1 10.7 0.4 24.0 10.3 22.2 7.5 4.8 20.6 4.9 8.9 5.2 6.2 7.2 11.7 31.2 12.0 9.8 17.0 3.7 28.1 7.4 13.6 12.4 3.8 8.8 8.9 4.0 40.2 12.0 7.6 3.5 0.8 10.6 5.2 18.7 10.3 9.1 9.2 10.6 6.6 7.9 3.4 16.0 2.1 16.1 11.0 1.6 8.5 6.6 9.4 33.8 2.6 8.4 0.0 0.0 0.0 9.9 0.1 0.4 0.2 0.0 13.0 10.3 0.0 69.2 0.0 3.1 12.4 0.5 2.8 0.0 0.1 0.2 0.7 1.1 4.8 4.3 0.0 18.1 0.0 0.3 0.0 0.4 0.9 52.6 0.0 1.3 6.1 1.9 13.7 0.1 0.1 3.2 8.1 3.4 0.0 0.3 22.8 27.7 0.1 0.2 0.0 0.6 53.5 0.2 6.0 24.3 0.1 68.1 0.1 6.4 0.1 7.5 0.1 0.4 0.3 0.1 1.5 31.3 0.0 0.0 0.0 7.3 0.1 10.0 0.0 4.3 5.6 0.0 0.0 3.6 1.9 0.1 0.0 0.4 1.3 2.3 2.1 14.7 10.7 10.3 22.2 12.0 9.8 13.6 12.4 12.0 10.6 16.0 9.4 75.0 0.0 1.1 0.0 0.6 2.8 1.2 3.8 1.2 0.7 5.1 7.1 3.1 0.0 1.3 7.3 0.0 7.3 4.0 0.1 0.0 20.0 1.3 4.0 0.7 60.6 1.8 0.0 2.8 3.6 6.5 1.6 0.0 5.6 0.0 13.1 16.8 1.4 7.7 0.0 0.9 0.7 4.1 2.6 44.3 0.1 0.6 25.5 1.8 14.0 1.1 0.3 0.0 0.0 0.2 54.7 0.0 0.0 0.0 2.7 0.1 1.9 0.9 0.1 6.6 4.7 9.6 0.3 1.6 1.1 1.4 4.5 2.0 1.2 0.1 0.6 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 135.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8" "Group enriched" "Detected in many" 4 "glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 38: EFO-21 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 61.5 3.3 8.9 55.9 9.3 0.0 20.9 13.7 8.1 43.1 23.5 16.6 3.8 25.9 11.3 15.8 33.4 42.1 20.3 8.0 14.6 3.4 0.6 32.4 9.8 24.9 15.6 29.4 6.4 1.1 3.3 135.6 19.1 14.0 10.6 22.7 9.1 14.1 30.0 20.0 15.9 34.5 16.4 0.3 24.7 4.5 22.5 10.3 6.2 11.3 18.5 96.1 25.2 21.2 0.1 0.0 149.5 0.1 0.5 0.0 0.1 2.4 0.1 0.0 0.0 0.0 0.1 0.2 356.4 9.0 0.1 0.7 253.3 44.7 0.0 1.0 46.1 0.1 0.0 0.0 216.0 0.0 0.2 29.5 82.9 18.6 21.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 116.0 0.0 0.6 0.3 0.2 0.1 0.0 4.0 0.1 0.1 0.2 0.0 0.3 119.0 0.1 0.6 242.2 41.8 34.6 0.6 0.1 0.1 0.3 1.0 88.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.9 9.3 13.7 8.1 8.0 14.6 24.9 15.6 19.1 16.4 22.5 21.2 2.4 105.8 11.2 3.9 0.2 14.5 30.4 98.5 14.8 1.4 0.5 19.9 8.4 2.8 18.8 0.0 4.2 2.0 0.1 0.0 0.0 0.5 0.7 1.6 37.6 22.4 0.0 0.0 2.6 0.0 2.1 123.1 0.0 2.8 1.3 3.4 6.4 0.0 6.5 0.0 3.5 0.0 8.2 0.0 14.0 1.8 20.2 5.3 7.2 5.6 116.3 97.7 0.0 19.6 0.2 0.4 0.0 62.8 0.0 15.8 0.0 0.0 5.4 3.4 0.0 17.0 8.4 1.0 8.2 3.9 7.0 2.9 1.3 0.9 0.0 3.4 PELO ENSG00000152684 "Pelota mRNA surveillance and ribosome rescue factor" Q9BRX2 5 52787916-52804044 "Predicted intracellular proteins" "Cell cycle, Cell division, Translation regulation" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 90.7;Sertoli cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031458 Approved Approved "Nucleoli fibrillar center" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Nucleoli fibrillar center" "HPA031458: AB_10602141" "prognostic unfavorable (6.42e-4)" "unprognostic (2.44e-1)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (6.28e-3)" "unprognostic (1.71e-2)" "unprognostic (1.71e-2)" "unprognostic (6.13e-3)" "unprognostic (3.40e-1)" "unprognostic (3.72e-2)" "unprognostic (1.78e-1)" "unprognostic (4.18e-1)" "unprognostic (2.33e-2)" "unprognostic (4.56e-2)" "unprognostic (2.44e-1)" "unprognostic (1.99e-3)" "unprognostic (8.21e-2)" 9.4 17.6 5.3 5.2 5.9 8.2 7.3 5.7 5.2 6.9 4.9 11.3 4.6 9.8 7.5 6.7 7.9 6.3 10.3 5.7 6.1 9.9 10.7 11.7 6.3 5.4 6.3 5.1 5.3 7.4 6.0 11.6 5.7 6.7 3.7 4.4 4.9 6.7 12.2 8.4 6.2 9.9 5.9 12.6 7.5 4.4 6.7 4.8 7.2 8.8 3.6 8.4 6.7 5.2 18.1 18.3 8.1 14.5 14.0 10.3 7.1 20.4 22.4 19.6 23.9 18.4 13.8 5.9 36.0 22.1 29.4 14.8 11.9 17.3 16.9 6.3 16.8 6.6 15.2 15.5 42.6 12.5 7.6 13.0 17.5 22.7 18.6 16.9 11.8 8.8 8.4 18.5 17.3 14.1 13.1 7.7 6.1 3.3 19.3 4.5 10.4 17.6 14.3 8.5 13.3 10.3 10.8 13.3 11.9 13.7 12.2 4.5 11.7 11.8 11.4 12.5 26.0 7.9 10.4 7.8 22.5 11.6 10.4 22.3 5.9 7.6 4.8 3.9 5.9 4.8 6.2 5.4 6.1 3.6 5.0 4.7 19.0 4.7 2.2 2.3 4.8 4.4 5.3 5.9 5.7 5.2 5.7 6.1 5.4 6.3 5.7 5.9 6.7 5.2 49.9 9.6 7.4 0.0 9.8 46.9 53.0 24.4 14.2 16.5 12.7 18.7 12.7 17.2 20.2 9.2 2.1 35.9 10.5 8.7 35.2 31.5 65.1 18.7 23.1 50.5 10.2 8.0 0.0 25.5 90.7 36.7 9.2 27.6 1.3 11.4 40.4 18.7 20.1 8.4 0.1 16.0 14.2 6.6 23.3 9.2 17.7 15.8 7.2 0.0 7.7 15.5 6.2 0.0 0.0 24.5 6.0 12.0 14.3 36.5 12.3 29.0 16.9 11.0 85.5 13.7 56.5 22.1 13.9 14.9 35.8 53.9 23.0 18.8 11.5 38.3 PF4V1 "CXCL4L1, CXCL4V1, SCYB4V1" ENSG00000109272 "Platelet factor 4 variant 1" P10720 4 73853296-73854483 "Plasma proteins, Predicted secreted proteins" "Cytokine, Heparin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.7;lymphoid tissue: 2.4" "Cell type enhanced" "Detected in some" "Cholangiocytes: 10.0;Club cells: 2.6;Enteroendocrine cells: 5.3;Macrophages: 6.4;Theca cells: 2.2" "Cancer enhanced" "Detected in some" "renal cancer: 3.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "basophil: 14.2;neutrophil: 9.9" "Lineage enriched" "Detected in single" 45 "granulocytes: 14.2" "Cell line enhanced" "Detected in single" "EFO-21: 1.7" HPA052485 Supported "Secreted to blood" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 10: Non-specific - Unknown function" "HPA052485: AB_2681847" "unprognostic (4.95e-1)" "unprognostic (5.68e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-3)" "unprognostic (9.88e-2)" "unprognostic (1.72e-2)" "unprognostic (1.68e-3)" "unprognostic (2.66e-1)" "unprognostic (6.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.95e-3)" "unprognostic (1.39e-2)" "unprognostic (2.11e-1)" 0.2 0.0 0.0 0.1 0.2 1.2 0.2 0.0 0.3 0.2 0.1 0.1 1.7 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.7 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.4 1.1 0.0 0.0 0.9 0.0 0.0 2.4 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 9.9 0.0 0.1 0.3 0.0 11.2 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.1 0.0 10.0 2.6 1.8 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.1 0.7 2.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 6.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 1.4 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.4 2.2 0.0 0.5 PIGR ENSG00000162896 "Polymeric immunoglobulin receptor" P01833 1 206928522-206946466 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 2641.0;salivary gland: 1645.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 7090.1;Intestinal goblet cells: 2361.1;Paneth cells: 3208.3;Proximal enterocytes: 1558.6;Undifferentiated cells: 4954.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 731.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "EFO-21: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006154, CAB009454, HPA012012" Enhanced "Secreted to digestive system" NA NA 1300000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 9: Intestine - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371" "prognostic favorable (1.22e-5)" "unprognostic (7.42e-2)" "unprognostic (4.78e-3)" "prognostic favorable (2.57e-4)" "unprognostic (2.31e-2)" "unprognostic (6.71e-2)" "unprognostic (1.13e-1)" "unprognostic (3.07e-2)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (5.23e-2)" "unprognostic (2.13e-1)" "prognostic favorable (5.08e-5)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (6.92e-3)" "unprognostic (3.39e-2)" 2.4 0.5 0.4 187.3 0.2 0.3 131.0 0.5 0.4 547.0 0.2 1693.4 2641.0 20.5 0.2 12.4 3.6 455.0 0.5 0.4 0.2 108.9 34.5 101.6 1.7 0.2 0.2 0.6 13.3 0.1 1.3 0.3 0.4 13.6 1222.6 0.1 1645.1 5.3 0.3 0.6 809.8 39.1 0.1 0.8 414.6 0.3 0.6 0.4 0.2 0.0 0.6 80.3 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 36.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 1.9 0.3 0.0 0.0 0.2 0.0 6.9 0.2 1.7 0.8 2.5 0.0 6.8 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.3 0.6 0.3 0.4 1.3 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.3 0.8 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.4 0.2 0.5 0.4 0.4 0.2 0.2 0.2 0.4 0.1 0.6 0.6 2.1 93.0 604.3 0.0 22.1 0.3 4.0 106.6 0.0 0.0 392.4 192.0 1.4 876.4 638.4 108.5 0.0 0.1 2.5 7090.1 17.6 92.5 0.0 65.9 14.6 5.4 426.4 2.7 0.0 64.5 0.0 4.7 482.1 120.1 52.0 0.0 1.8 28.0 0.4 0.0 0.0 2361.1 59.0 2.2 1.1 0.0 0.0 5.7 1.8 0.0 0.6 0.0 0.0 0.0 0.0 221.5 3208.3 0.0 0.7 53.9 1558.6 328.4 415.4 0.0 0.0 0.0 21.0 0.0 0.0 6.9 0.0 0.0 15.6 0.1 4954.6 761.3 PLVAP "FELS, gp68, PV-1, PV1" ENSG00000130300 "Plasmalemma vesicle associated protein" Q9BX97 19 17351450-17377342 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 436.2" "Group enriched" "Detected in many" 4 "Adipocytes: 439.2;Endothelial cells: 344.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "plasmacytoid DC: 35.2" "Lineage enriched" "Detected in many" 6 "dendritic cells: 35.2" "Cell line enriched" "Detected in some" 27 "EFO-21: 549.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002279 Supported Approved "Plasma membrane,Centrosome,Cytosol" NA NA 53000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "Plasma membrane, Centrosome" "HPA002279: AB_1079636" "unprognostic (3.19e-1)" "unprognostic (8.22e-2)" "unprognostic (7.87e-2)" "unprognostic (2.38e-2)" "unprognostic (1.93e-2)" "unprognostic (2.49e-3)" "unprognostic (4.17e-3)" "unprognostic (1.01e-1)" "unprognostic (2.35e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-2)" "unprognostic (8.96e-2)" "unprognostic (4.24e-3)" "unprognostic (4.70e-3)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (8.17e-2)" 283.0 51.1 2.7 54.6 3.1 1.7 210.5 2.9 4.2 102.7 18.2 95.7 86.7 90.0 5.1 48.9 83.3 139.2 92.5 3.3 3.1 153.0 6.9 31.0 50.5 3.7 3.5 16.7 96.1 98.6 64.3 48.8 3.6 68.4 22.3 0.0 77.9 38.0 32.7 58.9 103.3 50.5 3.6 166.7 116.6 4.4 3.5 18.9 436.2 12.9 16.2 104.4 80.8 4.1 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 549.1 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 9.5 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 1.1 20.0 0.0 2.3 0.1 0.3 0.5 2.2 2.5 0.0 0.2 0.0 0.0 0.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.7 35.2 0.0 0.6 2.7 3.1 2.9 4.2 3.3 3.1 3.7 3.5 3.6 3.6 3.5 4.1 439.2 6.4 0.0 0.3 0.7 22.9 1.0 0.0 8.0 0.0 2.7 3.3 3.7 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 1.7 3.6 0.4 0.3 344.9 0.0 0.4 0.4 2.5 0.1 48.9 0.0 0.3 0.0 0.4 79.6 0.2 1.8 0.0 0.3 0.0 0.0 3.5 28.8 0.8 0.0 5.5 23.2 6.5 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 7.6 1.5 0.0 0.0 0.0 0.1 0.0 1.4 6.1 0.5 0.7 2.9 16.8 0.1 1.4 0.7 0.0 2.3 POLD4 "p12, POLDS" ENSG00000175482 "DNA polymerase delta 4, accessory subunit" Q9HCU8 11 67350772-67356972 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 272.0" "Cell type enhanced" "Detected in all" "Distal enterocytes: 538.2;Paneth cells: 572.5;Proximal enterocytes: 403.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 177.0" "Low region specificity" "Detected in all" HPA078008 Approved "Centriolar satellite" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 18: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite" "HPA078008: " "unprognostic (7.55e-3)" "unprognostic (2.71e-1)" "unprognostic (3.93e-2)" "unprognostic (2.75e-1)" "unprognostic (1.19e-2)" "unprognostic (1.03e-1)" "unprognostic (8.25e-2)" "unprognostic (1.43e-2)" "unprognostic (4.82e-1)" "unprognostic (2.02e-1)" "unprognostic (3.19e-2)" "unprognostic (2.53e-1)" "unprognostic (2.39e-3)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" "unprognostic (1.95e-1)" "unprognostic (9.36e-2)" 80.6 78.1 9.5 60.4 9.8 37.1 66.5 8.3 19.6 60.6 9.7 110.1 86.0 53.1 5.6 118.3 47.3 19.1 98.4 8.9 8.5 106.9 272.0 73.5 83.1 12.0 11.1 48.3 104.8 4.0 39.7 17.2 11.2 87.1 14.7 3.0 72.7 9.5 91.7 56.2 118.8 9.8 8.9 111.5 81.7 27.9 11.4 8.7 49.3 9.3 25.3 82.1 75.4 10.0 48.0 125.5 2.0 13.6 14.4 27.8 7.6 58.3 12.1 8.5 6.0 21.9 147.7 126.4 177.0 16.9 31.1 64.2 0.4 39.5 1.1 53.4 7.2 29.1 29.6 29.2 31.9 10.3 142.1 31.4 19.7 15.4 13.1 42.6 25.4 19.5 27.1 42.2 14.3 79.4 13.2 22.7 10.1 94.7 83.7 21.6 23.4 34.7 19.9 33.1 1.0 13.2 29.7 21.9 95.8 6.9 51.8 37.5 82.5 28.7 20.2 75.2 19.8 52.9 19.1 72.4 95.8 24.3 34.3 129.3 147.8 258.6 63.2 192.4 59.1 333.3 72.5 65.6 143.8 354.7 78.9 71.0 143.4 50.7 376.9 101.1 115.6 128.9 9.5 9.8 8.3 19.6 8.9 8.5 12.0 11.1 11.2 8.9 11.4 10.0 8.0 19.2 44.9 12.4 115.3 43.3 3.1 152.6 47.8 2.6 14.8 8.6 2.3 12.8 86.1 7.3 6.2 8.6 15.5 538.2 15.6 144.7 7.8 4.8 7.8 19.1 83.1 26.1 6.5 188.5 10.5 25.3 180.4 11.9 68.5 5.6 22.1 40.7 31.3 3.3 4.9 226.0 105.8 31.3 92.5 18.7 6.8 66.9 60.5 34.7 114.1 4.2 36.0 5.5 12.6 220.3 572.5 3.8 66.8 4.5 403.3 30.2 18.7 4.2 6.6 5.8 26.8 4.7 3.0 96.4 68.9 12.4 49.4 2.2 130.8 4.5 PPP1R14A "CPI-17, PPP1INL" ENSG00000167641 "Protein phosphatase 1 regulatory inhibitor subunit 14A" Q96A00 19 38251237-38256532 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 492.0;intestine: 450.3" "Cell type enhanced" "Detected in many" "Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9" "Group enriched" "Detected in many" 24 "B-cells: 299.4;dendritic cells: 246.9" "Group enriched" "Detected in some" 4 "A549: 164.1;EFO-21: 112.2;K-562: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005044, CAB009803, HPA042097, HPA054534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 880000 "Cluster 37: B-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "Nuclear bodies" "CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518" "unprognostic (5.40e-2)" "unprognostic (4.00e-3)" "unprognostic (4.02e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-1)" "unprognostic (8.92e-3)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.25e-5)" "prognostic unfavorable (7.12e-4)" "unprognostic (4.13e-1)" "unprognostic (5.81e-2)" "unprognostic (2.22e-2)" 134.0 144.2 175.2 22.1 347.5 2.9 111.9 321.5 226.5 149.7 63.2 450.3 18.6 273.5 5.2 47.6 153.7 14.8 94.6 175.2 219.6 53.3 17.9 163.1 2.6 402.3 322.9 125.1 31.1 2.8 12.6 34.1 336.3 142.0 12.6 0.3 19.0 86.1 27.5 28.6 82.1 57.2 222.0 101.2 140.3 77.6 365.3 1.7 25.8 12.3 1.4 301.6 106.1 492.0 0.0 164.1 0.4 0.0 1.0 0.0 6.1 10.8 0.0 0.1 0.0 12.8 0.2 0.0 112.2 1.0 0.0 0.5 13.6 0.2 0.0 1.4 0.0 25.5 0.0 0.0 4.6 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 64.5 0.3 0.0 0.8 0.0 0.3 4.9 0.0 0.0 0.2 2.4 0.4 0.4 0.0 3.5 0.2 0.0 0.0 0.1 9.2 0.0 0.4 0.4 0.0 0.8 0.4 0.0 0.4 0.0 0.5 0.2 0.0 0.1 11.3 0.6 1.2 0.1 0.7 0.2 299.4 0.2 0.4 44.3 283.9 0.6 0.1 1.7 8.7 0.2 246.9 0.2 21.6 175.2 347.5 321.5 226.5 175.2 219.6 402.3 322.9 336.3 222.0 365.3 492.0 332.5 0.0 1.1 1.3 29.9 9.6 3.0 1.2 3.4 0.4 8.8 209.8 19.6 2.8 0.7 0.0 0.0 48.3 48.7 32.7 0.0 0.7 14.1 15.4 239.5 108.5 1.8 34.7 0.5 10.9 7.4 66.8 2.0 10.8 3.8 435.0 224.5 2.3 9.5 0.0 0.6 0.4 0.0 5.6 24.6 42.1 341.1 41.4 8.8 14.0 66.1 0.5 4.1 3.5 155.6 2.2 2.6 656.0 4.8 2.4 3.8 0.3 0.0 1.6 979.5 8.7 465.2 9.9 46.2 0.6 8.0 26.4 3.7 66.0 0.4 1.2 PTTG1IP "C21orf1, C21orf3, PBF" ENSG00000183255 "PTTG1 interacting protein" P53801 21 44849585-44873903 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034146, HPA061827" Uncertain Supported Nucleoplasm NA Yes 26000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "CAB034146: AB_1568894, HPA061827: AB_2684620" "unprognostic (1.78e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (5.24e-3)" "unprognostic (3.18e-2)" "unprognostic (1.68e-2)" "unprognostic (2.03e-2)" "unprognostic (3.59e-2)" "unprognostic (1.22e-2)" "unprognostic (1.98e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (9.30e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.40e-4)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.90e-1)" 127.8 131.8 147.6 98.4 158.9 92.0 114.0 150.8 146.8 131.1 131.1 132.7 123.2 132.4 118.5 89.1 109.4 141.8 164.3 138.1 168.7 157.6 130.5 160.5 75.3 178.8 152.9 110.7 85.6 84.1 68.8 180.1 169.9 108.5 111.5 29.7 118.3 151.4 70.7 88.9 127.3 145.0 152.0 97.7 169.9 66.9 175.3 57.9 127.4 63.2 62.0 139.6 93.3 157.5 245.3 134.6 155.3 148.2 300.6 174.8 127.0 212.9 309.8 174.1 166.6 290.0 323.9 32.9 789.8 344.4 417.0 109.8 73.0 140.2 161.1 56.3 81.0 254.3 80.0 260.1 293.8 97.6 83.5 269.9 225.1 189.1 130.8 346.3 376.6 88.6 131.7 83.1 539.5 106.0 71.0 99.5 166.8 352.9 169.8 70.4 158.4 162.0 735.6 82.7 117.2 182.0 240.0 262.5 482.0 188.7 203.7 163.7 511.8 216.9 126.5 170.6 340.0 78.5 79.4 42.2 146.7 220.6 199.8 336.2 181.2 109.1 48.4 146.7 79.5 25.5 62.7 51.3 203.3 23.6 59.7 41.0 248.8 67.3 167.0 92.5 87.3 223.7 147.6 158.9 150.8 146.8 138.1 168.7 178.8 152.9 169.9 152.0 175.3 157.5 140.9 394.2 169.6 39.8 28.0 50.7 84.1 181.3 61.5 14.6 102.0 96.8 173.0 75.8 248.9 145.3 6.2 218.6 56.8 321.4 49.0 323.0 51.5 115.0 115.0 191.6 79.3 37.8 8.5 120.6 72.7 117.1 140.6 187.7 81.5 181.3 124.2 102.2 109.3 11.8 10.7 89.1 130.2 88.0 69.6 98.7 72.1 136.3 87.2 22.5 91.1 78.8 51.5 20.1 31.9 294.3 255.2 98.9 36.4 112.8 268.1 71.2 192.3 15.2 65.7 61.1 127.9 73.7 43.4 92.4 42.9 366.7 45.6 54.6 100.3 169.9 QPRT QPRTase ENSG00000103485 "Quinolinate phosphoribosyltransferase" Q15274 16 29663279-29698699 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 119.4;liver: 183.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 404.7;Extravillous trophoblasts: 315.1;Hepatocytes: 367.4;Proximal tubular cells: 598.8;Syncytiotrophoblasts: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 4.2;intermediate monocyte: 5.3;myeloid DC: 5.8;non-classical monocyte: 9.0;plasmacytoid DC: 3.1" "Group enriched" "Detected in many" 8 "dendritic cells: 5.8;monocytes: 9.0" "Cell line enhanced" "Detected in many" "EFO-21: 597.1;Hep G2: 258.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA011887, HPA076010" Enhanced Approved Vesicles "Intracellular and membrane" NA NA 780000 "Cluster 7: Monocytes - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA011887: AB_2668555, HPA076010: " "prognostic unfavorable (5.10e-5)" "unprognostic (2.00e-1)" "unprognostic (9.48e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (9.31e-4)" "unprognostic (1.44e-2)" "unprognostic (8.75e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (6.81e-2)" "unprognostic (3.37e-2)" "unprognostic (1.33e-2)" "unprognostic (2.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.58e-2)" 8.4 89.4 20.6 4.3 20.2 4.8 6.7 25.8 19.8 50.6 19.4 19.2 61.6 26.1 95.2 4.0 43.6 10.2 26.8 18.5 22.2 119.4 183.5 9.2 6.8 28.6 26.6 31.0 34.5 16.2 5.8 27.3 32.4 7.0 15.2 7.5 13.4 26.1 5.1 5.1 30.3 13.7 23.6 17.2 7.1 4.1 22.8 8.2 6.5 1.2 5.2 10.5 11.5 23.3 0.6 1.4 51.8 56.4 8.8 21.6 167.8 6.0 5.2 8.6 11.0 145.9 91.9 2.3 597.1 10.8 10.0 1.0 18.5 0.6 4.5 0.8 16.7 27.1 2.2 258.0 52.5 4.1 10.4 69.8 1.4 4.8 0.2 12.8 0.2 28.2 75.1 2.9 0.4 154.6 17.6 100.3 162.1 1.9 0.2 89.3 16.3 58.5 47.9 4.2 48.6 103.5 0.0 142.1 118.8 85.1 106.5 112.8 0.6 2.5 24.9 0.9 0.5 1.8 4.9 18.8 4.4 10.4 8.1 0.0 4.2 0.3 0.8 5.3 0.9 0.1 0.6 0.7 5.8 0.0 0.1 0.4 0.8 0.4 9.0 3.1 0.9 1.9 20.6 20.2 25.8 19.8 18.5 22.2 28.6 26.6 32.4 23.6 22.8 23.3 3.1 9.6 24.8 5.2 10.1 3.6 11.7 0.5 1.8 3.3 5.0 2.0 43.2 8.6 3.0 64.4 0.0 404.7 5.8 84.5 50.9 1.2 0.0 93.8 49.5 5.5 28.3 10.5 1.3 55.2 315.1 35.8 0.5 81.0 5.1 6.7 9.7 367.4 147.5 6.7 5.6 47.3 0.0 21.2 18.3 0.5 29.2 19.8 42.7 12.2 4.4 20.8 3.1 11.1 0.5 11.5 78.5 27.1 8.7 4.2 161.0 598.8 1.5 5.0 6.6 3.3 16.2 0.5 3.0 0.2 2.0 215.6 5.7 36.5 104.7 8.3 RAPGEF3 "bcm910, cAMP-GEFI, EPAC" ENSG00000079337 "Rap guanine nucleotide exchange factor 3" O95398 12 47734363-47771040 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 130.6;Astrocytes: 143.0;Collecting duct cells: 69.9;Endothelial cells: 53.0;Oligodendrocytes: 45.7" "Cancer enhanced" "Detected in all" "thyroid cancer: 13.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 26.9;HUVEC TERT2: 12.1;NB-4: 14.3;RPTEC TERT1: 13.3;TIME: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004386, HPA040365, HPA043518" Approved Uncertain "Endoplasmic reticulum,Cytosol" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "Endoplasmic reticulum" "CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524" "unprognostic (2.12e-1)" "unprognostic (2.88e-2)" "unprognostic (2.99e-2)" "unprognostic (1.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.82e-2)" "unprognostic (1.23e-4)" "unprognostic (9.35e-2)" "unprognostic (1.25e-2)" "unprognostic (5.32e-3)" "unprognostic (4.67e-2)" "unprognostic (4.37e-2)" "prognostic favorable (6.67e-7)" "unprognostic (9.16e-2)" "unprognostic (2.92e-1)" "unprognostic (2.61e-3)" "unprognostic (3.38e-2)" 44.6 2.8 29.2 2.6 35.0 1.4 44.0 30.3 29.2 26.0 12.5 9.9 4.0 16.4 6.9 13.2 24.1 13.2 21.1 31.4 21.3 40.0 1.9 11.9 4.4 33.6 29.6 38.2 4.7 5.8 6.4 8.9 28.0 13.5 2.4 0.9 21.2 11.0 11.4 9.8 8.8 5.1 22.4 16.2 11.5 3.5 28.9 1.6 32.4 9.0 2.1 14.9 21.3 39.7 2.3 0.6 0.7 2.4 0.3 2.3 0.9 1.7 1.5 0.7 0.4 0.3 6.1 0.1 26.9 3.0 1.1 2.4 0.8 4.5 0.3 3.0 0.4 0.2 2.6 0.2 0.2 0.4 0.3 0.9 0.3 1.3 0.8 3.4 12.1 0.6 0.1 2.9 0.5 1.5 0.0 14.3 0.6 1.0 3.7 0.4 0.1 1.0 13.3 2.5 0.2 0.3 0.2 1.7 0.4 0.8 6.7 0.6 12.0 6.6 1.1 1.5 0.6 1.0 0.4 0.2 4.1 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 35.0 30.3 29.2 31.4 21.3 33.6 29.6 28.0 22.4 28.9 39.7 130.6 0.0 11.7 143.0 0.7 2.7 5.8 2.6 13.1 0.5 4.5 4.8 15.7 2.8 3.6 69.9 0.0 0.2 1.4 1.7 7.9 1.1 1.6 11.8 2.4 53.0 0.0 0.0 1.5 0.7 0.4 6.3 18.3 21.2 3.8 1.5 20.7 0.2 0.9 0.0 2.9 6.6 4.1 0.6 2.6 3.7 24.2 1.5 5.4 12.2 0.0 1.5 2.1 10.6 45.7 5.8 6.3 8.6 4.4 11.6 0.8 41.3 1.9 0.5 6.6 2.7 5.1 1.2 1.6 1.4 3.3 0.3 1.3 6.6 0.8 17.2 RASL12 RIS ENSG00000103710 "RAS like family 12" Q9NYN1 15 65053337-65076690 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7" "Cancer enhanced" "Detected in all" "glioma: 21.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (6.13e-3)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (6.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.21e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-3)" "unprognostic (1.60e-1)" "unprognostic (4.45e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (1.76e-2)" "unprognostic (4.72e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.17e-4)" 27.9 3.9 32.9 5.1 36.8 0.0 15.7 30.8 24.4 49.8 8.5 35.6 3.6 61.6 27.9 19.2 54.7 13.2 53.4 26.0 38.4 6.9 1.1 38.4 3.3 39.4 57.4 16.5 2.4 1.8 7.0 17.0 38.0 52.5 6.7 3.3 8.0 76.4 37.1 12.1 9.4 33.0 38.8 9.6 7.7 15.6 66.1 0.9 8.4 20.6 1.7 40.2 33.5 32.6 0.1 0.1 0.2 0.0 0.6 5.0 0.2 0.0 0.5 0.0 0.0 14.5 0.1 0.0 22.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 9.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 36.8 30.8 24.4 26.0 38.4 39.4 57.4 38.0 38.8 66.1 32.6 7.4 0.0 0.0 22.5 0.0 1.5 3.9 0.0 0.0 0.3 2.0 5.6 16.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.7 0.3 12.6 3.6 0.0 0.0 0.1 0.0 0.1 15.2 0.5 0.5 0.0 12.3 1.4 0.1 0.3 0.0 0.1 0.0 2.0 0.0 1.3 3.9 13.1 0.2 0.0 2.8 0.0 17.9 0.0 0.0 0.0 0.1 0.0 57.9 0.0 0.4 0.5 0.0 0.0 0.8 98.6 0.9 55.7 0.7 1.1 0.4 0.1 0.3 0.2 0.4 0.2 0.1 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Leydig cells: 397.3;Peritubular cells: 314.8;Skeletal myocytes: 347.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 7.3" "Group enriched" "Detected in many" 4 "granulocytes: 7.3;T-cells: 1.9" "Cell line enhanced" "Detected in many" "EFO-21: 250.6;HaCaT: 332.7;SuSa: 315.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000265 Uncertain Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 22: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 79.8 38.3 58.8 11.9 81.2 8.1 23.8 59.1 64.2 27.7 12.1 22.5 14.8 13.1 27.0 17.0 16.5 19.7 33.7 55.6 47.8 28.3 21.7 16.9 6.8 81.5 56.4 83.0 111.1 55.6 13.2 54.0 52.1 28.8 20.8 29.0 41.9 20.6 29.8 13.2 16.6 20.6 50.6 11.3 22.6 21.4 64.5 8.3 19.9 32.7 2.3 25.5 13.4 67.4 53.7 20.4 51.1 55.1 188.4 108.5 0.5 91.0 86.4 34.7 54.0 96.5 9.6 0.2 250.6 45.8 88.5 332.7 27.7 6.6 59.4 2.2 36.6 18.3 185.8 28.9 148.6 4.3 25.5 176.6 4.8 52.0 0.9 147.6 27.0 15.5 74.7 13.4 139.3 14.8 5.8 14.9 19.7 33.4 33.4 8.2 100.3 6.5 29.1 35.6 90.3 118.9 71.8 31.0 85.7 315.9 23.6 26.3 44.5 46.1 195.7 31.1 35.8 13.5 28.3 2.7 14.8 1.1 76.8 0.1 0.6 7.3 1.9 0.3 0.7 0.5 1.4 1.6 0.1 0.1 1.8 0.4 0.4 0.3 1.0 0.8 0.8 0.6 58.8 81.2 59.1 64.2 55.6 47.8 81.5 56.4 52.1 50.6 64.5 67.4 23.4 176.3 13.3 229.9 5.4 10.8 65.8 25.9 13.6 68.3 81.2 44.1 79.4 44.3 49.8 141.6 20.9 62.2 15.7 21.4 60.7 69.7 11.4 55.3 118.6 15.7 92.0 32.6 35.2 111.0 139.7 201.3 3.1 76.8 100.1 178.3 14.3 77.3 33.3 6.7 57.3 66.9 14.2 23.0 11.6 22.1 397.3 20.4 42.7 30.0 3.7 270.3 71.1 117.6 64.8 40.7 70.1 314.8 7.1 53.8 19.9 3.1 33.7 35.9 32.9 347.6 99.2 4.6 8.8 10.1 27.4 115.2 9.8 177.2 84.5 102.2 RNF7 "CKBBP1, ROC2, SAG" ENSG00000114125 "Ring finger protein 7" Q9UBF6 3 141738249-141747560 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 898.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036995 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA036995: AB_10673627" "unprognostic (5.68e-2)" "unprognostic (4.94e-3)" "unprognostic (1.83e-1)" "unprognostic (3.24e-1)" "unprognostic (9.11e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (4.53e-2)" "unprognostic (1.24e-2)" "unprognostic (3.98e-3)" "unprognostic (5.17e-3)" "unprognostic (8.58e-3)" "prognostic unfavorable (1.54e-9)" "unprognostic (4.60e-1)" "unprognostic (2.20e-1)" "unprognostic (3.69e-2)" "unprognostic (2.36e-2)" 67.1 114.5 62.7 40.8 65.6 65.0 63.5 63.4 80.0 69.5 72.2 98.2 69.7 58.7 70.8 86.5 61.0 46.1 102.8 64.2 67.2 92.3 83.9 58.4 44.5 64.4 64.8 73.8 80.3 44.0 81.5 51.2 65.7 77.6 59.8 37.6 59.8 43.8 142.0 72.0 64.1 47.8 65.1 58.7 68.3 71.2 66.3 45.4 52.6 113.1 44.1 77.9 71.9 65.9 172.6 67.4 98.1 80.0 91.6 125.7 65.5 94.6 87.5 78.2 82.6 79.4 82.5 57.7 214.5 104.7 192.7 80.8 61.5 88.1 98.3 56.0 119.1 56.6 64.8 116.4 122.6 89.7 52.9 118.2 96.9 63.4 105.5 104.3 112.3 96.1 61.6 77.0 117.2 131.0 56.6 100.1 105.1 170.7 113.3 61.1 63.1 124.0 169.2 74.0 54.8 68.1 108.7 108.8 161.4 126.4 102.4 114.8 86.2 78.1 75.6 139.2 80.5 73.7 66.5 121.2 122.4 98.4 90.3 119.0 128.2 87.7 78.0 116.4 77.7 82.6 82.8 83.2 112.9 74.1 79.6 83.7 45.5 61.8 125.7 103.4 108.8 121.6 62.7 65.6 63.4 80.0 64.2 67.2 64.4 64.8 65.7 65.1 66.3 65.9 128.7 60.9 55.2 7.5 81.4 132.4 143.0 290.5 150.2 34.3 159.7 207.3 104.1 105.8 151.1 101.2 27.1 183.8 133.2 262.0 254.3 225.1 348.9 99.3 112.0 134.9 125.7 41.4 12.9 247.3 249.1 114.2 73.9 100.0 72.9 206.4 129.9 132.0 214.4 28.6 12.6 195.2 134.3 126.7 123.5 898.4 117.8 137.6 144.1 18.7 174.1 111.7 140.1 10.6 19.6 233.2 261.4 121.9 102.0 181.8 295.1 324.1 105.7 56.7 85.5 84.3 126.2 212.2 129.1 183.7 144.6 129.8 112.7 281.4 174.5 185.9 RRAGB ENSG00000083750 "Ras related GTP binding B" Q5VZM2 X 55717749-55758774 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 72.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003734 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" "Golgi apparatus, Vesicles" "HPA003734: AB_1079851" "unprognostic (2.01e-1)" "unprognostic (2.82e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.44e-2)" "prognostic favorable (3.31e-5)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "prognostic favorable (3.64e-6)" "unprognostic (8.89e-3)" "unprognostic (1.56e-2)" "unprognostic (1.31e-2)" "unprognostic (2.71e-3)" "unprognostic (2.74e-2)" "unprognostic (3.35e-2)" "unprognostic (6.21e-2)" "unprognostic (1.23e-1)" "unprognostic (2.00e-3)" 12.6 14.8 13.1 7.1 13.4 8.2 14.7 11.0 12.9 14.0 9.9 12.3 6.9 18.5 34.7 8.9 20.5 13.0 15.2 13.5 14.2 16.2 8.0 11.1 8.3 11.2 14.0 22.2 8.0 23.1 14.9 11.4 12.5 16.4 9.6 17.1 8.9 18.0 12.0 12.1 8.8 17.3 12.4 11.3 9.6 9.2 15.2 10.2 22.9 15.9 8.7 12.0 10.0 12.5 11.9 8.9 10.0 7.6 34.7 32.2 2.6 10.3 19.0 9.1 12.2 5.2 7.7 3.5 72.6 14.4 7.6 7.5 9.1 5.8 8.4 6.5 12.7 5.2 12.1 10.5 24.6 8.4 8.0 38.4 21.9 6.8 8.8 36.8 12.3 9.3 7.3 8.1 15.3 8.8 4.5 11.7 10.4 3.2 14.4 17.0 11.1 10.0 13.9 15.3 10.0 8.9 14.2 4.4 15.6 25.4 12.9 8.8 6.8 11.2 5.2 10.4 5.6 11.1 16.4 6.7 8.5 18.2 5.0 7.1 4.7 4.1 5.0 6.7 7.5 6.8 6.5 6.9 7.3 10.4 7.4 7.5 1.4 6.5 3.9 4.6 7.5 4.0 13.1 13.4 11.0 12.9 13.5 14.2 11.2 14.0 12.5 12.4 15.2 12.5 14.5 12.8 17.4 22.9 16.0 8.7 15.3 16.1 19.4 20.4 9.7 10.2 16.4 4.3 10.4 18.4 14.6 7.4 6.8 4.9 27.4 9.8 1.8 14.3 16.1 12.7 4.2 11.1 32.4 5.0 5.5 15.6 10.7 11.9 17.1 16.7 5.7 2.6 7.3 20.2 29.6 5.1 8.2 5.4 7.8 2.9 9.9 7.9 5.4 23.4 7.8 27.0 2.1 28.6 38.2 4.3 10.8 15.4 6.4 9.0 7.3 19.3 10.4 25.6 0.0 17.9 16.6 7.7 14.6 11.2 7.7 4.8 11.8 26.9 6.9 6.9 RXFP1 "LGR7, RXFPR1" ENSG00000171509 "Relaxin family peptide receptor 1" Q9HBX9 4 158315311-158653372 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 7.6;endometrium 1: 6.2" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 61.4;Excitatory neurons: 167.9;Glandular and luminal cells: 174.6" "Cancer enriched" "Detected in single" 9 "endometrial cancer: 3.9" "Group enriched" "Detected in many" 4 "amygdala: 4.6;basal ganglia: 5.3;cerebral cortex: 7.6;hippocampal formation: 4.6;white matter: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 29.0;HEL: 9.7;RPTEC TERT1: 14.4;THP-1: 4.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebral cortex: 11.8;hippocampal formation: 7.8" HPA027067 Approved NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "HPA027067: AB_10602127" "unprognostic (3.07e-3)" "unprognostic (3.02e-3)" "unprognostic (1.05e-1)" "unprognostic (2.53e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-3)" "unprognostic (6.13e-2)" "unprognostic (6.18e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-6)" "unprognostic (8.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.33e-4)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (6.22e-3)" 0.1 5.3 4.6 0.2 5.3 0.0 0.1 0.0 7.6 2.7 0.0 0.2 0.1 6.2 1.0 0.1 0.8 0.7 0.0 4.6 1.2 2.1 1.4 3.8 0.4 0.0 0.0 0.3 0.1 0.2 0.1 2.7 0.0 0.4 0.1 0.0 0.1 2.8 0.0 0.0 0.2 0.8 0.0 0.3 0.4 0.2 0.0 0.0 1.3 0.0 0.3 0.1 0.8 3.5 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 5.3 0.0 7.6 4.6 1.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.5 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 61.4 23.5 4.2 0.0 1.7 167.9 0.0 0.0 0.2 0.0 174.6 0.0 0.0 0.0 0.0 0.7 0.0 7.8 0.0 0.0 0.0 0.5 0.2 0.0 0.8 0.0 7.5 0.0 0.0 0.0 10.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.6 0.8 0.0 0.1 0.1 0.6 0.0 0.0 0.0 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208673-62213943 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix: 2021.0;epididymis: 1372.0" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0" "Cancer enriched" "Detected in many" 5 "endometrial cancer: 971.9" "Region enhanced" "Detected in some" "medulla oblongata: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 8.6" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.0 0.2 0.0 0.0 57.8 0.0 0.0 2021.0 0.1 12.7 1.3 118.8 1372.0 4.2 238.4 13.4 0.2 0.1 0.4 1.9 0.1 2.4 0.0 3.5 1.4 0.7 17.2 1.1 5.1 0.1 0.8 6.8 16.3 0.0 29.6 15.6 0.0 8.6 1.0 2.2 0.5 0.0 45.9 0.0 1.1 2.7 5.8 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.3 0.0 0.1 0.0 0.7 0.1 0.0 1.6 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 3.5 1.4 0.8 0.5 1.1 0.2 0.6 0.0 4.8 0.0 0.4 0.1 3.8 4.8 0.0 0.0 123.6 71.0 0.0 48.6 10.1 16.5 0.0 0.2 1.6 9.7 3.9 6.6 0.0 2506.4 397.7 7.6 37.1 0.0 0.0 5.3 0.0 3.8 26.5 2597.0 0.0 0.3 0.0 0.1 4.9 0.0 0.0 59.9 10.2 0.3 0.0 0.0 0.0 14.1 5.4 0.0 0.0 0.0 0.0 0.0 0.0 15.3 10.8 0.0 0.0 27.0 0.7 0.1 109.3 0.0 0.0 0.0 8.5 0.0 0.0 1.7 0.4 0.0 13.7 0.1 7.0 16.6 SERF1B "FAM2B, H4F5C" ENSG00000205572 "Small EDRK-rich factor 1B" O75920 5 70025247-70043113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 154.4" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 40.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 11.3" HPA075271 Approved "Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 38: EFO-21 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.00e-1)" "unprognostic (2.52e-4)" "unprognostic (2.60e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (5.98e-2)" "unprognostic (4.92e-3)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-4)" "unprognostic (1.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (6.74e-2)" "unprognostic (3.52e-1)" 27.3 27.0 0.8 1.6 1.3 1.7 30.3 1.3 2.1 34.4 0.3 45.0 0.7 31.9 0.5 28.6 25.5 1.0 44.7 1.5 2.3 36.4 14.9 30.5 2.1 0.8 0.7 27.1 27.7 1.4 38.0 1.0 0.9 30.4 1.2 11.4 25.1 2.1 46.5 22.7 30.8 2.9 0.8 23.3 28.4 154.4 0.7 1.3 33.8 1.2 1.6 28.3 32.4 1.5 2.6 0.7 4.1 6.0 3.8 1.5 1.1 1.0 1.8 1.7 3.7 0.6 3.0 3.1 11.3 1.1 3.8 1.3 2.6 1.9 1.6 8.0 0.9 3.0 1.3 1.6 1.5 0.1 2.9 1.2 5.3 1.9 0.3 1.3 1.7 0.9 1.2 2.5 0.5 0.2 4.7 2.1 3.6 0.0 0.4 2.4 6.3 5.0 1.3 1.5 7.8 5.1 2.7 0.1 3.7 1.8 2.6 1.1 6.3 1.6 1.8 1.0 1.7 2.0 3.4 3.5 1.6 0.2 3.2 0.3 0.2 1.8 4.1 1.5 4.8 3.3 5.9 2.9 2.9 6.3 7.0 4.9 0.5 2.6 1.5 4.6 2.8 1.9 0.8 1.3 1.3 2.1 1.5 2.3 0.8 0.7 0.9 0.8 0.7 1.5 0.4 9.6 2.2 0.0 1.0 0.4 0.7 0.3 1.2 0.1 0.5 0.5 40.3 0.0 3.2 0.0 2.1 0.1 0.4 0.6 1.9 0.2 1.6 0.3 0.7 4.4 0.0 0.4 0.0 0.0 0.1 3.4 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 1.0 1.8 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.1 1.1 5.2 1.4 0.0 0.5 8.8 1.6 0.6 0.9 0.6 0.0 0.7 0.1 0.4 0.4 SHISA9 ENSG00000237515 "Shisa family member 9" B4DS77 16 12901598-13240416 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8" "Group enriched" "Detected in many" 17 "Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 48.5;LHCN-M2: 40.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072399 Approved Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Cytosol" "HPA072399: AB_2686517" "unprognostic (1.88e-2)" "unprognostic (3.04e-2)" "unprognostic (2.74e-1)" "unprognostic (1.69e-5)" "unprognostic (2.23e-2)" "unprognostic (2.03e-2)" "unprognostic (5.90e-5)" "unprognostic (1.50e-2)" "unprognostic (1.98e-1)" "unprognostic (1.19e-2)" "unprognostic (3.66e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.53e-4)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (6.66e-2)" "unprognostic (1.26e-2)" 0.5 2.8 12.5 0.8 12.7 1.3 0.6 0.0 14.8 0.3 0.0 3.2 0.8 0.4 1.1 0.5 0.2 0.4 0.6 10.9 6.3 1.9 0.6 0.2 0.4 6.9 5.9 0.4 0.6 0.1 0.9 0.4 6.2 4.2 0.9 3.7 0.9 0.7 1.5 0.9 0.9 0.6 1.7 0.4 0.5 0.7 11.0 0.1 2.1 0.0 0.3 0.2 0.2 4.2 0.8 0.4 0.6 0.5 0.2 0.2 0.5 0.4 0.0 0.0 0.0 0.3 0.5 0.5 48.5 0.1 0.7 0.6 0.1 0.2 0.1 0.6 0.2 0.6 0.9 0.3 0.1 0.6 0.6 1.5 0.1 0.1 3.3 0.4 0.1 0.6 0.4 1.0 40.5 5.5 0.4 0.7 10.2 0.7 0.5 0.6 0.4 0.3 10.9 1.5 10.1 0.5 0.4 1.4 0.4 4.4 0.9 0.4 0.4 0.6 5.8 0.6 0.4 0.9 1.0 0.5 0.4 0.3 1.0 0.8 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 12.5 12.7 0.0 14.8 10.9 6.3 6.9 5.9 6.2 1.7 11.0 4.2 0.0 25.6 20.1 5.2 0.1 0.1 0.5 0.2 0.0 0.8 1.7 0.8 1.3 1.5 7.0 1.8 0.0 0.1 0.0 0.3 1.9 1.4 4.8 0.1 0.5 1.1 0.0 0.0 265.0 0.0 0.0 2.0 0.0 0.3 11.4 0.0 0.0 0.0 0.0 0.0 427.9 0.3 0.0 0.0 0.4 3.4 0.3 1.0 0.0 5.6 0.0 0.5 0.0 636.3 4.9 0.1 2.3 0.0 0.0 1.8 0.0 1.3 11.8 0.3 0.0 6.6 0.2 0.5 2.0 0.0 0.1 0.1 1.3 0.0 0.8 0.6 SIAH3 FLJ39203 ENSG00000215475 "Siah E3 ubiquitin protein ligase family member 3" Q8IW03 13 45777242-45851753 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;fallopian tube: 3.1" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 0.5;ovarian cancer: 0.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "EFO-21: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060576 Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 21: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria Nucleoplasm "HPA060576: AB_2684325" "unprognostic (1.07e-3)" "unprognostic (1.26e-1)" "unprognostic (3.00e-2)" "unprognostic (1.14e-1)" "unprognostic (4.96e-2)" "unprognostic (1.00e-2)" "unprognostic (1.05e-1)" "unprognostic (7.53e-2)" "unprognostic (3.24e-4)" "unprognostic (1.11e-1)" "unprognostic (4.77e-3)" "unprognostic (3.24e-3)" "unprognostic (9.03e-4)" "unprognostic (2.03e-1)" "unprognostic (2.18e-1)" 0.0 0.2 0.7 0.1 0.9 0.1 0.0 2.3 0.8 0.9 0.0 0.0 0.0 0.3 0.3 0.0 3.1 0.0 0.0 0.6 0.7 0.6 0.0 0.0 0.0 0.8 3.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.2 0.3 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 2.3 0.8 0.6 0.7 0.8 3.0 0.8 0.6 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.5 0.0 0.0 1.8 2.1 0.0 0.0 0.0 1.9 0.0 0.0 28.6 0.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.6 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 SIRT5 ENSG00000124523 "Sirtuin 5" Q9NXA8 6 13574227-13615158 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 52.5;Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021798, HPA022002, HPA022992" Approved Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915" "unprognostic (8.53e-2)" "unprognostic (7.79e-2)" "unprognostic (4.71e-2)" "unprognostic (5.26e-3)" "unprognostic (6.19e-2)" "unprognostic (1.63e-1)" "unprognostic (8.72e-2)" "unprognostic (1.38e-1)" "unprognostic (8.54e-3)" "unprognostic (2.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "prognostic favorable (8.76e-10)" "unprognostic (2.39e-1)" "unprognostic (6.88e-2)" "unprognostic (6.86e-2)" "unprognostic (2.36e-3)" 7.2 6.0 9.4 5.2 10.6 5.8 6.6 10.4 12.2 5.4 13.5 8.1 7.7 6.1 5.6 5.6 9.2 5.2 28.6 10.5 10.6 11.5 33.5 5.4 8.3 9.2 9.6 10.1 6.7 16.2 7.3 5.6 9.9 6.4 8.7 6.1 10.6 6.8 33.4 7.9 9.8 5.9 8.4 9.6 8.2 6.8 10.9 8.2 9.0 38.0 7.2 6.0 5.4 11.1 10.5 8.9 8.1 10.4 5.7 8.9 7.6 5.1 5.3 6.1 8.0 12.9 11.1 14.1 35.7 4.3 10.9 16.9 7.4 11.1 7.6 5.9 10.3 8.5 5.6 20.5 11.0 6.7 6.7 7.8 19.9 4.5 19.9 12.7 10.3 20.3 13.8 4.6 6.5 12.3 8.2 13.2 7.7 16.9 13.7 15.4 4.4 24.4 10.3 11.0 13.7 4.5 4.3 7.9 25.9 25.0 11.6 4.9 8.6 6.6 3.4 4.2 5.8 11.6 15.4 10.7 4.5 7.3 8.4 0.7 6.0 16.7 9.9 9.2 10.7 14.0 13.0 9.5 6.3 12.7 11.8 10.8 2.6 11.8 17.3 5.9 10.7 7.9 9.4 10.6 10.4 12.2 10.5 10.6 9.2 9.6 9.9 8.4 10.9 11.1 16.6 28.9 3.2 30.0 8.2 4.1 11.4 14.9 10.8 7.3 9.7 9.9 52.5 15.7 16.8 11.0 0.0 20.5 6.6 9.4 52.8 13.0 2.9 13.1 5.4 12.3 6.1 15.8 36.6 6.7 10.5 6.7 6.6 8.1 0.0 23.5 9.7 25.7 9.4 1.7 39.2 13.2 8.2 13.9 3.8 2.0 8.1 8.4 5.4 14.0 6.3 11.6 10.3 15.1 25.8 7.2 13.4 5.7 4.7 6.2 18.1 34.1 22.5 7.2 0.0 9.8 6.6 8.5 12.0 9.8 4.5 10.7 7.9 13.2 15.0 9.0 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782751 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 135.6" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 102.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favorable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favorable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 27.5 37.4 98.8 6.9 131.6 12.3 27.6 116.7 104.3 26.8 58.5 26.8 7.4 20.2 16.2 28.9 28.4 15.4 29.0 96.2 99.8 44.1 15.2 22.3 7.0 125.5 127.0 53.1 19.5 29.4 17.7 17.7 113.4 20.4 10.6 11.2 20.2 22.7 29.9 22.0 14.3 16.6 103.2 25.8 22.1 9.9 126.8 7.9 52.6 21.5 8.2 27.6 22.6 135.6 11.9 36.3 5.7 42.8 36.4 15.5 12.3 8.3 18.3 7.8 8.0 11.7 31.0 7.2 102.7 23.3 15.5 45.4 7.3 9.6 6.0 59.1 6.8 49.4 30.4 16.1 20.8 13.3 27.9 9.2 19.3 11.2 13.6 40.6 22.1 20.0 13.1 28.3 5.1 24.7 6.5 13.7 3.9 21.9 17.1 6.0 1.6 39.0 31.5 31.3 7.3 3.3 11.0 13.8 7.8 10.2 46.0 12.2 12.3 10.9 14.3 21.1 6.0 21.6 14.3 2.2 14.2 62.8 6.7 0.1 17.9 12.4 5.2 13.5 4.7 10.4 6.4 5.5 12.9 9.9 7.7 6.4 36.7 2.0 7.7 2.6 5.5 6.3 98.8 131.6 116.7 104.3 96.2 99.8 125.5 127.0 113.4 103.2 126.8 135.6 35.2 9.6 13.5 35.3 6.2 6.6 9.7 6.4 22.2 11.1 15.5 15.2 16.4 20.0 5.5 51.5 2.1 9.5 2.3 9.0 23.5 10.4 8.5 10.9 6.2 22.3 8.4 53.0 9.1 9.8 2.3 15.6 4.6 18.0 1.3 16.4 16.8 11.8 24.1 15.2 8.3 13.5 6.1 18.0 9.9 12.5 32.6 14.1 5.4 8.4 28.4 26.8 2.1 11.1 100.3 6.6 5.2 23.0 10.1 12.9 9.2 34.9 2.3 11.2 6.6 11.9 11.6 4.1 10.5 20.9 11.9 3.6 3.3 18.0 7.5 11.6 SLCO2A1 "MATR1, OATP2A1, PGT, SLC21A2" ENSG00000174640 "Solute carrier organic anion transporter family member 2A1" Q92959 3 133932701-134052184 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 123.7" "Group enriched" "Detected in many" 4 "Distal enterocytes: 47.1;Endothelial cells: 65.2;Hepatic stellate cells: 146.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 90.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA013742 Enhanced NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA013742: AB_2668877" "unprognostic (4.39e-3)" "unprognostic (2.84e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.69e-4)" "unprognostic (8.53e-2)" "unprognostic (2.32e-3)" "prognostic favorable (9.24e-5)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (7.60e-2)" "unprognostic (2.04e-2)" "unprognostic (6.87e-2)" "unprognostic (5.63e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (3.07e-2)" 30.4 42.5 1.6 16.8 1.6 0.0 18.1 1.3 2.7 30.9 9.1 24.7 10.2 46.3 6.1 18.8 28.3 18.8 26.4 1.5 1.6 52.8 2.4 123.7 9.2 2.0 1.6 5.2 20.8 28.7 15.8 23.4 2.2 36.5 18.0 0.0 20.8 84.7 2.1 13.5 29.3 33.5 1.9 24.2 23.6 1.3 2.3 8.4 89.3 3.4 9.6 21.3 20.3 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.5 4.3 0.5 0.0 0.1 0.1 0.0 90.6 0.9 0.0 11.2 0.1 0.0 0.1 0.1 0.1 0.0 5.8 0.0 2.4 0.0 0.0 3.4 0.2 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.6 6.0 0.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 4.6 1.5 0.0 3.7 0.1 0.0 22.1 0.0 4.5 0.1 0.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 1.6 1.3 2.7 1.5 1.6 2.0 1.6 2.2 1.9 2.3 1.7 19.8 0.0 2.5 0.0 2.1 5.1 9.1 0.5 8.6 0.0 0.8 3.9 4.6 1.5 1.6 3.7 0.0 1.5 0.0 47.1 0.0 2.8 1.0 0.9 0.2 65.2 1.2 0.0 8.1 3.3 4.0 8.7 18.8 1.6 1.3 0.1 146.7 0.6 0.2 0.0 1.7 4.1 0.0 2.2 0.4 0.8 0.3 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.1 14.0 15.8 0.0 0.0 1.5 3.2 2.1 0.8 0.0 0.0 0.4 1.1 0.4 0.2 2.0 1.7 0.8 1.1 0.1 0.6 2.2 SMIM15 "C5orf43, DKFZP686E2158" ENSG00000188725 "Small integral membrane protein 15" Q7Z3B0 5 61157704-61162468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (1.18e-1)" "unprognostic (2.56e-1)" "unprognostic (2.33e-2)" "unprognostic (3.82e-1)" "unprognostic (3.32e-2)" "unprognostic (6.03e-2)" "unprognostic (9.83e-3)" "unprognostic (4.43e-2)" "unprognostic (2.44e-2)" "unprognostic (4.09e-1)" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (5.34e-3)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "prognostic favorable (9.23e-4)" 19.0 23.6 13.5 24.6 14.7 22.5 29.1 14.4 17.2 26.9 12.0 49.1 42.6 22.3 23.4 32.5 30.9 25.1 15.8 12.8 15.2 31.8 43.3 24.3 26.8 14.1 13.7 33.1 27.5 36.4 16.1 30.3 14.6 30.7 41.4 21.4 27.1 27.7 11.2 18.5 40.8 23.7 15.6 19.5 46.6 15.3 13.6 27.7 35.6 15.6 28.9 40.3 21.5 17.7 95.3 79.6 51.4 84.1 48.8 58.0 52.9 78.5 86.0 77.1 103.2 69.4 141.4 46.2 133.4 82.6 101.3 54.5 0.0 94.3 90.3 97.4 42.1 72.9 60.7 67.9 95.4 54.2 65.9 69.0 85.9 95.7 108.6 58.9 62.9 57.1 87.0 61.7 87.4 99.5 27.9 0.7 63.4 38.7 92.7 9.8 63.8 106.2 83.3 112.6 71.0 67.9 90.4 48.2 99.4 35.9 90.9 58.3 72.4 46.1 73.9 58.9 100.9 62.6 117.3 85.9 63.2 29.6 96.7 33.2 56.4 20.2 34.7 70.5 38.7 41.6 38.3 39.9 51.4 33.9 46.0 32.1 11.3 58.8 57.8 41.2 55.9 39.4 13.5 14.7 14.4 17.2 12.8 15.2 14.1 13.7 14.6 15.6 13.6 17.7 26.8 57.7 37.1 4.9 39.4 86.8 122.1 58.1 60.3 25.7 45.2 33.4 21.2 35.8 53.2 42.3 8.4 71.9 34.6 79.9 135.0 70.8 23.3 35.6 40.3 25.7 55.2 29.2 3.9 61.3 62.9 50.0 57.1 40.9 23.5 35.4 25.7 40.4 73.4 40.4 4.3 74.0 42.7 40.8 30.5 24.5 46.3 40.5 40.9 2.8 33.8 59.3 44.3 4.5 8.7 75.2 116.1 42.2 41.9 108.6 73.2 93.0 37.0 20.8 26.3 28.2 37.6 18.7 12.3 78.6 82.7 47.5 34.9 45.7 82.8 152.6 SMR3B "P-B, PRL3, PROL3" ENSG00000171201 "Submaxillary gland androgen regulated protein 3B" P02814 4 70370093-70390244 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 946 "salivary gland: 217144.9" "Group enriched" "Detected in some" 55 "Breast glandular cells: 2.3;Early spermatids: 8.4;Late spermatids: 6.0" "Cancer enriched" "Detected in some" 22 "breast cancer: 32.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "EFO-21: 4.5" "Secreted to digestive system" NA NA 1900000 "Cluster 24: Salivary gland - Salivary secretion" "Cluster 38: EFO-21 - Unknown function" "Cluster 34: Spermatids - Unknown function" "unprognostic (3.72e-1)" 0.0 9.1 0.0 0.0 0.0 7.6 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 1.1 8.9 0.0 0.0 44.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 47.3 229.5 0.0 1.6 23.2 0.0 1.6 0.0 0.0 217144.9 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SOX17 ENSG00000164736 "SRY-box transcription factor 17" Q9H6I2 8 54457935-54460892 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 49.1" "Group enriched" "Detected in many" 8 "Adipocytes: 464.9;Endometrial ciliated cells: 377.3;Endothelial cells: 171.5;Glandular and luminal cells: 520.0" "Group enriched" "Detected in many" 4 "endometrial cancer: 122.8;ovarian cancer: 96.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "EFO-21: 108.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025594, HPA068399" Enhanced Approved Nucleoplasm NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB025594: , HPA068399: AB_2685981" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (1.76e-3)" "prognostic favorable (2.76e-4)" "unprognostic (1.01e-1)" "unprognostic (3.85e-2)" "unprognostic (3.34e-2)" "unprognostic (1.28e-1)" "unprognostic (1.39e-2)" "unprognostic (7.90e-2)" "unprognostic (3.62e-2)" "unprognostic (1.18e-1)" "unprognostic (4.98e-2)" "unprognostic (7.28e-3)" "unprognostic (1.12e-1)" "unprognostic (3.76e-1)" "unprognostic (1.88e-1)" 49.1 1.6 2.9 1.4 2.3 0.0 32.6 2.6 3.3 20.4 1.4 8.3 0.7 18.8 1.2 3.6 23.0 7.7 19.1 2.1 2.2 5.6 1.3 9.9 0.7 2.9 2.5 4.2 1.9 0.8 2.3 5.7 2.7 6.0 0.8 0.1 3.9 1.1 10.3 5.1 5.0 4.3 2.5 13.2 5.7 3.4 2.8 0.4 5.8 5.8 0.4 8.4 9.4 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.7 0.0 0.6 0.0 0.0 0.0 0.0 1.8 0.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.3 2.6 3.3 2.1 2.2 2.9 2.5 2.7 2.5 2.8 2.6 464.9 0.0 0.0 0.0 0.2 13.9 0.3 0.0 0.0 0.1 0.7 1.3 2.1 1.5 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.2 2.6 377.3 44.5 171.5 0.0 2.7 0.0 0.2 0.1 7.7 0.0 520.0 0.0 0.0 46.8 0.1 0.1 0.0 0.0 0.0 0.0 0.9 16.6 1.8 2.5 3.5 19.6 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 7.3 5.1 3.2 6.4 0.3 13.5 0.0 4.5 0.2 0.0 3.7 SPECC1 "CYTSB, FLJ36955, HCMOGT-1, NSP" ENSG00000128487 "Sperm antigen with calponin homology and coiled-coil domains 1" Q5M775 17 20008865-20319026 "Disease related genes, Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 217.1;Inhibitory neurons: 220.8;Microglial cells: 187.4;Oligodendrocytes: 317.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 42.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 75.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021421, HPA021430, HPA061073" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol" NA NA 9800 "Cluster 46: Basophils - DNA binding" "Cluster 65: Brain - Ion transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Vesicles" "Nucleoli fibrillar center, Cytosol" "HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: " "unprognostic (1.13e-3)" "unprognostic (2.39e-1)" "unprognostic (1.98e-2)" "unprognostic (8.10e-3)" "unprognostic (8.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.06e-5)" "unprognostic (9.29e-2)" "unprognostic (5.81e-2)" "unprognostic (6.23e-3)" "unprognostic (2.65e-1)" "unprognostic (3.15e-1)" "unprognostic (6.86e-2)" "unprognostic (1.79e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" 12.5 9.6 30.8 7.3 35.1 23.6 9.2 24.1 43.7 6.1 22.3 15.1 9.8 12.8 4.7 9.2 8.3 14.8 5.0 41.4 21.4 4.7 1.2 5.7 5.3 32.8 25.8 16.6 4.8 3.3 6.4 3.6 24.5 6.1 10.0 6.1 6.2 5.0 5.1 3.6 10.5 9.5 21.0 13.5 10.3 22.8 41.1 3.0 5.2 2.8 5.2 4.6 4.3 47.3 26.2 37.3 15.7 7.2 14.7 6.9 29.1 10.0 12.4 12.4 21.4 67.6 17.1 1.5 45.3 11.4 24.3 21.1 10.7 33.4 3.7 12.8 18.5 14.5 34.4 10.5 4.9 1.3 5.6 10.6 36.9 10.2 24.9 46.8 0.0 4.4 1.0 15.1 10.4 24.0 0.3 5.3 14.5 17.0 6.3 11.8 49.5 23.6 32.2 11.4 7.1 6.9 75.7 35.6 13.9 62.2 26.3 9.1 0.3 0.5 21.1 0.9 30.8 5.4 11.7 0.9 19.1 12.6 6.5 42.1 15.8 33.0 2.2 8.4 3.2 1.8 1.5 3.4 26.6 1.4 1.0 1.4 11.1 13.0 7.9 4.6 0.6 5.5 30.8 35.1 24.1 43.7 41.4 21.4 32.8 25.8 24.5 21.0 41.1 47.3 28.7 22.4 14.7 170.4 5.7 5.5 12.5 22.0 10.8 7.4 5.8 4.7 10.3 7.2 21.1 18.4 68.8 5.5 10.2 56.8 9.8 30.9 100.0 40.1 44.1 13.1 7.7 82.5 217.1 36.3 11.5 18.6 34.1 64.1 116.4 29.5 3.9 0.2 22.0 0.0 220.8 54.8 12.2 12.4 15.9 54.5 5.0 29.0 21.4 187.4 84.7 13.6 11.3 125.2 317.8 67.7 24.7 44.8 7.0 19.7 25.2 3.6 18.1 31.4 59.2 7.3 81.3 73.8 68.9 5.9 2.6 2.2 10.0 87.8 27.4 21.5 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 119.9" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 191.1;Glandular and luminal cells: 249.4" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 44: Endometrium - Transcription" "Endoplasmic reticulum, Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favorable (2.84e-4)" "prognostic favorable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favorable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favorable (4.69e-4)" 10.6 16.0 8.4 10.9 9.4 12.0 10.9 8.9 10.4 119.9 14.5 12.8 18.1 53.9 8.2 10.7 48.6 14.0 13.0 7.9 9.9 29.2 15.7 10.8 13.2 9.4 8.9 11.3 22.5 16.9 14.6 12.8 10.1 10.6 13.4 8.3 12.1 8.9 16.5 12.0 15.6 15.7 8.2 10.6 18.5 30.5 10.2 9.4 11.3 9.9 12.4 11.0 11.8 9.3 26.6 16.7 19.3 20.0 16.2 23.7 26.1 30.1 26.9 27.6 22.8 35.5 37.3 35.1 69.7 27.1 24.9 13.9 34.6 17.2 27.0 15.1 18.6 22.0 22.3 43.4 24.2 38.6 17.8 22.2 14.7 23.4 16.9 15.4 23.5 27.5 21.7 30.0 19.9 14.0 35.6 27.2 26.0 21.3 36.1 31.4 14.6 28.2 28.2 15.6 24.7 22.0 22.2 14.7 26.4 16.5 21.6 18.3 27.2 16.7 18.4 15.4 32.1 21.6 35.4 40.1 20.4 29.3 21.0 10.6 15.6 10.8 15.1 16.0 18.2 16.7 14.0 13.7 23.8 14.4 11.7 13.4 3.1 16.9 20.6 37.6 14.3 14.0 8.4 9.4 8.9 10.4 7.9 9.9 9.4 8.9 10.1 8.2 10.2 9.3 17.5 32.1 9.0 52.5 15.8 7.9 8.3 20.3 9.6 39.3 14.4 11.6 20.4 18.6 25.3 20.2 20.9 31.0 27.9 33.8 70.5 32.5 80.6 191.1 38.4 14.8 4.9 15.6 40.2 27.9 19.0 18.5 23.9 249.4 8.2 21.6 6.8 10.8 28.1 10.1 48.0 22.8 32.6 13.7 12.4 76.5 14.0 21.3 14.2 48.7 26.5 25.8 16.5 37.7 56.4 36.5 28.8 14.7 20.4 15.7 32.8 25.2 34.5 17.7 6.6 13.1 18.1 94.9 35.7 13.1 9.7 31.7 18.9 27.2 20.0 13.9 SYN3 ENSG00000185666 "Synapsin III" O14994 22 32507820-33058381 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 25.0" "Cell type enhanced" "Detected in some" "Early spermatids: 54.5;Excitatory neurons: 347.7;Inhibitory neurons: 198.6;Late spermatids: 250.7;Oligodendrocyte precursor cells: 75.9" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Region enhanced" "Detected in many" "cerebral cortex: 25.0" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.2" "Group enriched" "Detected in many" 11 "B-cells: 3.2;granulocytes: 1.6" "Cell line enhanced" "Detected in many" "A-431: 15.0;EFO-21: 12.5;NTERA-2: 7.0;PC-3: 9.0;SCLC-21H: 7.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034566 Uncertain NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA034566: AB_10603120" "unprognostic (1.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-1)" "unprognostic (3.03e-2)" "unprognostic (5.13e-3)" "unprognostic (2.34e-1)" "unprognostic (9.39e-2)" "unprognostic (3.24e-1)" "unprognostic (7.77e-2)" "unprognostic (8.91e-2)" "unprognostic (8.59e-2)" "unprognostic (7.44e-3)" "unprognostic (4.35e-3)" "unprognostic (1.80e-2)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (3.52e-1)" 0.7 0.8 12.4 0.6 0.0 2.5 0.6 0.0 25.0 0.3 0.0 0.7 0.6 0.6 0.6 1.5 0.7 1.0 0.6 6.8 0.0 0.8 0.5 0.8 1.2 3.6 0.0 0.4 1.2 0.4 1.6 2.6 6.4 0.6 0.6 4.1 0.5 0.4 0.5 1.8 1.0 0.6 0.0 1.4 0.8 3.9 0.0 0.7 0.9 0.4 0.6 0.3 0.2 0.0 15.0 0.7 0.4 1.9 0.0 0.4 0.6 0.5 0.1 0.0 0.2 1.4 1.1 0.7 12.5 0.1 6.2 3.6 5.4 0.1 0.0 0.3 1.1 0.7 5.1 3.0 0.0 0.9 0.6 0.2 1.0 0.1 0.0 0.3 0.1 0.3 0.9 0.6 0.0 0.1 0.6 0.5 7.0 0.2 9.0 0.4 0.6 0.6 0.0 1.0 7.4 0.6 1.2 0.1 1.2 3.3 0.2 0.4 0.4 0.7 4.8 1.0 1.0 0.5 0.7 0.6 0.4 0.4 2.8 0.9 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 1.6 0.1 0.2 0.1 0.0 0.1 12.4 0.0 0.0 25.0 6.8 0.0 3.6 0.0 6.4 0.0 0.0 0.0 1.6 0.0 0.0 8.5 1.5 0.4 0.1 0.0 0.0 3.1 0.1 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 54.5 0.1 0.4 0.9 0.0 0.0 347.7 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.4 0.1 0.3 5.0 198.6 0.0 0.0 0.0 0.5 250.7 1.5 0.1 0.0 12.2 0.0 0.0 0.0 75.9 8.1 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.6 6.6 0.0 0.9 3.7 9.0 0.0 0.1 1.1 0.0 0.7 0.0 0.0 TFPI2 "PP5, REF1, TFPI-2" ENSG00000105825 "Tissue factor pathway inhibitor 2" P48307 7 93885396-93890753 "Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "placenta: 954.6" "Cell type enhanced" "Detected in many" "Ductal cells: 1476.3;Glandular and luminal cells: 575.6;Prostatic glandular cells: 412.6;Syncytiotrophoblasts: 2184.1" "Cancer enhanced" "Detected in all" "renal cancer: 65.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 3001.0;hTEC/SVTERT24-B: 1373.4;U-138 MG: 1245.9;U-2197: 1050.8;U-87 MG: 2051.0" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 29.7" "CAB010142, HPA049158, HPA070525" Enhanced "Secreted to extracellular matrix" NA NA 51000 "Cluster 28: Placenta - Pregnancy" "Cluster 38: EFO-21 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "CAB010142: AB_628166, HPA049158: AB_2680659, HPA070525: " "prognostic favorable (8.33e-7)" "unprognostic (2.20e-2)" "unprognostic (2.10e-2)" "prognostic favorable (5.42e-4)" "unprognostic (5.19e-3)" "unprognostic (3.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-2)" "unprognostic (6.86e-2)" "unprognostic (7.54e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (3.38e-3)" "unprognostic (3.65e-2)" "unprognostic (1.97e-1)" "unprognostic (7.91e-2)" 51.3 28.3 0.6 36.5 0.7 0.3 30.0 0.5 1.6 2.7 1.2 3.5 1.3 32.1 5.5 2.2 19.1 15.6 7.8 0.6 4.0 20.5 21.2 11.3 3.0 5.0 0.7 46.7 76.6 0.1 9.7 954.6 0.7 7.1 2.0 51.7 4.0 5.5 2.6 1.0 1.4 9.6 0.6 4.1 5.1 0.7 1.4 6.9 0.8 1.4 1.2 26.6 1.0 0.9 1.4 179.6 42.0 1.9 99.8 15.4 0.5 178.3 33.5 20.6 15.0 0.3 1.6 0.0 3001.0 47.0 43.9 18.6 1.1 216.1 24.6 2.8 1.3 0.1 10.2 0.7 545.7 0.0 0.9 9.1 10.7 1373.4 90.1 200.0 449.0 0.0 0.4 2.2 210.1 0.3 0.4 0.7 10.8 0.0 45.7 0.5 0.0 0.2 52.1 5.4 1.6 110.2 0.0 12.7 1.2 29.9 1.5 2.9 680.3 1245.9 13.2 1050.8 1.8 0.1 4.4 14.6 2051.0 0.3 140.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.7 0.5 1.6 0.6 4.0 5.0 0.7 0.7 0.6 1.4 0.9 141.3 3.2 3.9 0.0 1.2 0.6 311.3 77.9 0.6 17.5 37.2 7.9 0.5 21.5 122.9 318.2 39.6 16.1 0.6 0.0 0.0 1476.3 0.0 280.3 38.3 122.3 0.0 2.7 0.0 41.9 214.2 137.2 0.0 575.6 0.0 0.1 108.1 1.4 16.2 3.3 0.0 0.5 12.2 4.1 4.0 0.1 1.5 5.2 3.6 2.8 17.1 22.4 0.0 0.0 0.0 39.4 0.0 0.0 0.2 412.6 0.0 1.7 27.4 161.3 0.0 7.0 35.5 0.4 3.6 1.1 1.4 2184.1 4.9 0.7 0.0 35.0 TGFB2 ENSG00000092969 "Transforming growth factor beta 2" P61812 1 218345336-218444619 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Aortic aneurysm, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Astrocytes: 119.1;Muller glia cells: 87.1" "Cancer enhanced" "Detected in all" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 59.6;hTERT-RPE1: 155.6;U-2 OS: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006134 Approved Vesicles "Secreted to blood" NA Yes 4890000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "HPA006134: " "unprognostic (7.24e-2)" "unprognostic (7.23e-2)" "unprognostic (6.32e-2)" "unprognostic (2.45e-1)" "unprognostic (1.79e-1)" "unprognostic (3.86e-1)" "unprognostic (3.44e-2)" "unprognostic (1.99e-1)" "unprognostic (2.19e-2)" "unprognostic (2.35e-1)" "unprognostic (1.32e-2)" "unprognostic (1.31e-1)" "unprognostic (2.43e-2)" "unprognostic (2.64e-3)" "unprognostic (1.23e-1)" "unprognostic (4.90e-2)" "unprognostic (6.04e-2)" 1.5 1.2 8.2 1.1 11.6 0.1 4.0 9.2 14.9 7.1 7.1 2.4 0.6 6.5 4.5 1.8 3.9 2.0 6.4 11.5 11.1 1.4 0.6 7.8 0.6 18.5 12.7 4.6 1.8 1.1 2.1 12.9 10.7 17.0 0.9 10.5 8.5 11.2 4.8 2.1 0.7 5.1 8.4 2.6 1.2 0.9 10.0 0.4 2.6 2.1 0.8 3.0 3.0 11.0 4.0 20.2 1.8 15.1 4.3 2.1 0.0 2.9 0.4 30.1 21.2 5.5 46.7 0.0 59.6 0.2 25.8 11.1 1.2 2.3 32.0 0.1 0.2 0.0 1.7 0.0 46.7 0.0 0.0 1.9 5.3 4.1 15.8 155.6 8.1 0.0 0.0 0.0 29.6 0.3 0.0 0.0 1.6 0.0 1.8 0.0 8.8 0.0 10.1 0.0 0.3 0.1 34.8 3.9 0.7 39.7 2.9 1.1 38.3 21.3 58.4 17.9 30.7 0.0 0.1 0.1 9.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 11.6 9.2 14.9 11.5 11.1 18.5 12.7 10.7 8.4 10.0 11.0 2.2 76.9 6.3 119.1 0.5 8.7 8.7 35.3 4.0 9.9 8.4 5.8 4.1 14.3 29.8 5.5 0.0 0.4 0.2 0.0 0.0 40.2 19.3 2.1 6.7 8.1 0.0 0.0 8.6 16.9 13.9 28.8 0.0 6.8 1.3 0.9 4.2 0.0 1.4 1.7 36.0 0.0 8.2 0.6 13.2 28.0 8.1 3.2 12.4 30.0 1.0 87.1 0.0 3.5 1.0 21.5 0.0 13.9 1.2 15.0 0.0 0.8 12.3 3.0 0.0 27.7 19.7 0.3 0.8 0.6 2.8 0.5 0.5 0.8 0.0 2.1 TGM3 TGE ENSG00000125780 "Transglutaminase 3" Q08188 20 2296001-2341079 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "esophagus: 1838.1" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 46.2;Squamous epithelial cells: 22.5" "Cancer enriched" "Detected in many" 9 "head and neck cancer: 81.6" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 295 "neutrophil: 30.3" "Lineage enriched" "Detected in single" 303 "granulocytes: 30.3" "Cell line enriched" "Detected in single" 14 "EFO-21: 5.2" HPA004728 Approved NA NA 14000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 38: EFO-21 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA004728: AB_1080360" "unprognostic (7.14e-2)" "unprognostic (8.93e-2)" "unprognostic (2.18e-2)" "unprognostic (3.23e-3)" "unprognostic (4.27e-2)" "unprognostic (4.20e-2)" "unprognostic (8.62e-2)" "unprognostic (4.21e-2)" "unprognostic (1.50e-1)" "unprognostic (8.00e-2)" "unprognostic (4.88e-3)" "unprognostic (1.35e-1)" "unprognostic (7.78e-8)" "unprognostic (1.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (9.67e-2)" 0.6 0.3 0.2 0.2 0.0 1.4 3.9 0.0 0.1 54.3 0.0 0.3 0.0 0.2 0.8 1838.1 1.4 2.2 0.4 0.2 0.0 0.2 0.8 0.5 0.0 0.1 0.3 0.3 1.1 0.0 1.6 0.1 0.1 0.6 0.8 0.0 229.3 0.0 0.4 83.1 0.4 0.0 0.1 0.4 2.2 2.0 0.0 0.1 0.1 0.0 142.9 0.3 31.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 1.9 4.0 0.1 0.1 46.2 0.0 0.4 0.0 0.0 0.3 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 3.7 0.0 0.0 0.3 4.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.2 0.0 0.0 0.0 0.1 1.2 0.5 22.5 8.2 0.0 0.0 0.1 0.3 0.2 TGM7 TGMZ ENSG00000159495 "Transglutaminase 7" Q96PF1 15 43276271-43302255 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.6" "Group enriched" "Detected in some" 11 "Early spermatids: 62.0;Late spermatids: 16.7" "Cancer enriched" "Detected in single" 13 "endometrial cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 35 "EFO-21: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: Immune cells - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.5 TINAGL1 "ARG1, LCN7, LIECG3, P3ECSL, TINAGRP" ENSG00000142910 "Tubulointerstitial nephritis antigen like 1" Q9GZM7 1 31576485-31587686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1235.1;Sertoli cells: 427.3;Syncytiotrophoblasts: 1946.1" "Cancer enhanced" "Detected in all" "urothelial cancer: 87.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.0" "Cell line enhanced" "Detected in many" "BEWO: 322.7;CAPAN-2: 178.9;EFO-21: 403.6;HaCaT: 181.4;HBEC3-KT: 211.9;HUVEC TERT2: 173.4;TIME: 376.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048695 Approved "Secreted to extracellular matrix" NA NA 370000 "Cluster 17: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA048695: AB_2680497" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.80e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-3)" "unprognostic (8.29e-3)" "unprognostic (6.02e-3)" "unprognostic (4.18e-1)" "unprognostic (6.96e-2)" "unprognostic (7.02e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.65e-6)" "unprognostic (7.42e-2)" "unprognostic (6.64e-2)" "prognostic favorable (9.64e-4)" "unprognostic (3.43e-2)" 173.7 40.8 19.0 18.5 17.7 0.9 150.5 17.9 19.9 86.8 16.4 83.2 26.7 101.8 10.7 31.0 82.4 23.9 230.7 15.2 17.9 177.7 22.7 85.7 8.5 19.6 18.3 38.8 31.0 13.2 25.3 183.6 19.8 71.2 16.5 1.0 63.8 40.6 46.6 37.0 51.6 36.5 16.4 119.6 66.4 6.2 21.2 3.8 115.1 30.6 5.3 88.4 70.2 17.1 96.6 0.2 0.0 0.5 0.8 0.2 322.7 14.9 1.9 0.7 0.4 44.5 178.9 0.2 403.6 13.4 7.0 181.4 0.2 211.9 0.1 0.7 0.1 0.1 7.3 11.5 4.5 0.1 0.5 0.2 37.9 0.0 7.6 0.1 173.4 0.1 2.4 0.4 0.0 0.0 0.7 0.6 0.9 52.6 6.1 0.4 0.1 0.4 57.0 72.6 0.4 0.5 38.0 125.6 4.2 18.8 7.5 0.3 376.6 0.3 91.6 0.7 2.8 0.4 0.5 1.6 0.2 0.2 3.3 2.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.0 19.0 17.7 17.9 19.9 15.2 17.9 19.6 18.3 19.8 16.4 21.2 17.1 345.4 9.6 5.8 0.7 2.7 11.0 121.5 244.1 8.0 0.0 32.0 73.0 46.7 37.1 28.6 132.4 0.0 1235.1 2.6 158.9 1.9 378.7 1.4 8.4 3.2 161.4 11.4 13.5 0.1 92.2 223.5 35.0 50.0 14.4 14.7 49.7 306.6 4.4 89.3 0.0 1.1 35.5 14.2 8.8 10.3 0.7 7.5 4.2 23.2 13.1 2.0 0.2 0.0 0.5 0.0 344.6 115.3 4.1 0.2 131.4 45.2 80.9 9.1 0.4 427.3 9.5 357.4 0.3 0.8 4.9 6.5 1946.1 3.8 2.7 59.7 219.4 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.9" "Group enriched" "Detected in many" 4 "Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2" "Low region specificity" "Detected in many" "HPA053639, HPA069378" Approved Supported Vesicles,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles Cytosol "HPA053639: , HPA069378: AB_2686133" "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favorable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 21.3 5.2 9.4 4.9 9.6 0.1 16.3 9.2 11.5 8.3 10.4 3.4 3.9 7.6 4.7 3.4 6.4 10.6 8.4 9.1 10.3 19.1 7.9 9.2 6.6 12.2 9.6 3.2 9.8 6.8 3.1 17.4 11.5 4.0 3.3 1.1 4.0 6.5 5.9 2.4 3.6 14.9 10.0 33.9 3.4 1.9 12.1 2.1 12.7 5.7 5.0 6.7 2.5 10.4 0.1 94.8 3.5 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 1.2 0.0 194.9 0.0 38.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.3 0.1 0.7 0.0 0.0 0.0 24.7 65.9 0.0 0.0 0.0 6.2 0.7 0.0 0.2 47.2 0.0 0.0 0.1 2.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.5 1.5 0.1 0.1 8.4 0.1 1.2 0.0 0.5 0.1 0.1 0.5 0.0 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.4 9.6 9.2 11.5 9.1 10.3 12.2 9.6 11.5 10.0 12.1 10.4 226.1 0.0 4.4 0.3 1.6 3.2 0.2 0.0 0.6 0.2 41.4 23.9 2.8 4.3 0.0 1.8 0.0 0.0 1.0 0.0 9.8 35.2 0.4 0.7 1.1 188.9 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.9 1.3 0.3 151.0 1.1 0.1 0.0 0.1 0.0 0.0 9.1 3.0 1.8 2.1 1.2 1.8 33.7 0.6 0.4 0.0 0.5 0.6 0.9 0.0 6.8 2.5 1.3 0.0 35.8 0.7 0.0 0.0 1.5 2.5 0.2 0.5 0.2 2.8 0.0 1.1 5.2 0.0 0.6 TMED1 "Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L" ENSG00000099203 "Transmembrane p24 trafficking protein 1" Q13445 19 10832067-10836318 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018507 Uncertain NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 38: EFO-21 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "HPA018507: AB_1858063" "unprognostic (6.98e-2)" "unprognostic (3.42e-1)" "unprognostic (3.03e-3)" "unprognostic (1.28e-1)" "unprognostic (8.65e-2)" "unprognostic (2.27e-1)" "unprognostic (1.98e-2)" "unprognostic (4.20e-2)" "unprognostic (9.86e-2)" "unprognostic (7.27e-2)" "unprognostic (9.52e-2)" "unprognostic (4.93e-2)" "prognostic favorable (8.66e-5)" "unprognostic (9.49e-2)" "unprognostic (2.56e-1)" "unprognostic (5.16e-2)" "unprognostic (2.45e-2)" 23.6 31.2 13.4 15.4 15.3 21.6 25.1 15.6 17.3 30.0 24.9 19.5 18.9 25.0 16.3 19.9 24.8 18.8 42.3 13.0 16.9 37.8 51.9 19.6 14.3 16.6 15.1 34.4 34.5 24.4 35.9 21.4 15.5 26.5 8.1 4.4 24.2 14.8 64.4 19.1 17.4 10.6 15.2 22.3 26.2 20.2 14.5 10.2 28.7 34.9 7.0 22.3 21.0 17.4 40.4 63.3 26.7 43.6 26.2 28.5 27.8 63.3 53.0 59.0 82.3 59.2 57.2 29.1 146.5 46.0 30.8 32.2 18.8 33.4 23.6 44.2 38.5 41.5 49.8 48.5 35.4 35.2 91.4 42.2 35.1 34.9 24.9 25.8 37.4 22.3 30.3 80.6 25.3 63.9 25.4 38.0 41.3 23.6 60.5 27.8 22.9 44.6 35.0 33.3 29.5 29.0 37.6 37.0 33.9 11.2 43.8 38.5 41.5 75.1 34.4 80.3 71.6 48.9 56.6 27.8 58.1 63.5 41.6 12.3 94.6 44.3 59.3 94.0 40.9 50.9 39.9 48.6 81.1 42.2 36.6 40.5 35.7 122.8 103.0 59.9 38.9 66.0 13.4 15.3 15.6 17.3 13.0 16.9 16.6 15.1 15.5 15.2 14.5 17.4 20.2 9.6 15.3 4.6 16.5 18.5 24.4 53.9 12.0 10.2 31.8 32.0 0.2 41.5 33.0 53.3 8.4 111.5 24.5 22.7 41.1 54.4 5.5 30.9 26.7 26.4 23.5 30.7 1.0 44.2 94.0 38.1 15.8 21.7 27.3 43.7 24.3 43.9 52.5 5.0 1.2 21.1 46.8 20.2 16.6 6.3 22.4 20.0 42.7 1.0 25.0 40.3 28.8 4.0 3.2 41.7 35.5 20.3 24.4 35.4 37.7 57.4 42.9 18.0 32.9 28.9 27.1 21.7 30.9 14.8 17.5 146.3 15.1 62.3 28.8 23.3 TMEM132A "FLJ20539, GBP, HSPA5BP1" ENSG00000006118 "Transmembrane protein 132A" Q24JP5 11 60924460-60937159 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 187.8;choroid plexus: 117.3" "Cell type enhanced" "Detected in many" "Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051979, HPA060492" Enhanced Supported Approved Mitochondria No No 4100000 "Cluster 73: Brain - Neuropeptide signaling" "Cluster 38: EFO-21 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Mitochondria "HPA051979: AB_2681681, HPA060492: " "unprognostic (2.52e-2)" "unprognostic (2.01e-1)" "unprognostic (3.75e-2)" "prognostic favorable (1.98e-5)" "unprognostic (7.94e-3)" "unprognostic (3.74e-1)" "unprognostic (4.42e-3)" "unprognostic (2.39e-2)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (2.88e-1)" "unprognostic (5.98e-2)" "prognostic unfavorable (1.55e-9)" "unprognostic (3.31e-1)" "unprognostic (9.74e-2)" "unprognostic (1.50e-1)" "unprognostic (8.41e-3)" 7.7 21.0 137.9 8.6 134.3 0.3 7.7 119.4 187.8 12.0 117.3 5.5 2.5 13.6 1.2 19.5 4.8 5.5 13.7 134.1 136.9 13.9 2.1 10.1 1.7 154.5 131.2 18.8 6.8 12.4 23.6 16.6 126.4 9.4 1.0 28.1 25.9 1.8 3.9 6.1 6.0 3.7 123.0 5.7 32.4 6.7 144.6 1.3 4.8 3.1 5.4 4.2 9.2 114.7 37.0 50.7 44.1 88.0 3.6 1.7 78.1 27.0 84.5 24.6 20.3 18.0 33.3 0.3 174.1 7.8 79.9 67.6 10.3 46.0 9.5 0.5 14.8 1.1 33.3 32.7 30.8 0.5 1.3 7.7 8.6 45.8 7.1 38.7 42.1 7.0 2.3 2.3 7.8 177.8 0.9 0.2 58.5 1.2 26.9 0.4 18.6 4.2 36.4 18.7 43.7 104.1 19.3 176.4 16.7 22.3 123.7 0.6 49.4 9.5 43.2 2.7 52.3 0.4 0.3 2.1 78.5 0.1 46.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 137.9 134.3 119.4 187.8 134.1 136.9 154.5 131.2 126.4 123.0 144.6 114.7 11.8 0.0 0.0 82.3 0.6 1.3 2.7 56.2 5.7 62.8 17.1 11.7 0.8 4.3 22.2 5.5 18.8 31.4 0.1 0.7 1.9 80.0 0.5 12.4 7.0 11.9 15.6 0.0 22.6 13.3 28.7 7.7 9.2 27.7 0.0 57.5 11.4 0.0 3.3 254.1 29.1 2.7 20.3 0.3 1.0 1.0 1.8 0.7 0.0 7.5 3.1 188.8 0.0 12.1 3.3 63.2 1.6 3.4 0.0 9.7 0.0 0.4 4.0 165.3 6.6 4.4 15.2 1.2 4.0 5.7 0.9 27.1 0.3 19.2 2.3 7.2 TMEM185A "CXorf13, FAM11A, FRAXF" ENSG00000269556 "Transmembrane protein 185A" Q8NFB2 X 149596556-149631912 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 51: Myeloid cells - Hemostasis" "Endoplasmic reticulum" "HPA048295: AB_2680345, HPA071744: AB_2686441" "unprognostic (9.76e-2)" "unprognostic (2.83e-2)" "unprognostic (7.73e-2)" "unprognostic (2.71e-3)" "unprognostic (4.08e-1)" "unprognostic (1.97e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.78e-2)" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" 15.0 13.8 5.7 8.0 6.6 6.8 13.1 6.8 9.0 14.6 19.7 12.9 7.1 15.0 17.3 15.5 14.4 11.3 30.1 6.7 6.4 10.6 8.9 9.9 10.7 6.0 6.1 30.9 9.5 16.4 8.1 26.8 6.1 13.9 9.4 10.6 12.9 16.8 13.6 20.0 9.1 16.6 6.4 16.8 9.7 17.0 6.9 10.7 9.9 15.9 11.0 12.8 15.1 6.1 18.0 17.7 20.0 12.4 27.0 17.8 8.2 16.9 20.8 16.6 24.2 10.9 29.9 21.4 37.7 19.0 22.8 22.1 23.1 16.4 17.0 14.3 17.3 12.1 19.6 11.8 19.9 18.5 12.8 17.4 27.6 16.9 10.8 19.8 14.6 16.6 5.1 13.1 12.4 29.5 13.1 13.6 14.9 9.5 19.8 12.1 29.8 12.3 20.1 22.8 6.9 9.9 12.5 21.2 23.1 17.9 11.7 10.4 17.6 13.5 11.8 24.7 21.9 12.7 12.0 30.8 22.6 21.9 18.6 2.2 5.1 12.9 9.9 3.1 8.4 5.2 6.9 10.0 7.5 5.0 9.5 8.9 7.1 14.9 2.7 5.6 9.6 6.4 5.7 6.6 6.8 9.0 6.7 6.4 6.0 6.1 6.1 6.4 6.9 6.1 13.5 6.4 2.6 5.9 7.6 11.1 12.1 19.8 6.2 17.4 13.5 12.1 12.3 2.8 9.8 14.7 6.2 29.1 13.1 9.6 3.9 4.4 0.6 22.6 10.5 12.1 13.1 6.5 12.1 9.3 10.7 15.4 2.0 11.2 5.7 22.7 23.9 7.2 11.2 18.5 12.3 5.9 18.3 11.7 12.0 3.2 22.7 11.4 14.2 6.5 16.1 12.2 17.5 10.6 8.2 12.7 9.3 23.7 4.1 8.6 8.3 6.8 17.5 9.2 46.0 9.4 14.1 11.7 16.8 11.0 20.0 17.2 9.8 24.3 5.1 17.7 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972754-153983194 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038134 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 22: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favorable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 6.9 9.1 5.5 4.8 6.5 2.7 6.5 6.3 6.5 6.7 8.9 6.2 5.0 5.8 7.0 5.1 7.4 4.2 6.2 5.5 6.0 5.6 8.3 4.8 7.7 6.8 6.3 7.1 12.4 5.6 6.8 3.6 6.3 6.7 3.2 2.7 10.7 6.2 6.4 8.5 6.8 4.4 6.7 7.0 6.4 3.9 6.1 5.4 5.0 3.2 4.6 5.9 5.6 8.0 11.9 13.1 2.9 11.6 12.1 10.0 1.8 4.7 2.9 1.4 4.7 2.8 20.7 1.8 27.5 5.2 7.7 11.3 3.9 7.4 1.1 15.8 6.4 3.2 8.3 4.8 10.4 1.9 3.5 12.8 12.1 4.0 7.6 7.4 4.2 7.4 2.9 15.0 6.7 14.7 6.8 2.6 2.1 14.2 18.4 6.5 2.0 20.1 9.2 3.9 4.4 4.1 8.2 6.9 5.8 3.2 11.9 4.0 7.3 2.4 2.6 10.1 2.9 10.9 7.7 2.5 6.9 7.7 1.7 31.5 15.2 19.6 21.5 11.7 21.8 14.6 25.9 23.1 11.4 18.8 31.6 19.5 14.1 17.0 11.4 30.6 29.3 17.7 5.5 6.5 6.3 6.5 5.5 6.0 6.8 6.3 6.3 6.7 6.1 8.0 6.7 0.0 6.3 3.9 4.7 2.8 6.1 11.7 5.2 4.8 9.4 9.8 5.2 12.8 5.1 7.3 6.2 13.3 8.5 5.9 1.9 10.1 0.3 9.4 5.4 7.0 2.4 4.0 1.5 8.7 10.8 6.8 3.6 7.9 3.8 9.0 7.9 16.1 12.4 1.7 1.8 8.2 12.2 7.0 3.3 0.6 14.6 7.1 10.6 0.0 7.0 14.6 5.2 0.5 3.7 9.9 3.8 14.3 3.6 5.9 12.0 8.7 6.5 6.0 6.6 7.8 5.5 1.7 9.4 4.3 4.7 9.9 6.9 14.7 8.1 3.8 TMEM92 FLJ33318 ENSG00000167105 "Transmembrane protein 92" Q6UXU6 17 50271406-50281485 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.0;stomach 1: 23.0" "Group enriched" "Detected in many" 4 "Proximal enterocytes: 285.4;Urothelial cells: 88.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 7.5;CACO-2: 14.1;CAPAN-2: 10.6;EFO-21: 21.4;OE19: 16.8;SuSa: 18.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063009, HPA069820" Approved Enhanced Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "HPA063009: AB_2684921, HPA069820: AB_2686208" "unprognostic (3.54e-3)" "unprognostic (2.39e-2)" "unprognostic (9.85e-2)" "unprognostic (1.45e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.37e-3)" "unprognostic (2.45e-2)" "unprognostic (1.11e-1)" "unprognostic (4.39e-1)" "unprognostic (3.88e-3)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.14e-6)" "unprognostic (3.44e-2)" "unprognostic (1.40e-1)" "unprognostic (1.73e-1)" "unprognostic (7.81e-2)" 0.2 0.0 0.4 0.9 0.4 0.4 0.3 0.2 0.5 2.1 0.1 2.2 16.0 0.8 0.0 0.7 0.6 4.4 0.1 0.3 0.3 1.0 8.3 2.6 0.1 0.8 0.4 2.0 1.0 0.0 0.0 0.0 0.5 0.7 1.4 0.0 2.7 0.0 0.0 0.2 19.0 0.3 0.4 0.2 23.0 0.2 0.6 0.0 0.0 0.0 0.1 1.5 1.4 0.4 0.7 7.5 0.1 0.0 0.0 0.1 1.5 0.2 0.1 0.0 0.0 14.1 10.6 0.0 21.4 0.2 2.8 0.1 0.1 1.6 0.0 3.6 0.2 0.1 0.7 0.9 0.2 0.0 0.1 0.2 1.4 0.0 0.4 1.6 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.2 3.1 16.8 3.5 0.2 0.0 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 18.3 1.2 0.5 0.0 0.3 2.0 0.0 0.1 0.0 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.2 0.5 0.3 0.3 0.8 0.4 0.5 0.4 0.6 0.4 0.1 3.2 21.7 0.0 0.0 0.5 15.8 26.5 1.8 0.0 9.7 0.0 0.3 18.6 16.1 7.3 0.0 0.1 0.0 5.9 0.0 7.9 0.1 2.3 2.1 1.2 5.4 0.0 0.0 19.6 2.8 0.8 34.1 19.5 0.0 0.0 2.2 15.6 0.4 0.0 0.0 24.4 0.0 0.6 0.7 0.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 45.1 14.8 0.0 0.2 19.1 285.4 0.0 3.5 0.0 0.0 0.0 1.5 0.1 1.6 0.2 1.0 0.0 0.3 0.0 19.8 88.3 TMLHE "BBOX2, FLJ10727, TMLH, XAP130" ENSG00000185973 "Trimethyllysine hydroxylase, epsilon" Q9NVH6 X 155489011-155719098 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carnitine biosynthesis" "Dioxygenase, Oxidoreductase" "Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 51.5;Oligodendrocyte precursor cells: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034589, HPA040331" Approved Supported Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 68: Oligodendrocytes - Mixed function" Mitochondria "HPA034589: AB_10670571, HPA040331: AB_2676929" "unprognostic (1.98e-1)" "unprognostic (9.15e-2)" "unprognostic (3.04e-1)" "unprognostic (5.41e-2)" "unprognostic (6.66e-3)" "unprognostic (1.10e-3)" "unprognostic (6.50e-2)" "unprognostic (1.00e-1)" "unprognostic (3.27e-1)" "unprognostic (4.08e-2)" "unprognostic (1.20e-3)" "unprognostic (6.97e-2)" "prognostic favorable (3.68e-6)" "unprognostic (1.69e-1)" "unprognostic (5.74e-2)" "unprognostic (2.73e-1)" "unprognostic (7.75e-2)" 11.7 10.2 7.1 6.6 7.4 8.4 11.3 9.0 8.0 11.3 8.1 11.6 11.8 9.4 10.4 10.3 9.9 8.0 25.3 6.7 7.7 16.7 18.8 5.6 7.0 8.5 8.2 12.0 9.5 18.9 5.4 8.4 8.5 6.6 12.5 10.9 12.7 9.7 32.0 5.9 11.2 12.3 8.3 8.7 9.1 2.9 7.3 8.9 10.5 33.4 7.6 8.2 6.6 9.8 25.0 11.9 9.8 28.6 11.8 18.1 0.0 9.9 14.6 12.3 32.4 8.7 13.9 0.0 38.9 17.6 28.2 13.4 21.2 9.7 13.9 10.3 14.3 11.3 19.5 10.2 16.4 10.5 7.6 19.5 20.0 13.6 20.8 18.2 19.5 15.5 15.8 9.0 20.5 9.3 12.8 11.8 3.0 21.6 0.1 12.7 15.5 9.4 15.0 8.5 9.2 13.7 9.3 0.5 11.2 10.5 10.6 11.9 16.5 10.3 9.7 20.4 12.4 11.0 12.6 9.6 12.4 16.4 9.6 3.4 12.6 14.7 4.6 14.9 3.5 8.1 5.0 3.9 13.1 10.6 6.5 5.7 18.2 6.2 21.5 6.1 5.5 5.8 7.1 7.4 9.0 8.0 6.7 7.7 8.5 8.2 8.5 8.3 7.3 9.8 6.7 0.0 2.3 27.1 10.1 5.2 12.1 14.4 9.6 4.0 5.2 7.5 7.2 7.2 9.7 9.2 0.0 8.8 6.5 7.9 23.5 10.7 0.0 6.8 7.4 6.2 6.1 14.3 22.2 7.6 6.8 10.2 9.2 7.3 10.1 8.1 4.2 12.0 12.4 0.0 29.5 7.3 4.1 16.1 10.4 0.5 8.4 12.1 12.4 51.5 13.1 7.6 10.3 47.7 25.5 8.5 7.3 5.7 5.6 4.3 17.4 17.0 9.5 5.4 0.0 5.9 9.5 0.3 2.5 7.6 4.1 6.7 8.0 10.5 6.5 11.0 TOR4A "C9orf167, FLJ20245" ENSG00000198113 "Torsin family 4 member A" Q9NXH8 9 137277726-137282641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 45.6;Undifferentiated cells: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 45.4;TIME: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA044913 Enhanced Approved Nucleoplasm NA NA 260000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA044913: AB_10965030" "unprognostic (1.95e-1)" "unprognostic (1.51e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.99e-1)" "unprognostic (3.56e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (1.47e-1)" "unprognostic (1.11e-2)" "unprognostic (2.24e-1)" "unprognostic (5.20e-2)" "unprognostic (2.00e-3)" "unprognostic (4.39e-3)" "unprognostic (7.93e-3)" "unprognostic (2.56e-1)" 4.4 2.9 2.2 4.9 1.9 2.8 2.4 1.9 1.9 4.8 2.0 12.4 9.6 3.6 0.8 7.5 4.2 5.2 13.0 1.6 1.8 11.7 2.9 10.9 4.1 2.8 2.3 5.1 3.8 1.9 1.9 1.9 2.5 2.3 4.3 0.0 1.6 2.5 1.4 1.7 11.0 1.3 2.6 15.4 12.5 0.6 3.2 0.8 4.2 0.7 3.0 3.8 3.8 2.3 16.7 21.6 0.2 0.6 0.2 1.7 1.7 27.0 18.5 12.3 6.5 2.7 30.8 1.6 37.4 9.7 0.9 34.0 0.1 9.0 4.2 1.4 1.4 18.2 15.4 14.8 25.9 8.0 45.4 0.9 9.3 2.5 4.8 13.9 16.8 0.1 27.8 2.1 2.1 1.8 0.0 22.0 2.6 18.0 23.9 4.4 5.8 11.3 14.7 0.1 0.8 0.2 19.7 0.1 0.5 0.5 1.6 24.7 41.7 0.6 14.6 2.9 4.6 0.2 1.2 10.5 4.6 7.3 6.0 0.5 0.7 1.3 0.1 0.7 0.2 0.2 0.1 0.0 0.5 0.4 0.0 0.0 0.4 0.2 1.2 0.0 0.2 0.3 2.2 1.9 1.9 1.9 1.6 1.8 2.8 2.3 2.5 2.6 3.2 2.3 10.5 0.0 5.9 0.0 6.2 2.7 3.0 4.9 2.2 0.1 1.9 4.6 8.1 22.8 6.3 12.9 0.0 0.2 4.1 45.6 0.0 10.4 0.1 4.6 2.4 8.4 7.2 5.2 0.0 2.2 0.2 1.9 21.4 9.6 10.2 0.0 27.8 1.0 15.0 0.0 0.0 24.7 2.0 22.0 17.7 0.1 2.5 16.2 0.0 2.8 16.1 0.7 15.5 0.0 0.0 22.9 29.4 4.1 2.4 1.7 17.9 0.6 7.5 0.6 19.7 1.5 3.1 0.0 0.7 2.2 2.4 0.0 2.9 4.3 34.7 15.4 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451465-69507666 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 19.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 70.1 5.3 22.8 15.3 37.6 1.0 61.0 35.0 34.1 16.4 14.9 62.5 38.8 32.6 8.5 10.8 24.6 27.4 16.9 23.6 25.4 25.9 4.6 34.4 8.7 36.9 33.4 3.4 20.0 3.2 6.6 28.1 33.7 34.5 39.4 3.1 26.6 24.7 17.9 10.6 38.8 31.3 30.0 26.7 75.3 9.5 34.5 3.6 14.5 5.6 7.5 46.0 14.9 62.4 51.3 103.9 2.1 0.3 2.3 0.0 12.0 0.2 1.9 2.6 6.8 45.1 154.7 0.0 211.3 2.3 9.2 101.2 7.2 11.5 3.0 42.1 20.4 2.9 3.5 10.0 1.1 0.1 1.8 2.2 3.1 1.4 1.5 7.5 39.4 20.5 1.1 0.0 1.2 168.0 0.6 0.9 2.6 153.2 266.8 4.0 2.1 2.0 29.7 92.9 34.5 13.2 0.6 134.8 17.9 17.3 59.3 2.2 34.5 0.2 0.8 0.1 17.5 1.2 6.1 1.0 1.1 0.1 0.2 0.0 0.0 0.0 2.3 0.0 19.5 0.0 3.1 2.8 3.3 0.0 1.0 0.2 0.0 0.1 0.0 0.2 1.1 0.5 22.8 37.6 35.0 34.1 23.6 25.4 36.9 33.4 33.7 30.0 34.5 62.4 108.8 32.1 6.9 4.9 1.5 3.6 10.9 59.6 2.2 2.9 45.1 15.6 1.7 31.5 29.5 29.5 6.2 2.0 1.6 125.8 3.9 125.2 27.9 25.5 3.8 48.4 40.2 8.0 1.7 189.3 11.9 8.2 71.4 36.6 1.3 2.5 10.4 0.1 25.3 1.7 1.0 106.7 36.7 8.5 16.1 6.6 0.6 9.8 28.4 15.0 15.6 44.7 0.0 11.1 75.3 193.4 120.9 0.0 0.2 50.4 68.3 1.8 27.6 1.5 13.1 39.7 26.8 4.3 18.5 2.9 3.1 3.0 3.9 7.5 66.3 29.6 TSPAN2 "FLJ12082, TSN2, TSPAN-2" ENSG00000134198 "Tetraspanin 2" O60636 1 115048011-115089503 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.4;intestine: 55.4" "Cell type enhanced" "Detected in many" "Ductal cells: 35.3;Enteroendocrine cells: 39.4;NK-cells: 40.2;Prostatic glandular cells: 30.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 109.0;neutrophil: 109.8" "Group enriched" "Detected in many" 4 "granulocytes: 109.8;NK-cells: 86.2" "Cell line enhanced" "Detected in many" "EFO-21: 58.8;hTERT-RPE1: 16.9;U-937: 26.9" "Region enhanced" "Detected in all" "white matter: 842.5" "Low region specificity" "Detected in many" "HPA015640, HPA073306" Uncertain Enhanced Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA015640: AB_1858405, HPA073306: " "unprognostic (4.56e-2)" "unprognostic (6.86e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (1.57e-3)" "unprognostic (1.64e-1)" "unprognostic (9.73e-6)" "unprognostic (6.06e-3)" "unprognostic (3.07e-2)" "unprognostic (4.74e-2)" "unprognostic (7.66e-2)" "unprognostic (1.80e-1)" "prognostic unfavorable (8.48e-7)" "unprognostic (5.40e-2)" "unprognostic (1.59e-1)" "unprognostic (1.48e-3)" "unprognostic (7.80e-3)" 7.2 1.8 3.5 10.1 1.9 20.8 4.5 0.9 1.4 10.7 1.3 55.4 5.4 47.4 7.5 14.6 22.2 7.4 7.4 1.0 3.6 8.4 0.8 6.5 1.4 5.4 4.1 2.9 2.9 10.2 2.1 3.0 5.7 15.4 12.0 2.0 3.0 28.3 2.8 2.0 11.0 42.7 2.1 3.8 13.8 1.1 5.7 2.7 2.7 5.2 1.1 24.7 8.0 1.2 15.1 0.3 1.2 0.0 0.0 0.2 0.1 2.1 1.0 2.4 3.8 3.1 9.5 0.0 58.8 3.5 3.3 2.2 1.9 0.0 2.7 3.1 1.2 0.5 1.1 0.0 0.2 0.1 0.0 0.0 0.4 0.7 0.0 16.9 0.1 11.1 0.0 0.9 0.0 0.8 8.2 1.3 13.8 3.2 1.6 0.1 0.8 0.0 0.4 5.8 3.0 4.5 3.5 1.6 0.2 8.2 0.3 0.6 0.2 0.2 5.7 0.4 14.1 12.5 0.4 0.1 0.1 26.9 6.9 109.0 9.1 55.8 17.4 0.2 5.6 0.6 20.5 22.6 4.1 0.3 3.4 17.0 109.8 86.2 0.1 3.8 3.3 13.1 3.5 1.9 0.9 1.4 1.0 3.6 5.4 4.1 5.7 2.1 5.7 1.2 18.7 0.0 0.6 0.3 1.4 8.0 23.2 10.9 1.8 2.5 1.5 7.6 9.6 0.0 4.4 11.0 0.0 1.4 19.9 0.1 0.0 35.3 12.2 14.3 0.9 16.3 39.4 3.0 2.8 2.4 4.3 4.0 0.5 16.3 0.0 2.0 6.4 0.0 0.7 0.0 5.4 1.3 4.1 0.6 3.7 4.6 0.6 3.0 3.6 2.8 2.7 0.0 40.2 1.5 0.2 10.9 0.0 3.0 3.3 30.0 0.0 1.3 10.7 0.4 6.6 1.4 16.2 0.1 0.9 0.2 2.7 0.3 17.2 0.1 1.4 21.6 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" Cytosol "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favorable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 8.3 10.1 5.3 4.3 6.6 1.1 8.0 5.1 6.3 11.6 6.6 17.1 3.5 11.2 6.9 9.8 10.0 8.8 10.6 4.5 6.2 8.9 8.1 6.6 3.1 6.7 5.8 14.9 8.0 8.9 5.3 9.4 6.5 10.7 7.8 7.2 6.7 9.2 8.1 8.4 6.8 10.0 5.7 5.2 9.1 13.0 6.0 3.7 12.7 7.6 3.3 13.2 10.1 8.1 9.9 9.8 15.3 17.8 18.0 20.2 6.4 12.0 14.8 12.6 14.2 8.8 17.0 2.4 23.7 13.7 11.4 19.0 5.0 12.0 13.7 3.3 16.3 10.7 17.1 7.0 10.4 2.4 0.7 14.5 10.5 9.9 9.5 13.7 21.6 4.8 8.3 1.4 11.8 6.0 8.6 2.7 8.4 2.7 7.0 2.7 19.9 3.8 10.0 13.2 6.7 3.0 15.8 6.4 14.7 15.4 10.7 10.9 14.3 16.0 9.4 10.7 15.5 8.1 12.4 3.3 14.3 0.8 9.6 1.8 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.0 0.5 0.5 0.1 0.5 0.1 0.0 5.3 6.6 5.1 6.3 4.5 6.2 6.7 5.8 6.5 5.7 6.0 8.1 5.9 3.2 7.0 27.1 0.6 2.4 4.6 4.4 4.6 1.7 4.6 4.3 9.5 4.3 5.2 5.5 0.0 4.6 0.1 4.3 5.9 6.0 12.5 3.3 10.6 7.0 0.0 0.8 3.3 6.2 4.6 7.4 10.2 4.5 1.3 13.5 9.3 5.3 4.0 8.4 3.5 5.7 6.1 3.8 1.7 8.5 9.0 2.5 1.8 15.9 0.6 11.5 0.0 6.6 13.2 3.9 2.6 10.1 0.1 3.1 3.8 5.5 4.0 5.4 6.6 6.5 5.5 18.0 9.2 7.9 4.0 1.9 0.4 10.9 6.7 2.6 VNN1 Tiff66 ENSG00000112299 "Vanin 1" O95497 6 132680849-132714055 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "gallbladder: 89.2;intestine: 136.3;liver: 218.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7" "Cancer enhanced" "Detected in many" "liver cancer: 41.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "classical monocyte: 13.7;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 80 "dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7" "Cell line enhanced" "Detected in some" "A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5" "Region enhanced" "Detected in single" "white matter: 2.4" "Not detected" "Not detected" "HPA046103, HPA064145" Approved Approved Vesicles "Intracellular and membrane" NA NA 980000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Vesicles "HPA046103: , HPA064145: AB_2685197" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (9.95e-2)" "unprognostic (1.35e-3)" "unprognostic (6.11e-2)" "unprognostic (1.16e-2)" "unprognostic (2.20e-1)" "unprognostic (4.20e-2)" "unprognostic (2.06e-2)" "unprognostic (3.64e-2)" "unprognostic (2.11e-2)" "unprognostic (4.62e-1)" "prognostic unfavorable (2.52e-4)" "unprognostic (2.26e-2)" "unprognostic (4.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.34e-1)" 2.7 0.6 0.3 3.1 0.6 9.4 1.1 0.5 1.5 1.0 0.0 6.2 136.3 8.9 0.2 0.6 2.6 89.2 0.6 0.2 0.3 21.7 218.7 4.7 2.5 0.6 0.3 0.3 1.4 0.1 0.1 2.7 1.2 0.3 1.8 1.0 2.3 0.2 0.3 0.9 79.5 0.9 0.2 10.1 1.5 0.5 0.5 0.6 0.4 1.1 2.5 1.6 0.7 0.9 2.5 0.0 0.3 0.1 0.0 0.7 0.5 0.2 0.2 0.0 0.0 0.0 2.5 0.1 8.7 0.0 0.4 0.0 0.0 2.3 0.6 0.0 0.0 0.1 0.1 1.4 1.3 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 1.1 0.5 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.0 0.2 0.1 0.2 0.0 0.1 0.2 0.1 0.3 3.0 13.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 5.0 0.1 0.0 0.0 8.5 0.0 11.9 0.2 0.0 3.8 0.3 0.6 0.5 1.5 0.2 0.3 0.6 0.3 1.2 0.2 0.5 0.9 0.0 0.0 3.0 0.0 0.3 1.3 0.2 14.9 0.0 0.0 1.2 0.4 0.2 50.1 11.4 1.8 0.0 0.1 0.2 12.5 0.0 244.2 0.0 7.6 4.1 0.2 0.0 0.0 0.0 19.4 0.1 0.3 4.6 39.6 0.0 0.0 1.1 70.6 18.1 0.0 0.0 11.2 22.4 12.0 3.9 0.0 0.0 23.1 0.0 0.0 17.6 0.0 0.0 0.0 0.0 98.0 1.6 0.0 0.5 6.6 61.7 21.9 16.0 0.0 0.0 0.4 1.1 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.0 14.7 WFIKKN1 "C16orf12, RJD2, WFDC20A, WFIKKN" ENSG00000127578 "WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1" Q96NZ8 16 629239-634117 "Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.3" "Cell type enhanced" "Detected in some" "Astrocytes: 4.9;Horizontal cells: 10.1;Melanocytes: 3.6" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in single" "cerebellum: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.4;Hep G2: 1.0;NTERA-2: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in other tissues" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "unprognostic (3.12e-1)" "unprognostic (2.57e-1)" "unprognostic (3.17e-2)" "unprognostic (1.59e-2)" "unprognostic (3.55e-1)" "unprognostic (2.28e-2)" "unprognostic (3.36e-2)" "unprognostic (4.45e-2)" "unprognostic (8.53e-2)" "unprognostic (2.43e-1)" "unprognostic (3.78e-3)" "unprognostic (1.19e-1)" "unprognostic (5.56e-3)" "unprognostic (1.53e-1)" "unprognostic (3.02e-1)" "unprognostic (2.50e-3)" "unprognostic (4.70e-5)" 0.2 0.1 0.3 0.0 0.4 0.0 0.1 1.5 0.8 0.4 0.0 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.3 0.3 0.0 2.3 0.8 0.4 0.0 0.2 0.0 0.6 1.1 0.0 1.2 0.0 0.1 0.8 0.0 0.0 0.3 0.0 0.5 1.0 0.3 0.0 0.0 0.6 0.5 1.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.5 0.8 0.3 0.0 0.2 0.0 0.1 0.0 0.1 0.5 0.4 0.0 0.5 4.9 0.1 0.9 0.2 0.5 0.6 2.9 0.7 0.8 0.8 0.0 0.3 0.0 0.0 0.2 0.2 2.2 0.0 0.0 0.1 1.3 1.9 0.9 1.2 0.0 1.4 0.2 0.1 0.3 0.0 1.8 1.3 1.4 0.7 0.9 0.1 10.1 0.5 1.4 0.0 0.6 0.0 0.1 0.0 0.2 3.6 1.0 0.0 1.1 0.0 1.0 1.1 0.7 2.4 0.7 0.0 0.7 2.1 0.4 1.4 0.1 0.0 0.7 0.4 1.6 0.7 1.4 1.6 0.3 0.2 0.3 1.4 0.3 WNT11 ENSG00000085741 "Wnt family member 11" O96014 11 76186325-76210736 "Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.4" "Group enriched" "Detected in some" 5 "Adipocytes: 41.5;Fibroblasts: 23.2;Theca cells: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "NK-cell: 2.9" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.9" "Cell line enhanced" "Detected in some" "BEWO: 36.2;CACO-2: 12.1;CAPAN-2: 17.8;EFO-21: 57.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA050101 Uncertain "Secreted to extracellular matrix" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA050101: AB_2681015" "prognostic favorable (5.97e-4)" "unprognostic (9.27e-2)" "unprognostic (2.01e-2)" "unprognostic (2.52e-1)" "unprognostic (1.87e-2)" "unprognostic (8.43e-2)" "unprognostic (7.88e-2)" "unprognostic (1.03e-2)" "unprognostic (1.44e-1)" "unprognostic (3.85e-2)" "unprognostic (2.88e-2)" "unprognostic (4.36e-2)" "unprognostic (3.10e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (3.16e-3)" "unprognostic (1.09e-3)" 37.4 20.8 1.7 0.4 3.5 0.9 23.7 4.1 2.2 4.8 14.3 3.6 2.5 2.7 1.3 1.2 6.7 2.1 8.3 3.8 3.5 2.8 8.0 6.3 1.1 7.4 2.7 4.5 9.5 1.2 3.1 4.1 6.9 4.3 1.1 0.3 4.3 1.1 12.3 8.1 3.3 0.6 2.8 3.5 1.4 0.9 2.8 0.9 17.2 7.1 0.2 4.0 3.8 2.1 0.0 0.0 0.0 0.0 2.9 0.2 36.2 0.0 0.0 0.1 0.2 12.1 17.8 0.0 57.0 0.1 0.2 5.5 1.1 0.0 0.0 5.5 2.1 2.9 1.4 2.2 0.0 0.0 0.4 0.1 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.1 0.0 1.4 0.3 0.0 0.4 0.9 0.0 2.9 0.4 0.0 2.1 0.2 0.0 2.5 0.1 1.4 0.0 0.0 2.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.2 1.7 3.5 4.1 2.2 3.8 3.5 7.4 2.7 6.9 2.8 2.8 2.1 41.5 0.0 0.0 0.3 0.5 1.3 0.5 0.0 1.2 0.0 0.9 1.9 4.7 0.0 0.0 0.0 0.0 0.9 2.3 2.2 0.0 0.0 0.0 5.0 2.9 1.8 0.0 0.0 0.2 0.2 3.3 23.2 0.0 1.1 0.0 0.4 0.7 2.5 0.1 0.0 0.5 0.5 0.0 0.3 2.3 0.0 0.0 0.7 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 2.6 0.7 0.7 0.1 3.8 0.0 0.0 0.0 0.0 1.8 5.7 0.4 0.5 0.1 0.9 1.4 0.9 24.3 1.5 0.1 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 229.3;Endothelial cells: 221.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 41.6 13.8 19.2 22.4 20.8 0.2 37.2 18.9 19.6 41.8 32.6 74.9 8.0 42.1 13.4 35.8 33.7 39.6 36.4 20.7 53.9 45.9 19.0 41.2 7.2 52.6 39.9 43.9 31.8 14.1 13.6 44.0 35.9 34.5 13.5 4.2 27.6 32.1 13.2 24.8 21.6 43.7 37.1 19.5 32.7 7.2 23.0 4.7 31.6 15.0 6.1 59.2 34.3 41.0 58.9 80.5 40.6 48.7 48.6 86.8 43.0 32.6 57.5 17.7 17.8 46.7 53.2 0.1 212.1 45.0 53.3 36.1 28.4 28.5 17.9 22.0 19.3 0.0 18.6 37.8 27.3 0.0 0.1 45.3 7.4 61.8 26.6 65.4 136.3 0.0 0.0 0.2 61.7 9.2 0.2 0.2 8.2 0.2 96.6 0.0 50.6 0.4 151.1 9.4 0.0 0.4 21.1 17.2 160.2 31.5 26.5 1.6 94.2 29.0 16.2 24.8 67.4 0.6 0.5 0.8 66.8 0.1 78.8 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.1 19.2 20.8 18.9 19.6 20.7 53.9 52.6 39.9 35.9 37.1 23.0 41.0 125.7 64.1 89.7 60.4 1.1 51.7 229.3 34.6 60.9 2.2 58.1 56.8 46.8 141.5 87.8 49.7 4.2 12.2 2.0 0.5 7.9 72.0 21.9 136.3 89.1 221.2 0.0 3.2 8.7 27.1 82.3 77.9 10.2 144.4 7.6 45.0 111.4 21.9 4.1 0.0 6.1 1.2 10.2 6.0 32.3 7.9 57.8 4.6 30.2 94.6 2.1 11.0 0.0 7.5 12.7 45.8 0.0 126.4 2.9 86.7 1.2 59.8 53.9 2.0 59.2 76.1 58.0 2.2 0.8 46.3 35.5 14.8 6.5 48.4 2.4 93.5 ZBTB46 "BTBD4, BZEL, FLJ13502, RINZF, ZNF340" ENSG00000130584 "Zinc finger and BTB domain containing 46" Q86UZ6 20 63743668-63832038 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 28.6;Excitatory neurons: 26.0;Hepatic stellate cells: 28.9;Microglial cells: 45.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013997, HPA048051" Uncertain Approved Nucleoplasm NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA013997: AB_1858961, HPA048051: " "unprognostic (1.11e-1)" "unprognostic (1.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.13e-2)" "unprognostic (1.36e-1)" "unprognostic (2.46e-2)" "unprognostic (9.33e-2)" "unprognostic (9.87e-2)" "unprognostic (1.92e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.17e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (3.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.70e-2)" "unprognostic (2.12e-1)" 8.4 5.0 5.1 2.2 4.7 1.2 7.5 13.9 5.5 8.0 4.3 2.5 1.2 7.2 4.5 2.1 7.7 2.5 10.7 4.3 5.5 9.1 4.7 5.8 3.5 4.3 3.5 12.2 3.2 2.2 10.0 4.1 3.9 4.5 0.7 4.1 2.9 2.6 3.7 2.4 3.4 1.8 3.4 16.6 2.7 3.9 5.1 1.3 9.8 3.7 1.2 3.5 3.4 3.0 1.6 0.6 6.9 1.9 0.4 0.8 3.6 0.4 2.7 0.4 0.2 1.8 4.7 0.2 7.2 0.1 1.5 1.2 0.4 0.1 0.4 0.5 1.7 0.3 1.0 3.3 1.8 0.5 1.0 0.4 0.1 0.1 0.0 0.8 0.8 0.2 2.4 0.5 1.5 4.1 0.1 9.7 1.0 1.9 2.4 1.8 2.4 2.9 0.5 1.1 7.2 1.7 0.7 3.9 0.5 3.8 4.0 5.7 0.1 4.1 2.4 1.7 0.6 1.2 3.3 0.4 0.2 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 4.7 13.9 5.5 4.3 5.5 4.3 3.5 3.9 3.4 5.1 3.0 28.6 0.0 1.1 14.4 0.8 0.4 1.3 2.0 1.2 4.7 2.6 2.0 10.8 1.5 2.8 1.8 18.8 4.3 0.6 1.0 0.0 1.6 0.6 1.5 11.2 14.5 1.2 4.0 26.0 0.6 0.9 5.1 0.0 1.6 2.5 0.1 28.9 0.3 3.0 1.7 6.9 0.0 4.1 3.8 14.6 2.3 8.1 4.2 1.8 45.0 1.7 3.9 0.0 12.1 2.0 2.3 0.1 8.6 0.5 2.6 0.2 1.3 1.7 10.1 0.0 2.2 8.0 0.7 1.9 0.3 0.4 3.7 0.5 13.4 0.2 2.0 ZNF720 ENSG00000197302 "Zinc finger protein 720" Q7Z2F6 16 31713229-31794869 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA041570 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "Nucleoplasm, Plasma membrane" "HPA041570: AB_10795126" "unprognostic (5.52e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (8.30e-2)" "unprognostic (2.58e-1)" "unprognostic (2.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.82e-3)" "unprognostic (8.72e-2)" "unprognostic (5.94e-2)" "unprognostic (1.54e-1)" "unprognostic (8.91e-3)" "unprognostic (5.47e-3)" "unprognostic (3.70e-2)" "unprognostic (9.62e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-2)" 6.0 6.9 5.9 6.8 5.7 6.5 7.2 10.8 6.4 5.1 5.9 7.3 4.1 6.2 9.4 7.8 7.0 5.9 4.6 5.7 6.3 8.7 6.7 6.1 11.0 6.8 7.3 4.4 7.2 7.2 7.3 9.2 7.7 7.9 7.9 6.1 5.8 7.0 6.3 10.0 5.3 6.1 6.6 8.2 8.3 8.2 6.5 7.4 7.7 4.4 10.8 6.2 5.7 6.3 15.1 10.5 12.6 10.7 10.9 16.5 12.4 15.9 10.1 7.6 10.1 7.9 15.8 7.3 27.2 5.3 11.2 10.2 12.7 6.2 11.3 32.7 6.6 4.1 5.7 21.8 16.4 8.8 21.6 11.1 16.7 5.3 7.3 15.1 14.3 17.4 13.8 9.4 8.3 24.5 8.9 11.6 12.5 10.4 8.2 17.0 5.7 11.5 8.5 9.4 5.6 8.6 15.9 6.8 15.4 19.9 13.5 17.3 9.5 5.5 4.3 11.1 4.9 15.5 18.3 21.0 4.9 13.3 8.8 21.2 6.7 33.7 18.6 7.6 14.3 19.9 13.0 17.2 7.4 20.3 12.2 15.1 8.8 20.2 8.5 12.9 18.1 6.8 5.9 5.7 10.8 6.4 5.7 6.3 6.8 7.3 7.7 6.6 6.5 6.3 19.4 16.0 21.0 25.8 19.8 9.1 16.9 23.4 6.8 25.6 15.0 18.4 12.2 5.7 19.4 5.5 6.2 35.4 24.5 10.3 23.5 16.9 7.3 20.6 19.2 21.5 17.4 9.9 32.0 13.5 12.3 16.4 15.3 20.1 21.5 25.8 15.7 10.6 16.8 23.5 28.7 13.5 22.4 9.5 14.5 4.1 13.4 13.0 10.6 24.4 14.5 18.1 40.2 40.2 31.0 19.0 10.8 18.4 13.9 28.4 7.2 15.7 19.5 9.8 32.9 21.3 15.3 28.2 19.3 9.4 11.5 71.0 20.9 25.7 10.6 24.3 ZSCAN31 "ZNF310P, ZNF323" ENSG00000235109 "Zinc finger and SCAN domain containing 31" Q96LW9 6 28324693-28356271 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 138.5;Late spermatids: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 10 "basophil: 17.6" "Lineage enriched" "Detected in many" 10 "granulocytes: 17.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 29.5;EFO-21: 40.1;TIME: 31.0;U-2 OS: 47.6" "Low region specificity" "Detected in all" HPA007124 Approved Approved Nucleoplasm,Cytosol NA Yes "Cluster 18: Basophils - Vesicular transport" "Cluster 21: Non-specific - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Cytosol "HPA007124: AB_1080703" "unprognostic (1.11e-1)" "unprognostic (4.23e-2)" "unprognostic (3.54e-3)" "unprognostic (1.68e-1)" "unprognostic (2.45e-3)" "unprognostic (6.90e-2)" "unprognostic (2.77e-1)" "unprognostic (1.29e-2)" "unprognostic (2.41e-2)" "unprognostic (4.96e-2)" "unprognostic (6.07e-2)" "unprognostic (5.10e-2)" "prognostic favorable (2.19e-5)" "unprognostic (8.43e-3)" "unprognostic (6.22e-2)" "unprognostic (1.19e-1)" "unprognostic (5.64e-2)" 5.3 3.4 10.5 2.5 12.9 4.7 13.0 24.1 18.3 8.1 4.4 9.9 4.1 19.2 9.5 11.3 7.9 18.7 7.9 15.5 8.7 6.2 5.6 10.7 2.5 14.0 10.8 19.7 7.2 4.4 6.2 3.0 14.6 8.3 6.1 8.2 6.4 9.3 9.6 13.4 4.4 12.6 11.7 2.7 16.9 20.9 12.7 4.6 13.5 8.0 4.1 5.7 6.3 21.2 2.0 2.7 4.1 19.1 0.7 0.9 6.0 0.9 1.2 0.9 0.8 2.5 29.5 0.5 40.1 1.4 5.9 6.2 2.1 1.8 0.6 3.6 1.7 6.5 16.0 4.5 1.7 14.0 8.3 0.7 16.2 1.1 1.7 1.9 28.0 5.4 7.7 4.9 4.3 2.9 2.4 3.4 1.3 1.4 12.1 6.2 3.7 3.7 2.8 2.5 13.6 3.7 26.3 16.6 3.9 3.0 8.4 4.7 31.0 6.1 47.6 1.2 2.2 2.1 3.3 0.5 0.7 6.7 1.4 17.6 0.3 0.6 1.3 0.2 1.2 1.2 1.1 1.0 0.3 1.0 0.8 1.2 0.2 1.3 0.3 1.8 0.2 0.3 10.5 12.9 24.1 18.3 15.5 8.7 14.0 10.8 14.6 11.7 12.7 21.2 7.0 28.9 3.3 15.7 0.5 0.8 2.4 7.5 14.8 8.9 3.3 2.8 7.6 2.8 11.6 3.7 0.0 1.9 1.8 4.9 7.9 2.9 138.5 6.6 1.5 7.4 6.0 0.8 27.9 8.1 0.9 4.1 10.2 5.8 2.5 2.2 1.8 4.8 0.7 1.7 11.7 2.5 16.2 0.8 1.2 65.0 3.7 0.7 1.8 4.7 0.7 7.2 1.0 4.0 18.5 4.8 2.6 5.3 2.0 1.4 1.2 8.1 3.9 5.9 6.6 2.7 3.4 11.2 4.5 6.8 2.3 0.8 1.1 2.3 3.3 1.5